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Synopsis 
 
 
Brominated flame retardants (BFRs) and alkylphenols (APs) are pollutants commonly 
found within the environment and have human health concerns due to their endocrine 
disrupting and cytotoxic effects. BFRs are used to reduce the flammability of a variety 
of consumer products such as foam furnishings, whereas APs are found in plastic 
products used by the food industry. This study investigated the neurotoxicity of the 
most commonly used groups of BFRs and APs on SH-SY5Y human neuroblastoma 
cells. The results presented in this thesis showed (using cell viability assays) that these 
pollutants are toxic at low concentrations. Some compounds such as 
hexabromocyclododecane (HBCD) and 4-nonylphenol (4-NP) induce cell death 
(apoptosis) by caspases activation (Casp-8, Casp-9 and Casp-3) and cytochrome c 
release at low micromolar concentrations (IC50 ~ 4µM and 6µM, respectively). 
Consequently this study also showed that these compounds increased intracellular 
[Ca
2+
] levels and the production of reactive oxygen species (ROS) within SH-SY5Y 
cells by causing Ca
2+
-dependent depolarization of the mitochondria. In support of a 
Ca
2+
-mediated mechanism, the data presented here shows that some BFRs and APs 
inhibit Sarcoplasmic/ Endoplasmic Ca
2+
-ATPase (SERCA) and to corroborate this 
over-expressing SERCA1 improved cell viability especially in cells exposed to certain 
cytotoxic chemicals such as HBCD; this study is the first experiment of this type to be 
performed. This study also showed that some of these chemicals, at low 
concentrations had amyloidgenic effects causing the cleavage amyloid precursor 
protein (APP) into Beta-amyloid (Aβ) and could therefore be implicated in 
Alzheimer‟s disease (AD).  
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PVC:        polyvinylchloride  
ROCC:     receptor-operated Ca
2+
-channels   
RyRs:        ryanodine receptors   
ROS:         reactive oxygen species  
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SOCC:      store-operated Ca
2+
-channels  
SERCA:   sarco/endo plasmic reticulum Ca
2+ 
ATPase  
SMOC:     secondary messenger operated ion channel 
STIM:       stromal Interaction Molecule  
SPCAs:     secretory pathway Ca
2+ 
ATPase  
SLN:         sarcolipin 
SULT:      sulfotransferase enzymes  
SDS:         sodium dodecyl sulphate  
TRP:         transient Receptor Potential Channels,  
TM:           transmembrane  
Tg:             thapsigargin  
TBBPA:    tetrabromobisphenol A  
TNF:         tumor necrosis factor  
TNF-α:      tumor necrosis factor-α  
TRADD:   TNFR associated death domain  
TMBP:      1,1,3,3-tetramethylbutylphenol 
THs:          thyroid hormones  
T4:            3,3‟,5,5‟-tetraiodo-L thyronine  
T3:            3,3‟,5-triiodo-L-thyronine  
TRs:          thyroid hormone receptors  
TRH:         thyrotropin-releasing hormone  
TSH:          thyrotropin 
TCA:         trichloroacetic acid  
Thr:           threonine 
TTR:         transport protein transthyretin  
TNFRs:     tumor necrosis factor (TNF) receptors  
TRAIL:    TNF related apoptosis inducing ligand  
UDPGT:   UDP-glucuronosyl transferases  
VOCCs:    voltage-operated Ca
2+
-channels  
VSCCs:     voltage-sensitive Ca
2+
 channels  
Val:            valine 
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1.0-Introduction 
1.1- Background 
 
The human body contains many different organs, such as the brain, heart, lung, and 
kidney, with each organ performing a different function. Cells are the major structural 
and functional units of the body's functions (Shuster, 2003). However, cells use an 
enormous number of signaling pathways, which are part of a complex system of 
communication to regulate cellular activities and coordinate cell actions (Berridge et 
al., 1998). This ability to communicate within a cell or between cells is very 
significant for the correct integration, coordination and control of these cellular 
events, as any error in the translation of information may result in diseased conditions. 
 
1.2- Cell Communication 
 
Some cell-to-cell communication requires direct cell-cell contact. Some cells can 
form gap junctions that connect their cytoplasm to the cytoplasm of adjacent cells. 
Cell communication occurs through both electrical and chemical signals. 
Communication through electrical signals is found mainly in excitable systems, 
particularly in the heart and brain. It is usually fast and requires the cells to be coupled 
together. Communication can also be by a chemical stimulus like neurotransmitters 
(Kistler et al., 1982), hormones (Sugden et al., 2004) or growth factors (Carpenter 
and Cohen, 1990), which are released by one cell and move to communicate with 
another cell, thus altering in the activity of the target cell (Kistler et al., 1982). The 
latter has receptors capable of detecting the chemical signal and responds to it by 
producing secondary messengers which regulates many of the cellular processes, such 
as growth, metabolism, secretion and contraction (Berridge et al., 1998; Li  and 
Hristova, 2006). 
 
Stages of cell signaling are divided into three parts; signal reception, signal 
transduction, and cellular response. The transduction stage is the translation of 
extracellular signaling molecules (or ligands) to cell-surface receptors that face 
outward from the plasma membrane and trigger events inside the cell. Most processes 
of signal transduction involve ordered sequences of biochemical reactions inside the 
cell, which are carried out by enzymes and activated by second messengers. 
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Secondary messengers include, calcium ions (Ca
2+); 3‟,5‟-cyclic AMP (cAMP); 3‟,5‟-
cyclic GMP (cGMP); 1,2-diacylglycerol (DAG); phosphatidylinositol 3,4,5-
triphosphate (PIP3) and Inositol 1,4,5-triphosphate (IP3) (Berg et al., 2006; Berridge, 
2008a).  
 
Receptors can be divided into two major classes: intracellular receptors and cell-
surface receptors. Some receptors such as an ion channel-linked (Role, 1992; Gasic 
and Heinemann, 1991) or a tyrosine kinase-linked one (Porter and Vaillancourt, 
1998), may not utilize secondary messengers to detect extracellular signals, although 
their activation can lead to a cascade of intracellular signals. The receptor type on the 
target cell and the intracellular trigger induced by receptor-ligand binding determines 
the response of a cell to external stimuli. The phosphoinositide signaling and Ca
2+
 
signaling systems have been grouped together and form one major signaling pathway. 
The phosphoinositide pathway has been implicated in the regulation of a wide variety 
of cellular processes and diseases, i.e cell differentiation, apoptosis, cancer and 
Alzheimer's disease (Berridge, 2008a; Bunney and Katan, 2010; Fowler, 1997).  
 
1.3- Neurons 
 
The nervous system consists of nerve cells (neurons) and non-neuronal cells (glial 
cells which are known as support cells for the neurons in brain) (Azevedo et al., 
2009). Neurons are the basic structural and functional units of the nervous system. 
They transmit electrochemical impulses from the brain to different parts of the body. 
A neuron has three fundamental parts: the cell body (soma), the dendrites, and the 
single axon (fig. 1.1). The cell body is the main part and has all of the necessary 
components of the cell, such as the nucleus (contains DNA which controls cellular 
activity), endoplasmic reticulum and ribosomes (for building proteins) and 
mitochondria (for making energy) (Berridge, 2008b). The dendrites are cellular 
extensions with many branches, and its overall shape and structure is referred to as a 
dendritic tree. The dendrites are short, relative to the axon. The single axon comes off 
the cell body and transmits information away from the cell body to other neurons. The 
axon terminal contains synapses, which are specialized structures where 
neurotransmitter chemicals are released in order to communicate with adjacent 
neurons.  
 
- 21 - 
 
 
 
 
 
Figure 1.1: neuron structure (adapted from web site: 
www.health.howstuffworks.com/.../brain1.htm).  
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1.3.1- Signal transmission between neurons 
 
Neurons communicate with structures called synapses through a process called 
synaptic transmission. The synapse consists of the two neurons, one of which is 
sending information to the other. The sending neuron is known as the pre-synaptic 
neuron while the receiving neuron is known as the post-synaptic neuron. 
Communication among neurons is a chemical process via synapses. The process is 
initiated with a wave of electrochemical excitation called an action potential, when an 
action potential reaches a synapse; channels in the cell membrane are opened allowing 
an influx of Ca
2+
 (positively charged calcium ions) into the pre-synaptic terminal. 
This causes a small 'packet' of a chemical neurotransmitter to be released into the 
small gap between the two cells, known as the synaptic cleft. The neurotransmitter 
diffuses across the synaptic cleft and activates receptors on the pos-tsynaptic neuron. 
Ca2+ is essential for this transfer process (Berridge, 2008b). 
 
1.3.2 - Types of neurotransmitters 
 
Neurotransmitters can be divided into three classes. The first class is composed of 
monoamines such as norepinephrine, dopamine, serotonin and acetylcholine (Meyers, 
2000; Garraway and Hochman, 2001; Urban et al., 1989). The second class is 
composed of amino acids such as glutamic acid, glycine, gamma-amino butyric acid, 
(GABA), N-methyl-D-aspartate (NMDA) and aspartic acid (Meyers, 2000). The third 
classes of neurotransmitter are peptides. For example, they are compounds that 
contain at least two amino acid such as neurotensin, vasopressin, somatostatin, etc 
(van den Pol and Tsujimoto, 1985). However, once neurotransmitters have been 
secreted into synapses and have passed on their chemical signals, the pre-synaptic 
neuron clears the synapse of neurotransmitter molecules. For instance, acetylcholine 
is broken down by the enzyme acetylcholinesterase into choline and acetate (Beri  
and Gupta; 2007), while, neurotransmitters such as dopamine is removed by a 
physical process called reuptake, causing the neurotransmitters to re-enter the pre-
synaptic neuron, where they can be broken down by enzymes or re-packaged for reuse 
(Arias-Carrion and Poppel; 2007). 
 
Neurotransmitters can act as inhibitory or excitatory signals to the post-synaptic cell. 
A neurotransmitter binds and activates one or more types of receptors. These 
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receptors are classified into ionotropic and metabotropic receptors. Ionotropic 
receptors are ligand-gated ion channels that open or close through neurotransmitter 
binding. Metabotropic receptors (known as G protein-coupled receptors (GPCRs)), 
produce second messenger such as cAMP, IP3 and DAG. 
 
1.3.3- Roles of neurotransmitters in diseases 
 
There are many diseases that are caused by or associated with abnormalities in 
neurotransmitter pathways. Major types include:-  
 
 Alzheimer disease (AD) is known as a neurodegenerative disease characterized by 
reduced synthesis of the neurotransmitter; practically in acetylcholine. Patients of 
AD suffer from loss of intellectual capacity, disintegration of personality, mental 
confusion, hallucinations, and aggressive-even violent-behavior. These symptoms 
are the result of progressive degeneration in many types of neurons in the brain 
(Alloul et al., 1998; Wenk, 2003). 
 
 Parkinson disease (PD) is a degenerative disorder of the central nervous system 
(CNS) which is caused by deficiency of neurotransmitter dopamine. PD belongs 
to a group of conditions called movement disorders. The clinical features of PD 
include weakens in motor skills, speech, muscle rigidity, tremor, a slowing of 
physical movement (bradykinesia), and in extreme cases, a loss of physical 
movement (akinesia) (Di- Monte et al., 2002; Jankovic, 2008). 
 
 Myasthenia Gravis (MG) is a neuromuscular disease leading to muscle weakness. 
MG is caused by circulating antibodies that block the acetylcholine receptor 
(ACRs) at the post-synaptic neuromuscular junction, inhibiting the stimulatory 
effect of the neurotransmitter acetylcholine (Conti-Fine et al., 2006; Lane et al., 
2009). 
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1.4 - Neuronal calcium 
 
Neurons modulate Ca
2+
 signals by regulating the influx of Ca
2+ 
into the cell from the 
extracellular environment or by its release from internal organelles such as the 
endoplasmic reticulum (ER) (Michelangeli et al., 2005). The ER is an essential 
intracellular organelle involved in calcium homeostasis, and in the folding and 
processing of proteins (Baumann and Walz, 2001). 
 
The concentration of cytosolic free Ca
2+
 (intracellular [Ca
2+
]i) in most neurons at rest 
is about 100nM. This very low resting concentration is raised rapidly to the low 
micromolar (0.5-1µM) range when specifically stimulated (Burgoyne and Petersen, 
1997). Increased [Ca
2+
]i is vital for the effective regulation of numerous cellular 
functions, in particular synaptic plasticity  and memory (Berridge et al., 1998). It is 
essential for a resting cell to maintain a low cytosolic Ca
2+ 
concentration or regain the 
resting Ca
2+
 level, immediately after an agonist-induced response; otherwise this 
could lead to adverse effects such as apoptosis. The level of free [Ca
2+
]i is regulated 
and maintained at approximately 100 nM through the action of a number of binding 
proteins and transport mechanisms. Some signals can open Ca
2+
 channels in the cell 
membrane to allow Ca
2+
 entry (Miller, 2001). The Na
+
/ Ca
2+ 
exchanger (NCX, also 
known as NCE) and the plasmalemma Ca
2+
-ATPase, can pump Ca
2+ 
out of the cell 
(Carafoli, 1992), while the sarco/endo plasmic reticulum Ca
2+ 
ATPase (SERCA) 
pump Ca
2+ 
back into the intracellular stores (fig. 1.2) (Rosado et al., 2004; Pozzan et 
al., 1994; Berridge et al., 2000).  
 
The main Ca
2+ 
stores in cells are in the lumen of the ER. Studies have also 
demonstrated that the Golgi apparatus may be a Ca
2+
 store in a variety of cells (Hu et 
al., 2000; Sudbrak et al. 2000; Michelangeli et al., 2005), where the Ca
2+ 
concentration approaches 500-1000 μM (Mogami et al., 1998; Alvarez et al., 1999), 
which is about 10000 times higher than within the cytosol. Ca
2+ 
release from the ER 
occurs through two types of calcium channel: ryanodine receptors (RyRs) and 
inositol-1,4,5-trisphosphate receptors (IP3Rs) (Berridge et al., 2000). Furthermore, 
SERCA Ca
2+
 pumps helps to maintain low cytosolic resting Ca
2+
 level by actively 
pumping Ca
2+
 from the cytosol into the ER stores (Ogunbayo and, Michelangeli, 
2007). 
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Figure 1.2: mechanisms of calcium signalling. Cell stimulation by agonists 
activates the formation of second messengers that induce the release of Ca
2+
 stored in 
the ER through IP3R and RyR. In addition, agonists stimulate the entry of 
extracellular Ca
2+
 through plasma membrane channels. Most of the cytosolic Ca
2+
 is 
bound to to Ca
2+ 
binding protein, and only a small percentage binds to effectors and 
activates cellular functions. Ca
2+
 removal is mediated by various pumps and 
exchangers, including the NCX and the plasma membrane Ca
2+
-ATPase (PMCA) that 
extrude Ca
2+
 from the cytosol and the SERCA that pumps Ca
2+
 back to the ER. 
During the Ca
2+
 signal mitochondria sequester Ca
2+
 through an uniporter that might 
be then released slowly into the cytoplasm through the NCX or the permeability 
transition pore (PTP) (Rosado et al., 2004). 
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1.5- Ca
2+
 entry (influx) Channels 
 
The entry of Ca
2+
 across the plasma membrane of a cell is by activating many Ca
2+
 
influx channels, which open in response to different external signals. They can be 
divided into groups on the basis of their activation mechanisms (Berridge et al., 
2000). These include:- 
 
I- Voltage-operated Ca
2+
-channels (VOCCs)- such as dihydropyridine (DHP)-
sensitive Ca
2+
 receptor (Lu et al., 1995; Bers, 2002; 2004).  
II- Receptor-operated Ca
2+
 channels (ROCCs)- such as N-methyl-D-aspartate receptor 
(NMDAR) and glutamate receptor (Bertolino and Llinas, 1992; Bootman et al., 
2001). 
 
III- Store-operated Ca
2+
-channels (SOCCs)- such as Transient Receptor Potential 
(TRP) Channels, Stromal Interaction Molecule (STIM) and Orai (Huang et al., 2006; 
Yeromin et al., 2006; Guo and Huang, 2008). 
 
 
1.6- Ca
2+
 release (efflux) channels 
 
Release of Ca
2+
 from the intracellular stores that are implanted in the ER is mediated 
by several different types of messenger-activated channels, and potentially by 
activation of the mitochondrial PTP. IP3Rs and RyRs are the most important channels, 
which regulate the release of Ca
2+
. These channels are sensitive to Ca
2+
, and this Ca
2+
-
induced Ca
2+
 release (CICR) process contributes to the rapid rise of Ca
2+
 levels during 
the “on reaction” and plays a central role in the development of regenerative Ca2+ 
waves (Bootman et al., 2001). Nicotinic acid–adenine dinucleotide phosphate 
(NAADP) has also been proposed to be involved in intracellular Ca
2+ 
release from 
lysosomal Ca
2+
 stores (Churchill et al., 2002; Boittin et al., 2002; Kinnear et al., 
2004). 
 
 
1.6.1- Inositol 1,4,5-trisphosphate receptors (IP3Rs) 
 
The IP3R is one of the Ca
2+
 channels found within the membrane of the ER and 
belongs to a group of the secondary messenger operated ion channel (SMOC), which 
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plays a key role in the Ca
2+
 signaling used during learning and memory (Berridge et 
al., 2000). From molecular studies, IP3Rs are large structures composed of four 
subunits (total molecular mass about 1200 kDa). Three IP3R isoforms have been 
identified: IP3R type 1 (IP3R1), IP3R type 2 (IP3R2), and IP3R type 3 (IP3R3), which 
are derived from three different genes and each of them, has different affinity to IP3 
(Patel et al., 1999, Yamamoto-Hino et al., 1994; Iwai et al., 2005; Dyer and 
Michelangeli, 2001) Furthermore, analysis of IP3R expression has shown that both 
homomeric and heteromeric IP3Rs exist in different tissues/cells (Taylor et al., 1999).  
 
IP3 is water soluble and produced from lipid breakdown. Elevation of cytosolic Ca
2+ 
through IP3Rs requires the activation of G proteins on the cell surface which leads to 
the activation of an enzyme phospholipase C (PLC), which catalyses the cleavage of 
phospholipids to PIP2 to produce the intracellular messenger DAG and IP3 (Berridge 
et al., 2000). IP3 diffuses into the cytosol and binds the IP3R increasing its sensitivity 
to Ca
2+
 (Kasri et al., 2004; Taylor, 2002), resulting in a rise in cytosolic Ca
2+ 
level. 
After the activation of IP3R, the IP3 is then inactivated either by phosphorylation (to 
IP4) or dephosphorylation (to IP2) and the IP3R is restored to the unstimulated state by 
an inactivation process (Dyer and Michelangeli, 2001). The IP3R can be 
phosphorylated by protein kinases, such as PKA, PKC, PKG, PKB and CaMKII 
(Ferris et al., 1992; Wojcikiewicz and Luo, 1998; Szado et al., 2008). The 
consensus sites of phosphorylation for many different protein kinases are present in 
the primary sequence of all IP3R isomers. IP3R1 can be phosphorylated by PKA at 
two sites located in the regulatory domain (Suppatapone et al., 1988).  
 
IP3R has a long N-terminal and short C-terminal with six transmembrane domains 
(M1-M6) located near C-terminal region (Mikoshiba, 2007). The type 1 IP3R isoform 
is expressed in neurons such as SH-SY5Y cells (Mackrill et al., 1997) and 
structurally divided into five different domains according to function: an N-terminal 
coupling domain (or suppressor domain), an IP3-binding core domain, a modulatory 
domain (also known as an internal coupling domain), a transmembrane/ channel-
forming domain, and a gatekeeper domain. The IP3-binding signal is transmitted by 
the N-terminal coupling domain and the modulatory domain to the C-terminal tail 
(gatekeeper domain and transmembrane/ channel-forming domain), which triggers a 
conformational change in the activation gate (opening) (Mikoshiba, 2007) (fig.1.3). 
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Figure 1.3: the structure of IP3Rs 
Five domains structural model of IP3R1, which triggers a conformational change in 
the activation gate channels (Mikoshiba, 2007). 
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1.6.2- Ryanodine receptors (RyRs) 
 
RyRs is another channel by which Ca
2+ 
is
 
mobilized from intracellular stores 
(Berridge et al., 2000; Carafoli, 2002; Fill and Capello, 2002).  
 
RyR channels are formed by the assembly of four subunits with a large cytoplasmic 
assembly and a small transmembrane region. Three different isoforms of RyRs, each 
encoded by a different gene on different chromosomes with specific tissue 
distributions and distinct functions have now been identified in mammals, designated 
as skeletal (RyR1) (Fleischer et al., 2008), RyR2 was identified in neurons (SH-
SY5Y cells) (Mackrill et al., 1997) and cardiac cells, and most other tissues express 
RyR3 or a combination of all three isoforms (Fleischer et al., 2008). Each channel is 
composed of four identical subunits that contain about 5,000 residues aas in length (~ 
560 kDa) depending on the isoform (Du et al., 2002; Fleischer et al., 2008). The 
primary domain of the RyR is present upon the cytosolic face of the membrane 
(known as the “foot” region) (fig. 1.4). 
 
Each subunit consists of a cytoplasmic region and a transmembrane (TM) domain (Du 
et al., 2002). Based on sequence analysis, RyR proteins contain at least two functional 
domains: a large N-terminal cytoplasmic domain (about 4500 aas) and C-terminal 
(about 500 amino acids) region. The large cytoplasmic domain containing many of 
the regulatory and several binding sites for modulators such as calmodulin (CaM), 
FK-506-binding proteins (FKBP), high and low affinity binding sites for Ca
2+
, as well 
as phosphorylation sites (protein kinase A (PKA), phosphatases 1 and 2A (PP1, 
PP2A) (Wagenknecht et al., 1997; Williams et al., 2001). However, several models 
have predicted 4, 6 and 10 TM-spanning segments, but the consensus is for six (Bers, 
2004) (fig. 1.4). 
 
The RyR channels activity are modulated by numerous factors, involving a number of 
physiological agents (e.g., Ca
2+
, ATP, and Mg
2+
), various cellular processes (e.g., 
phosphorylation, oxidation, etc.), and many pharmacological agents (e.g., Ryanodine, 
Caffeine, Tetracaine, and Ruthenium red) (Franzini-Armstrong and Protasi, 1997; 
Shoshan-Barmatz and Ashley, 1998). Moreover, the three known isoforms have 
different sensitivities to Ca
2+
, whereas only RyR1 isoforms is activation by Ca
2+
 at 
bell-shaped response (Sarkozi et al., 2000). 
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Figure 1.4: schematic showing the predicted structure of the RyR2, including the 
sites of interaction with ancillary proteins and the phosphorylation sites. Proteins 
interacting with RyR in the ER are also depicted. Protein phosphatase (PP); 
phosphorylation sites (P); calmodulin (CaM) (adapted from Bers, 2004). 
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1.6.3- Permeability transition pore channels of mitochondria 
 
Mitochondria have been known as key regulators of cell death (apoptosis) through the 
release of mitochondrial proteins such as cytochrome c by mitochondrial permeability 
transition pore (PTP) (Bernardi et al., 1999; Halestrap et al., 1997). The PTP is a 
channel found in the outer mitochondrial membranes and is regulated by pro-
apoptotic members of the Bcl-2 family (Bax and Bak) (Isenberg and Klaunig, 2000; 
Tsujimoto and Shimizu, 2007). PTP can also release large amounts of 
mitochondrially stored Ca
2+
 into the cytoplasm when opened (Bernardi et al., 1999). 
 
1.7- The Ca
2+ 
Pumps  
 
Ca
2+ 
transport ATPases are ion pumps which belong to a large family of membrane 
proteins that are responsible for the active transport of cations across biological 
membranes. There are at least three members of these ATPase pumps essential for 
cellular Ca
2+
 homeostasis: (i) the Plasma membrane Ca
2+
-ATPase (PMCAs) (Shull 
and Greeb, 1988; Strehler et al., 1990; Carafoli, 1994; Strehler and Zacharias, 
2001); (ii) the Sarcoplasmic / Endoplasmic Ca
2+
-ATPase (SERCA) (MacLennan et 
al., 1985; Brandl et al., 1986; Burk et al., 1989); (iii) the Secretory pathway Ca
2+ 
ATPase (SPCAs) (Gunteski-Hamblin et al., 1992; Ton et al., 2002; Wuytack et al., 
2003; Shull et al., 2003; Van Baelen et al., 2001; Wootton et al., 2004). These 
pumps depend on the auto-phosphorylation of a conserved aspartic acid residue, 
utilizing ATP and forming a phosphorylated intermediate during the reaction cycle 
(Axelsen and Palmgren, 1998). PMCAs and SERCAs play a vital role in 
maintaining Ca
2+
 homeostasis, controlling contractility and contributing to excitably 
and cell signalling in smooth muscle (Floyd and Wray, 2007). They fundamentally 
exhibit the same basic properties, such as, membrane topography and high affinity for 
Ca
2+
, but are different in their functional properties for example; SERCAs are 
inhibited by thapsigargin, while PMCAs and the SPCAs are not. Additionally, 
PMCAs are stimulated by fatty acids, while SERCAs are inhibited (Carafoli and 
Brini, 2000). As this project essentially focuses on SERCA, this will only be 
considered in further detail. 
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1.7.1- The Sarco/Endoplasmic Reticulum Ca
2+
-ATPases (SERCA) 
 
 
SERCA represent a highly conserved family of Ca
2+
-ATPase pumps which actively 
transport two Ca
2+ 
ions from the cytosol into the lumenal side of the SR/ER against a 
large concentration gradient (in exchange for 2 or 3 H
+ 
per one ATP hydrolysed) 
(Carafoli and Brini, 2000; Inesi, 1987). SERCA is an integral membrane protein 
with molecular mass ~110 KDa, consisting of a single polypeptide chain 
(MacLennan et al., 1985). Three genes have been identified which code for SERCA 
pumps (SERCA 1, SERCA 2 and SERCA 3) In the human, these genes are located on 
chromosomes 16, 12 and 17, respectively and the genes products can also be 
expressed in a number of spliced variants (Dode et al., 1996; MacLennan et al., 
1987; Floyd and Wray, 2007).  
 
 
1.7.1.1- Characteristics of the different isoforms of SERCA 
 
SERCA1a and -1b are expressed in skeletal muscle (adult and neonatal, respectively),                                                                                                                                                          
whereas SERCA2a is expressed in cardiac muscle (Aubier and Viires, 1998; Green 
et al., 2009) and SERCA2b is the major ER Ca
2+
-ATPase in non-muscle tissues, is 
expressed in the heart, smooth muscle and neuronal tissues (Lytton et al., 1989; 
Baba-Aissa et al., 1998). Moreover, SERCA 1 is exclusively expressed in fast 
skeletal muscles, and it is of high concentration in adults, representing up to 80 % of 
the total protein of the SR of striated muscle (Michelangeli and Munkonge, 1991). 
SERCA3 has limited expression in various non-muscle tissues (Baba-Aissa et al. 
1998; Martin et al., 2002, Green et al., 2009). In humans, six different splice 
variants of SERCA3 are known (SERCA3a-f) (Bobe et al., 2004). 
 
 
1.7.1.2- Regulation of SERCA activity  
 
Due to the prominent importance of SERCA for the control of [Ca
2+
]i changes in 
many cell types, any modulation of its activity should have a considerable effect upon 
Ca
2+
 homeostasis, the regulation of SERCA in vivo is comparatively limited. 
Therefore, SERCA pump activity is regulated by two different proteins; 
Phospholamban
 
(found in the heart) (Simmerman and Jones, 1998) and (ii) 
Sarcolipin (found in fast-twitch skeletal muscle) (Odermatt et al., 1997).  
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1.7.1.3- Molecular structure of SERCA 
 
 
The SERCA pump functions as an H
+ 
exchanger, where the translocation of Ca
2+ 
ions 
is coupled to the liberation of protons into the cytoplasm, at the expense of ATP 
hydrolysis (Inesi, 1987). The pump may be catalytically active as a monomer; 
however, Carafoli and Brini (2000) have shown that oligomerization is needed for 
transport function. The Ca
2+ 
-ATPase comprises a large cytoplasmic headpiece, short 
lumenal loops and a transmembrane domain made of 10 transmembrane α-helices 
(M1-M10) (with exception of SERCA2b, which has 11) (Toyoshima and Inesi, 
2004). Both the C- and N-termini protrude into the cytosol (with the exception of 
SERCA2b). The cytoplasmic headpiece consists of three domains, which are 
represented as A (actuator), N (nucleotide binding) and P (phosphorylation) domains. 
The A domain functions as the „actuator‟ of the gating mechanism that regulates the 
binding and release of Ca
2+
, while the N domain contains the binding site for ATP 
(Toyoshima et al., 2000) (fig. 1.5).  
 
 
All the three cytoplasmic domains (A, P and N) of the ATPase are broadly spaced in 
the Ca
2+ 
bound form (E1Ca
2+
) and more closely associated in the Ca
2+ 
free and 
thapsigargin (Tg)-bound structure, E2(Tg) (Toyoshima et al., 2000; Toyoshima and 
Nomura, 2002). During the subsequent hydrolysis of E2-P to E2, the compactly 
organized state of the cytoplasmic domains becomes more relaxed (Danko et al., 
2001a; Danko et al., 2001b), and the postulated Ca
2+ 
release pathway (M3-M5) 
(Toyoshima et al., 2000) and lumenal gate should be closed (Toyoshima and 
Nomura, 2002) to prevent possible Ca
2+ 
leakage, and prepare for the entry of new 
Ca
2+ 
from the cytoplasmic side to the transport sites (Toyoshima and Nomura, 
2002).  
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Figure 1.5 shows the crystal structure of SERCA 1a in the two conformational 
states (E1 and E2). The conformational change of SERCA by Ca
2+
 was established 
from the crystal structures of (A) the E2-thapsigargin (Tg) form and (B) the E1Ca2 
form of SERCA1a. There are three different domains in the cytoplasmic region (A 
domain, actuator; N domain, nucleotide-binding domain; P domain, phosphorylation 
domain) that are close to each other in the E2 Tg form. When Ca
2+
 binds to SERCA1a 
(E1 Ca2 form), these three domains are separated, allowing ATP to bind to SERCA1a. 
At the same time, large-scale rearrangements in 6 of the 10 transmembrane helices are 
induced. By hydrolysis of ATP, Ca
2+
 is released into the lumen of the SR, changing 
conformationally to E2 form and creating a pathway for entry of new calcium ions on 
the cytoplasmic side. These are cartoon representations based on the two forms of the 
crystal structures of SERCA1a (modified figure from Asahi et al., 2003). 
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1.7.1.4- Catalysis and transport mechanism of SERCA 
 
The catalysis and transport mechanism of SERCA is via alternation of enzyme 
between two major conformational states, known as E1 and E2 (de Meis and Vianna, 
1979; de Meis, 2000; Danko et al., 2004). In the catalytic cycle, the ATPase is 
activated by the binding of two Ca
2+ 
ions at high affinity transport sites (Ca2-E1) 
(fig.1.6). The transition between the two states (E1 and E2) is dependent on many 
factors, including the presence of Ca
2+
, ATP and Mg
2+
, in addition to pH and 
temperature. Phosphorylation at Asp
351
 with MgATP to form the ADP-sensitive 
phosphoenzyme (E1-P). Upon this E1-P formation, the two bound Ca
2+
 are occluded 
in the Ca
2+ 
binding sites (E1-P.Ca2 and transforms the enzyme into an E2 
conformation. During this conformational change, Ca
2+ 
is then released from the 
binding site as a result of a decrease in Ca
2+ 
affinity associated with the 
transformation of E1 to E2 state and Ca
2+ 
passes through the ATPase into the lumen. 
Finally, Asp
351
-acylphosphate in E2-P is hydrolyzed to form the Ca
2+
-unbound 
inactive E2 state. Mg
2+
 bound at the catalytic site is required as a physiological 
catalytic cofactor in phosphorylation and dephosphorylation and consequently for the 
transport cycle. (MacLennan et al., 1997; McIntosh et al., 1998; Wuytack et al., 
2002; Toyoshima and Inesi, 2004; Toyoshima, 2008; 2009).  
 
1.7.1.5- ATP binding and phosphorylation  
 
Binding of ATP to the Ca
2+
-ATPase in the presence of Ca
2+
 leads to closer 
rearrangements of the N and P domains, so that the terminal phosphate of ATP bound 
to the N domain come into contact to Asp
351 
(D351), which is the residue of 
phosphorylation in the P domain (Hua et al., 2002). Further, it is hypothesized that 
Ca
2+ 
binding somehow triggers movement within the transmembrane domains to 
allow movement in the A domain. This domain in turn, acts on the N domain by 
bringing it closer to the P domain (fig. 1.7) (Toyoshima et al., 2000). The movement 
of the A domain upon Ca
2+ 
binding is quite substantial. 
 
The N domain contains the adenosine binding pocket formed by residues including 
Phe
487
, Lys
492
, and Lys
515
. Lys
515
 is actually located in the depth of the ATP binding 
packet (fig. 1.7) (Toyoshima et al., 2000), and not over the mouth of it, as previously 
suggested (Pick, 1981).  
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. 
Figure 1.6: scheme of Ca
2+
transport cycle of SERCA (Wuytack et al., 2002). 
 
 
 
 
 
Figure  1.7: schematic models for four distinct arrangements of the three 
cytoplasmic domains in the reaction cycle of Ca
2+
-ATPase. D351 (Asp
351
) is the 
residue of phosphorylation. Transfer of “occluded” Ca2+ to the lumenal side is thought 
to take place between E1P and E2P (Toyoshima and Inesi, 2004). 
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Because of the high resolution of SERCA structures to 1.9Å, Toyoshima and Inesi 
(2004) assumed that since the position of the A domain is affected by the N and P 
domains, the interfaces between them must be critical and should be altered during 
ATPase reaction cycle. These researchers elucidated that phosphorylation or the 
binding of the γ-phosphate (which accompanies the dissociation of Mg2+ from ATP 
and the binding of Mg
2+ 
to the P domain around Asp
703
) makes the position of the 
hinge between the N and the P domains substantially higher and also alters the 
direction of the inclination of the N domain. They suggested that this Mg
2+ 
bound to 
the P domain directly alters the position of the A domain in E2-P and therefore, one of 
the roles of phosphorylation is to change the interface between the cytoplasmic 
domains. 
 
Although ATP can bind to the ATPase in the absence of Ca
2+
, the reaction cycle 
cannot proceed without Ca
2+
. With the arrangement of the cytoplasmic domains in the 
E2, the γ-phosphate of ATP comes close to, but cannot reach the phosphorylation 
residue, Asp
351
. However, in the presence of Ca
2+
, the transmembrane helices will 
shift into different positions and will prevent the tilting of the P domain to form a 
close configuration, thus, resulting in a deeper inclination of the N domain or the 
rotation of the A domain which will consequently release the N domain (Toyoshima 
and Nomura, 2002). Interestingly, the rotation of the A domain occurs during the 
transition of E1-P to E2-P (Danko et al., 2001a), and the enzymatic cleavage of the 
link between this domain and the M3 helix, results in the complete inhibition of the 
ATPase activity (Juul and Moller, 2003; Jorgensen and Collins, 1986). Since the 
position of the A domain regulates the gates from and to the binding sites, it has to be 
fixed in the E2 conformation by the N and P domain (Toyoshima and Inesi, 2004). 
The closed configuration of the cytoplasmic domains in the E2 conformation will thus 
limit thermal movements of the transmembrane helices and therefore the leakage.  
 
1.7.1.6- Beta-amyloid production is regulated by SERCA activity 
 
Alzheimer‟s disease (AD) is a progressive neurodegenerative disorder and the most 
common form of dementia in the elderly (Yamin et al., 1999; Wang et al., 2002). 
The AD is associated with accumulation of Beta-amyloid (Aβ) deposits in senile 
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plaques and neurofibrillary tangles (NFTs) lesions in specific areas of brain (Jang 
and Surh, 2003; Kayed et al., 2003). Aβ is a peptide composed of 38-43 amino acids 
and a proteolytic product of a large precursor protein (amyloid precursor protein; 
APP) through the α-, β- and -secretase (Selkoe, 1994; Checler, 1995). β-secretase 
(called BACE) works as a single protein, while -secretase is formed by at least four 
proteins: presenilin (PS), nicastrin, anterior pharynx (Aph-1) and presenilin enhancer 
2 (Pen-2). Presenilins (PS1 and PS2) are of exceptional pathophysiological 
importance because association with other protein forms the -secretase complex 
(Imbimbo, 2008). Further, the presenilins are an integral part of the -secretase 
complex that is responsible for cleavage of the C99 fragment of APP to form Aβ and 
the APP intracellular domain (AICD) (Green et al., 2008). Also, PS and APP 
mutations are the primary cause of familial AD (Hwang et al., 2002; Patel and 
Brewer, 2003).  
 
Several studies have shown that the ER stress has been implicated in many diseases, 
including neurodegenerative conditions such as AD (Nakagawa et al., 2000; Reddy, 
2006) also, increasing intracellular Ca
2+
 will invariably alter the activity of SERCA 
(Yano et al., 2004). 
 
A recent study by Green et al. (2008) found that modulation of SERCA (SERCA2b) 
affected Aβ production. Reduced SERCA pump activity lead to decreased Aβ 
production and increased SERCA activity lead to increased formation of Aβ. This 
observation suggests that activity of SERCA has a modulatory role in -secretase 
function or can increase in cleavage of APP, which then leads to more generation of 
the Aβ peptide. However, it has been showed that both stimulation (Pierrot et al., 
2004) and inhibition (Yoo et al., 2000) of capacitative Ca
2+
 entrance (CCE) via 
SOCCs also caused increased production of Aβ (Aβ 1-42).  
 
1.7.1.7- Pharmacological modulators of SERCA Ca
2+ 
pumps 
 
Many pharmacological agents have been used to study the regulation of the SERCA 
Ca
2+ 
pumps, most of which act as inhibitors. These inhibitors have proved invaluable 
in helping to elucidate mechanistic steps within the Ca
2+
 transport process (Wictome 
et al., 1992a; Longland et al., 1999; Wootton and Michelangeli, 2006).  
- 39 - 
 
A- Thapsigargin 
 
The best known inhibitor of the SERCA Ca
2+
 pump is Thapsigargin (Tg), a potent and 
specific inhibitor of all SERCA isoforms (Lytton et al., 1991). Tg was first shown to 
increase free cytosolic Ca
2+ 
concentration in platelets (Ali et al., 1985) and later 
shown to inhibit the Ca
2+
ATPase activity (Sagara and Inesi, 1991), indicating that it 
triggers Ca
2+ 
release from the intracellular stores as a result of leakage, rather than 
through a specific Ca
2+ 
channel (Thastrup et al., 1990). Tg has been shown to be a 
specific inhibitor of the SERCA pumps, having little effect on the plasma membrane 
Ca
2+
-ATPase or any ATP and Ca
2+ 
-dependent ion channel (Sagara and Inesi et al., 
1991). Tg has been observed to reduce the affinity of ATPase for Ca
2+ 
binding in a 
non-cooperative manner, since an increase in concentration of Tg beyond a 1:1 ratio 
with the ATPase did not cause any further decrease in the Ca
2+ 
binding affinity 
(Wictome et al., 1995).  
 
B- Estrogenic compounds  
 
The majority of estrogenic compounds contain phenolic groups which have the 
pathobiological effects on human cells (Chang et al., 2000). Further, some of these 
chemicals can act as xenoestrogens (pollutants, which mimic estrogens or 
antiestrogens but have toxic properties on humans and animals). Estrogens are 
hydrophobic steroid hormones that control cell proliferation and differentiation (Olea 
et al., 1998). Estrogenic alkylphenols have also been shown to inhibit SERCA pump 
activity (Hughes et al., 2000; Sokolove et al., 1986; Michelangeli et al., 2008). 
Consequently, such disruption in the tight regulation of cellular Ca
2+ 
can lead to 
deleterious effects, such as, apoptosis (Hughes et al., 2000; Michelangeli et al., 
2008). Therefore, these compounds affect other cell signaling pathways in addition to 
affecting steroid-signaling pathways. There are however other known inhibitors of the 
SERCA family such as 4-n-nonylphenol (NP), bis-phenol A (BPA), 3,5-dibutyl-4-
hydroxytoleuene (BHT), butylated hydroxyanisole (BHA) (Sokolove et al., 1986), 
quercetin (Shoshan and MacLennan, 1981), 1,1,3,3-tetramethylbutylphenol, 
diethystibestrol (DES) (Khan, 2001) and BFRs (TBBPA) (Ogunbayo et al., 2007). 
Another compound 2,5-di (tert-butyl)-1,4-benzohydroquinone (BHQ) has also been 
shown to be a potent inhibitor of the ATPase (IC50 was 0.4 μM) (Wictome et al., 
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1992b). However, BHQ, though having a similar inhibitory effect as Tg, does not 
bind to the same site on the ATPase (Khan et al., 1995; Obara et al., 2005; 
Ogunbayo and Michelangeli, 2007).   
 
1.8- Apoptosis and Caspases 
 
There are two essential types of cell death; apoptosis and necrosis (Geske and 
Gerschenson, 2001; Kiechle and Zhang, 2002). Cellular necrosis occurs as a result 
of cell injury or exposure to certain cytotoxic chemicals, is distinct from apoptosis in 
both morphological and biochemical characteristics. Necrotic cell death begins with 
swelling of cell and mitochondrial contents, followed by rupture of the cell membrane 
(Manjo and Joris, 1995; Kanduc et al., 2002), whereas apoptosis (programmed cell 
death (PCD)) is a normal part of organismal development or a response to stressful 
environmental conditions and that usually is adaptive (White, 1996; Gray, 2004; 
Potten and Wilson, 2004). Further, apoptosis is a form of cellular suicide that 
involves DNA fragmentation, membrane blebbing, cell shrinkage and disassembly 
into membrane-enclosed vesicles and is also under strict control. Excessive apoptosis 
can cause number of clinical disorders such as neurodegenerative diseases and 
ischemic damage (ischemia occurs because of a lack of oxygen and nutrients), 
whereas disorders such as cancer and autoimmune diseases can be caused by 
insufficient apoptosis (Earnshaw et al., 1999). 
 
Apoptosis is classically divided into three sequential phases: the induction phase, the 
commitment phase, and the execution phase. During the execution phase, all the 
morphological characteristics of apoptosis occur, and the cell loses viability. Once 
this phase begins, death becomes irreversible (McCarthy et al., 1997). This phase is 
initiated by the activation of several subsets of proteases, called caspases. The name 
caspase derives from cysteine-dependent aspartate specific protease (Alnemri et al., 
1996). Caspases are essential in cells for apoptosis, and development. In most 
mammalian cells, there are fourteen caspases of which only eleven are found in 
humans (Wolf and Green, 1999; Stegh and Peter, 2002). Caspase-1 is the founding 
member of the caspases family, which was initially identified based on its ability to 
cleave pro-interleukin-1b to the mature cytokine. Other caspases are numbered in 
order of identification with caspase -3, -8 and -9 being most important in this study. 
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1.8.1- Structure of caspases 
 
All caspases are found as inactive pro-forms or zymogens (procaspases) within the 
cell cytoplasm (Nicholson and Thornberry, 1997). All procaspases contain a highly 
homologous protease domain. This domain can be further subdivided into two 
subunits, a large subunit of approximately 20 kDa and a small subunit of 
approximately 10 kDa (Chang et al., 2000; Fuentes-Prior and Salvesen, 2004). 
Furthermore, x-ray crystal structure and peptide sequencing studies have shown that 
procaspases can be divided into three major parts: a 17-21 kDa central large internal 
domain (p20) containing a large catalytic subunit (active site), a 10-13 kDa small C-
terminal domain (p10) also called small catalytic subunit, and a 3-24 kDa N-terminal 
prodomain which can bind to death domain (DD). In most of procaspases, the p20 and 
p10 subunits are sometimes separated by a small linker sequence. The large N-
terminal prodomains of procaspases contain 80-100 residue long structural motifs, 
called death domain superfamily, are involved in the transduction of apoptotic signals 
(Martinon et al., 2001; Weber and Vincenz, 2001; Kumar, 2007). The procaspases 
prodomains have three subdomains, DD, the death effector domain (DED) and the 
caspase-recruitment domain (CARD) (Fesik, 2000; Kumar, 2007). Also, caspases 
can be subdivided into three groups based on protein structure and putative function: 
the first group is classified as cytokine activators, this includes members of the 
caspase-1 subfamily with large prodomains (which also include caspase-1, -4, -5, -12, 
and -13); they are involved in the inflammatory process and called group-I caspases 
or inflammatory caspases (Deveraux et al., 1998). Second group of caspases with a 
long prodomain, include caspase -2, -8, -9, and -10; this group contains either DED 
domains (example include caspase -8 and -10) or CARD (example include caspase -2 
and -9) and are also called upstream initiator of apoptosis caspases or group-II (Zou 
et al., 1997). A third group contain short prodomains (20-30 amino acids) are called 
downstream executioners of apoptosis or group-III caspases, which include the 
caspases-3 subfamily (i.e. caspase -3, -6, and -7) (Deveraux et al., 1997, 1998; Xu et 
al., 2001). Caspase-14 has role in supporting the terminal differentiation of 
keratinocytes in the epidermis and cornea without promoting the characteristic 
features of apoptosis (Kuechle et al., 2001; Sanchez Mejia et al., 2001). Two 
tandem copies of DEDs are found in prodomains of procaspases-8 and -10 (Muzio et 
al., 1996; Sprick et al., 2002), whereas, the CARD is establish in procaspases-1, -2, -
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4, -5, -9, -11, and -12 (Fuentes-Prior and Salvesen, 2004; Lamkanfi et al., 2005). 
Further, DED and CARD are responsible for the recruitment of initiator caspases into 
death or inflammation-inducing signaling complexes, resulting in proteolytic 
autoactivation of caspases that afterward initiates apoptosis (Eckhart et al., 2005; 
Kumar, 2007).  
 
1.8.2- Substrate specificity of caspases 
 
Caspases commonly recognize a four amino acid sequence on their substrates and 
cleave after aspartic acid residues (Nicholson, 1999; Kelly et al., 2001). The tetra 
peptides (X-X-X-D) are subdivided into the following three categories based on their 
specific substrates: Group I (caspase-1, -4, and -5; choose WEHD or YVAD 
substrate), Group II (caspase-2, -3, -7, and -10; DEXD) and Group III (caspase-6, -8, 
and -9; (I/ V/ L- EXD) (Alnemri et al., 1996; Thornberry et al., 1997; Chowdhury 
et al., 2008). Activated caspases have also been shown to cleave nuclear enzyme poly 
(ADP-ribose) polymerase (PARP) at the carboxyl-terminus. The sequence of the 
cleavage site in PARP is DEVD (Asp-Glu-Val-Asp); for caspases -3, IETD (Ile-Glu-
Thr-Asp); for caspases -8, and LEHD (Leu-Glu-His-Asp); for caspase-9 (Thornberry 
et al., 1997; Chowdhury et al., 2008). These peptides have been incorporated into 
caspases-specific inhibitors and fluorescent substrates, which have been used in this 
thesis.   
 
1.8.3- Apoptosis pathways (Caspases activation) 
 
  
The initiation of apoptosis leads to caspase activation by two main pathways, the 
extrinsic pathway, which is characterised by the death-ligand-mediated receptor 
activation and the intrinsic pathway also known as the Bcl-2 family-regulated or 
mitochondrial pathway, and which is characterized by the activation of the 
mitochondria-apoptosome system (Kohlhaa et al., 2007). These pathways can be 
activated separately; for instance, caspase-9 plays a vital role in the intrinsic pathway 
which is activated after perturbation of mitochondria resulting from cellular stress, 
growth factor withdrawal, or cytotoxic insults (Reis et al., 2007). Caspase-8 is the 
essential caspase in the extrinsic pathway (Oliver and Vallette, 2005). There is also 
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some evidence to indicate that in some cells the extrinsic pathway can activate both 
caspase-9 and caspase-8 (Racke et al., 2002; Suzuki et al., 2008). 
 
Caspase cascade can result from activation of extrinsic (death receptor-mediated) and 
intrinsic (mitochondria mediated) pathways (Scaffidi et al., 1998; Wang et al., 2005; 
Chowdhury et al., 2006) (Fig.1.8). 
 
 
1.8.3.1- Death receptor signaling (extrinsic) pathways 
 
Most cells have death receptors in plasma membrane; death receptor signaling 
pathways plays an important role in the caspase activation (French and Tschopp, 
2003). The death receptors are a subfamily of the tumor necrosis factor (TNF) 
receptors (TNFRs) (Krammer et al., 1999). TNFRs family members include TNF-
related apoptosis-inducing ligand receptor 1 (TNFR1; also named as DR1, CD120a, 
p55, or p60) (Li and Yuan, 2008), CD95 (also called Fas, APO-1, or DR2), DR3 
(also known as APO-3, LARD, TRAMP, or WSL1), TRAIL-R1 ( known as DR4 or 
APO-2), TRAIL-R2 (also named DR5, KILLER, or TRICK2), and DR6, 
Ectodysplasin A receptor (EDAR) and Nerve growth factor receptor (NGFR) (French 
and Tschopp, 2003; Wajant, 2003; Gloire et al., 2008). Most of these are 
characterized by the presence of a DD motif within their intracellular domain. They 
play a significant role in apoptosis and can activate a caspase cascade within seconds 
of ligand binding (Curtin and Cotter, 2003; Lavrik et al., 2005). Several studies 
have shown that the receptors of the three main death receptors pathways (TNF-α, 
CD95, and TRAIL) may act as the main participant in the initiation of apoptosis by 
the extrinsic pathway (Sheard et al., 1997; Luce et al., 2009). 
 
1.8.3.1.1- Signalling by Tumor necrosis factor-α  
 
Tumor necrosis factor-α (TNF-α) is a pro-inflammatory cytokine with a broad variety 
of functions in many cell types. TNF-α exerts its biological activity by binding to 
receptors TNFR-1 and TNFR-2 and activating several signaling pathways 
(Ashkanazi and Dixit, 1998; Darnay and Aggarwal, 1997; Screaton and Xu, 
2000). The interaction of TNFα with its receptor, leads to trimerization and clustering 
of intracellular death domain. This allows the binding of intracellular adapter  
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Figure 1.8: extrinsic (death receptor-mediated) and intrinsic (mitochondria 
mediated) pathways. Intrinsic pathway is mediated by mitochondrial and the ER 
pathways. Distinct initiator caspases are activated in each pathway of apoptosis. 
(figure from web site: www. medscape.com ). 
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molecule called TNFR associated death domain (TRADD) by interaction with the 
death domains on TNFR. TRADD in turn associates with another adapter molecule 
the Fas associated death domain (FADD). This complex then bind to procaspase-8 to 
form a death-inducing signal complex (DISC) (Philchenkov, 2004; Thorburn, 
2004), and becomes caspase-8. Active caspase-8 is rapidly released from DISC to the 
cytoplasm and is a downstream effector for caspase-3, -6, and -7. Activation of 
effector caspases especially caspase-3 results in of apoptosis (Fuentes-Prior and 
Salvesen, 2004; Zimmerman et al., 2002).  
 
1.8.3.1.2- Signalling by CD95 
 
CD95/ Fas is expressed in various tissues, but its ligand (CD95-L) is expressed 
mainly in T lymphocytes and natural killer cells. It plays an essential role in the 
immune system, including the killing of pathogen-infected cells (Suda et al., 1993). 
Several studies have shown that cytotoxic T cells, which express CD95L in a 
membrane-bound form (mCD95-L) on their surface, can kill CD95+ target cells 
(Krammer, 2000; Nagata, 1997). CD95-L recruits an adapter protein called FADD 
which interacts with the death domain of CD95 (Debatin and Krammer, 2004). 
FADD also contains DED and through the homologous interaction, it recruits 
procaspase-8 and/or procaspase-10 to form DISC, Which serves as a platform to 
initiate enzymatic activation of the apoptotic pathway by the autoproteolytic cleavage 
of procaspases-8 to active caspase-8 (Gupta, 2003; Thorburn, 2004; Wolf and 
Green, 1999; Gloire et al., 2008). Further, Caspase-8 activation within the DISC 
occurs in two steps. First, recruitment of FADD to the intracellular region of CD95 
promotes via homotypic interaction of DED dimerization and a conformational 
change in caspase-8 within the DISC that allows caspase-8 to gain full enzymatic 
activity. Second, active caspase-8 undergoes autoproteolytic processing, which allows 
the enzyme to leave the DISC and gain access to substrates in other cellular 
compartments (Boatright et al., 2003). The active caspase-8 follows the apoptotic 
cascade to activate executioner caspase-3, which results in apoptosis (Chowdhury et 
al., 2006) (fig. 1.8). 
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1.8.3.1.3- Signalling by TNF related apoptosis inducing ligand  
 
 
TNF related apoptosis inducing ligand (TRAIL) is a member of the TNF superfamily 
that induces apoptosis upon binding to its receptors. TRAIL is also known as Apo-2L 
(Pitti et al., 1996) and is regulated by the expression
 
of two death receptors TRAIL 
receptor 1 (TRAIL-R1 and TRAIL-R2)
 
and two decoy receptors (TRAIL-R3 and 
TRAIL-R4) (MacFarlane, 2003). Furthermore, there are also four decoy receptors 
(DcR) known TRAILR3 (also known as DcR1), TRAILR4 (also known as DcR2), 
DcR3 and osteoprotegrin (OPG). DcRs possess functional extracellular ligand binding 
domains, but do not contain the intracellular DD and therefore, cannot recruit adaptor 
proteins required for apoptosis. The principle function of DcR is to modulate the 
sensitivity of death-receptor-mediated apoptosis in-vivo (Ashkenazi et al., 1999; 
Curtin and Cotter, 2003; Lavrik et al., 2005). TRAIL also binds DR4 and DR5. 
The signaling pathways of these are similar to CD95 and are mediated by FADD 
(Almasan and Ashkenazi, 2003). 
 
1.8.3.2- Mitochondrial (intrinsic) pathway of apoptosis  
 
Mitochondria play a central role in the initiation of apoptosis. Several stimuli, such as 
cytotoxic stress, oxidative stress, heat shock and DNA damage, lead to changes in 
mitochondrial membrane integrity and the release of cytochrome c from mitochondria 
to the cytosol (Armstrong, 2006; Finkel, 2001). The release of cytochrome c is one 
of the major factors in apoptosis related with permeabilization of outer mitochondrial 
membrane (Fuentes-Prior and Salvesen, 2004; Aleo et al., 2006). Cytochrome c 
release therefore is followed by the formation of a high molecular mass cytoplasmic 
complex called the apoptosome (Acehan et al., 2002). The apoptosome is a very large 
protein (700-1400 kDa) complex in the presence of cytochrome c, dATP and 
apoptotic protease activating factor-1 (Apaf-1). Procaspase-9 is then recruited to the 
complex by CARD interactions, which results in its activation (Hu et al., 1998; 
Costantini et al., 2002). Active caspase-9 cleaves executioner caspases such as 
caspase-3 to induce apoptosis (Aleo et al., 2006; Gupta, 2003; Chowdhury et al., 
2006). 
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1.8.4- Regulation of caspase activation 
 
Activation of caspases is vital for the induction of apoptosis 
 
1.8.4.1- Bcl-2 family proteins  
 
The mitochondrial pathway of apoptosis occurs when factors such as cytochrome c is 
released into the cytosol by permeabilization of outer mitochondrial membrane. This 
process is controlled by the Bcl-2 family proteins (named from B-cell lymphoma 2), 
which is composed of both pro- and anti-apoptotic proteins (Gross et al., 1999; 
Chipuk and Green, 2008). The Bcl-2 family of proteins is divided into three groups 
based on number of Bcl-2 homology domains (BH1-4 domains) (see fig. 1.9A). First 
group is Bcl-2 subfamily (named as anti-apoptotic) such as Bcl-2, Bcl-XL, Bcl-w, 
Mcl-1 and A1, which contain BH1-BH4 domains and are generally integrated in the 
outer mitochondrial membrane and also found in association with ER and nuclear 
envelope (Akao et al., 1994). These proteins function within the apoptotic pathway to 
directly bind and inhibit the pro-apoptotic Bcl-2 proteins. Second group is Bax 
subfamily (known as pro-apoptotic), which include Bax, Bak and Bok. They contain 
BH1-BH3 domains and permeabilize the outer mitochondrial membrane by creating 
the proteolipid pore responsible for cytochrome c release (Leber et al., 2007). Third 
group is BH3 subfamily (known as pro-apoptotic) contain Bad, Bid, Bik, Blk, Hrk, 
BNIP3 and BimL; which function in distinct cellular stress pathways and, by protein-
protein interactions with other Bcl-2 family members signal that a cellular stress has 
occurred (Chipuk and Green, 2008).  
 
Two pathways of caspases activation can be distinguished by whether they require 
Bcl-2 family proteins. The mitochondrial pathway (Bcl-2-regulated or intrinsic 
pathway) is strictly controlled by the Bcl-2 family of proteins. Furthermore, the pro-
apoptotic family members Bax and Bak are essential for inducing permeabilization of 
the OMM and the subsequent release of cytochrome c, which leads to the activation 
of caspase-9 (Hakem et al., 1998), but the role of Bax and Bak in release of 
cytochrome c is still unclear.  (Youle and Strasser, 2008). The anti-apoptotic family 
members, such as Bcl-2 and Bcl-xL, inhibit Bax and Bak. Recent evidence indicates 
that BH3-only proteins derepress Bax and Bak by direct binding and inhibition of 
Bcl-2 and other anti-apoptotic family members (Youle, 2007). By contrast, an 
- 48 - 
 
opposing model postulates direct activation of Bax and Bak by some BH3-only 
proteins (specifically Bim, tBid and PUMA) (Willis et al., 2007). One mechanism 
suggests that tBid induced the activation of Bax and Bak, resulting in dysfunction of 
mitochondria then release of cytochrome c (Wei et al., 2001). However, the extrinsic 
pathway can activate caspase-8 which leads to caspase-3 activation and cell death. 
The Bcl-2 family regulates the intrinsic pathway and can modulate the extrinsic 
pathway when the cleavage of Bid cross-talks between the two pathways (fig. 1.9B) 
(Youle and Strasser, 2008).  
 
1.8.5- Apoptosis induced by beta-amyloid 
 
It was found that DNA damage and increasing nuclear factor-kB (NF-kB) activation 
are associated with degenerating neurons in the brains of AD as the consequence of 
oxidative stress by Aβ deposition in brain (Culmsee et al., 2003). Neurofibrillary 
tangles (NFTs) are involved in AD. These are formed from tau proteins which are a 
highly soluble microtubule-associated protein (MAP) and are abundant in neurons in 
the CNS (Hyman, 1997; Goedert et al., 1991). Proteolytically cleaved and 
hyperphosphorylated tau proteins form paired helical filaments (PHFs) which 
aggregate to form NFTs (Trojanowski and Lee, 1995). It is believed that caspase-3 
cleaved tau proteins or its associated PHFs induces mitochondrial dysfunction causing 
mitochondrial Ca
2+
 release, reactive oxygen species (ROS) production and 
mitochondrial depolarisation (Parihar and Hemnani, 2004). All these consequences 
can then contribute to mitochondrial-dependent apoptosis (fig. 1.10). 
 
Toxic peptide A has been shown both to kill neurons and also to form A-plaques 
(Cantara et al., 2007). One current view is that A forms oligomeric pores within the 
plasma membrane of neurons and this causes excessive Ca
2+
 influx and the generation 
of ROS. This then leads to lipid peroxidation, and caspase activation, mitochondrial 
Ca
2+
 overload, oxidative stress and ultimately apoptotic cell death (Ferreiro et al., 
2008). (fig. 1.10). 
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Figure 1.9: (A) Bcl-2 family of proteins, which is divided into three functional 
groups, based on their composition of Bcl-2 homology domains. The anti apoptotic 
members include Bcl-2, Bcl-xL, Bcl-w, A1 and Mcl-1 and contain four Bcl-2 
homology domains (designated BH1–4). The pro-apoptotic multi-domains (Bax, Bak 
and Bok) contain BH1-3 domains. The BH3-only proteins are subdivided into direct 
activators (e.g. Bid and Bim) and de-repressors/ sensitizers (e.g. Bad, Bik, Bmf, 
bNIP3, HRK, Noxa and PUMA). (Cory et al., 2003). (B) role of Bcl-2 family 
member in release of cytochrome c from the mitochondria. (adapted from Mak and 
Yeh, 2002).  
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Figure 1.10: Aβ-mediated cell death in Alzheimer's disease. 
The β-Secretase (also called BACE) cleavage of the amyloid precursor protein (APP), 
followed by -secretase complex (containing Presenilin-1, nicastrin, Aph-1 and PEN-
2) forms A. The A then forms oligomers within the plasma membrane of neurons 
and this causes excessive Ca
2+
 influx then leads to lipid peroxidation, and caspase 
activation, mitochondrial Ca
2+
overload, oxidative stress and ultimately apoptotic cell 
death (figure from Mattson , 2003).  
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1.8.6- Role of reactive oxygen species in caspases activation 
 
ROS such as hydrogen peroxides (H2O2), hydroxyl radicals (

OH), and superoxide 
anions (O2
-
), are produced as a natural product of cellular metabolism (Fridovich, 
1999; Inoue et al., 2003), excessive levels in cells can cause apoptosis by the 
activation of the mitochondrial pathway of apoptosis via the activation of c-Jun N-
terminal kinase (c-JNK) and subsequently inducing cytochrome c release from 
mitochondria and activation of caspases (Javvadi et al., 2008; Singh et al., 2005; 
Wang et al., 2008; Kim et al., 2009). Furthermore, activated c-JNK leads to 
phosphorylation of anti-apoptotic proteins such as Bcl-2 and Bcl-xL, and inactivating 
their functions (Wullaert et al., 2006). 
  
1.9- Brominated flame retardants (BFRs) 
 
Fires kill on average over 37,000 persons pear year (CTIF, 2003), with more than 
4,000 people killed and more than 80,000 injured in Europe Union (EU) alone 
(Dawson, 2002). Flame retardants added to combustible materials prevent fires and 
thus save costs and human lives. A recent report has showed that the incidence of 
serious fires has dropped by 50% in the United States (US) over the past 30 years, 
because of the increasing use of flame retardant chemicals in many products (i.e. 
curtains, carpets, decorations, plastics in electrical and electronic equipment, 
upholstered furniture and textiles…etc) (Karter, 2008).  
 
Flame retardants (FRs) are chemicals that can be added to materials by blending or 
chemical incorporation, to reduce or delay the spread of a fire starting by providing 
increased resistance to ignition. There are more than 175 different commercial FRs in 
use on the market (Alaee et al., 2003), and those can be divided into inorganic, 
organic halogenated and organophosphate compounds. Inorganic FRs includes metal 
hydroxides such as magnesium hydroxide, aluminum hydroxide and ammonium salts 
(WHO, 1997). Inorganic FRs represent the largest portion of total amount of FRs 
produced (WHO, 1997). Organic halogenated FRs are primarily based on chlorine 
and bromine, and also often contains other heteroelements, such as phosphorus or 
nitrogen. One mechanism for the action of FR uses its ability to form a protective 
coating of either liquid or solid above the surface of the combusting material, which 
- 52 - 
 
prevents oxygen and volatile combustion products reaching the flame (BSEF, 2004). 
Another mechanism of halogenated FRs is to act as radical scavenger removing free radicals 
in material and reducing burning. Brominated flame retardants (BFRs) are the most 
efficient and possess the most constructive thermal stability of the halogenated 
products (Kirk-Othmer, 1993; Orn and Bergman, 2004). In 2005, the total global 
use of BFRs was 311,000 metric tonnes which represent approximately 21 percent 
(%) of the total consumption of FRs (Fink et al., 2005). Tetrabromobisphenol A 
(TBBPA) and hexabromocyclododecane (HBCD) are currently the most widely 
produced BFRs (since legislation to limit the use of polybrominated diphenyl ethers 
(PBDEs) was introduced a few year age). 
 
BFRs are the most commonly employed group of FRs, used to date. These are the 
largest market group of FRs because of their low cost and high performance 
efficiency. Currently, more than 75 different chemicals have been employed as BFRs 
commercially (WHO, 1994; BSEF, 2000). The major BFRs used are TBBPA, 
HBCD, PBDEs; which are include decabromodiphenyl ether (DBDE), 
octabromodiphenyl ether (OBDE), and pentabromodiphenyl ether (PBDE). These last 
three chemicals are referred to as commercial mixtures of PBDEs or biphenyl oxides. 
Each of the BFRs has very different properties and the structures (fig. 1.11). They are 
generally produced synthetically as mixtures. Furthermore, these chemicals can be 
incorporated into the material to be protected in two different ways, either covalently 
linked (reactive) or only added to the material (additive). For examples, PBDEs and 
HBCD are additive BFRs and TBBPA are a reactive BFRs (EHC-192, 1997). 
 
BFRs are a highly diverse group of chemicals, some of them are aliphatic and others 
cycloaliphatic or aromatic compounds. BFRs are used in a variety of consumer 
products, including computers, electronics, electrical equipment, televisions, textiles, 
foam furniture, insulating foam and building materials and BFR production has 
increased dramatically during the last few years (Alaee et al., 2003). TBBPA is the 
major BFR produced, followed by DBDE and HBCD. The production of BFRs differ 
by region, TBBPA is mostly produced in Asia. The EU produces most of the HBCD, 
while DBDE and PBDE are produced to a large extent in both the US and Asia. 
Interestingly, PBDE is produced nearly exclusively in the US (Orn and Bergman, 
2004).  
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Figure 1.11: different structures of BFRs congeners. 
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1.9.1- Tetrabromobisphenol A 
 
Tetrabromobisphenol A (TBBPA) is a crystalline solid and melting point of 180 -
184°C. TBBPA has the chemical formula: C15H12Br4O2. TBBPA consists of two 
brominated and hydroxylated aromatic phenyl rings, each bound to a propyl group as 
shown in fig. 1.11. TBBPA has proposed log partition coefficient (Kow) of 5.7, 
making it very hydrophobic/ lipophilic (Ogunbayo et al., 2007). The TBBPA is one 
of the most widely used brominated flame retardants, employed to reduce the 
combustibility of a large variety of manufactured products. TBPPA is formed by 
bromination of bisphenol A (BPA) in an organic solvent. Around 90% of TBBPA is 
used as a reactive intermediate in the production of epoxy and polycarbonate resins 
used in printed circuit boards and electrical equipment. The remaining 10% of 
TBBPA is transformed into derivatives such as dimethyl TBBPA and used as additive 
BFR in acrylonitrile-butadiene-styrene (ABS) resin and high-impact polystyrene. Bis 
(2-hydoxyethyl ether) TBBPA, another TBBPA derivative, is used as a flame 
retardant for paper and textile, adhesives and coatings. 
 
1.9.2- Hexabromocyclododecane 
 
1,2,5,6,9,10-hexabromocyclododecane (HBCD) is a white crystalline powder with 
74.7% bromine with the chemical formula: C12H18Br6, and has a lipophilicity value of 
log Kow of 5.6 (Birnbaum and Staskal, 2004). The configuration of the HBCD is 
presented in fig. 1.11. HBCD is a cyclic aliphatic and usually melts at a temperature 
range of 183-207 ºC. HBCD is one of the major BFR produced and mostly produced 
in the EU-region (Orn and Bergman, 2004). The global product of HBCD was 
estimated to be more 20,000 metric tons in 2006 (Heeb et al., 2007; BSEF, 2008), 
and is produced by bromination of cis, trans, trans-cyclododeca-1,5,9-triene (Becher, 
2005). HBCD has 16 possible stereo-isomers and the consequential industrial product 
consists of a mixture of three diastereomers of HBCD (α-, 6%; β-, 8% and γ-HBCD, 
80%) (ACC., 2001). The main application of HBCD is in polystyrene foam that is 
used in thermal insulation of building materials, electronics, textiles and upholstered 
furniture (BSEF, 2008).  
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1.9.3- Polybrominated diphenyl ethers 
 
PBDEs where the second highest production group of BFRs until recently. They are 
used in consumer items such as polyurethane foams, TV sets, computers, radios, 
textiles, paints, and plastics. These brominated compounds act in the gas phase of the 
fire by reacting with free radicals generated during combustion, thus terminating the 
reaction (Rahman et al., 2001). PBDEs are additive flame retardants, which are 
mixed with the polymer instead of mixing with the plastic before polymerization. 
Therefore, PBDEs are more prone to leak out of products during their lifetime 
because they not covalently attached to the polymer (Sjodin, 2003). PBDEs are 
produced by bromination of diphenyl ether. Diphenyl ether molecules contain 10 
hydrogen atoms, any of which can be exchanged with bromine, resulting in 209 
possible congeners, (fig. 1.11). PBDE congeners are commercially produced in three 
different degrees of brominated forms such as pentabromodiphenyl ether (PBDE), 
octabromodiphenyl ether (OBDE) and decabromodiphenyl ether (DBDE). The PBDE 
and OBDE were banned in the EU in 2004, and in the US from 2006, while DBDE 
still to be widely used (Giordano et al., 2008; fast facts: PBDEs, 2010). 
 
1.9.4- Polybrominated biphenyls 
 
Polybrominated biphenyls (PBBs) are a group of manufactured chemicals, of the 
polyhalogenated compounds. PBBs were produced as flame retardants in the early 
1970s. The commercial production of PBBs in the form of Firemaster
®
 in the United 
States continued until 1976 and approximately 6071 tonnes of PBBs were produced 
during those 6 years (Di Carlo et al., 1978; Pomerantz et al., 1978). In 1973, 
Firemaster BP-6
®
 and FF-1
®
 were unintentionally mixed into cattle feed at a 
production site and distributed throughout Michigan. The prevalent contamination of 
Michigan farm products that resulted from this accident led to the ban of PBB in the 
USA in 1974 (EHC-152, 1994). However, only three commercial PBB products were 
manufactured, hexabromobiphenyl (HxBB), octabromobiphenyl (OBB) and 
decabromobiphenyl (DBB), and these three products were based on a limited number 
of congeners (Norris et al., 1975; Pomerantz et al., 1978). In Europe, particularly in 
Germany, a mixture of highly brominated PBBs was in manufacture until 1985, 
whereas in France, decabromobiphenyl (EHC-152, 1994) was in production until 
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2000 (Hardy, 2002), then the EU banned the use of PBBs in electrical and electronic 
devices. Moreover, The PBBs are now limited in use; no more than 0.1 percent by 
weight of polybrominated biphenyl per homogenous material in electrical and 
electronic devices (ERA, 2006). 
 
1.9.5- Environmental and human exposure to BFRs 
 
As BFRs are extensively used due to their chemical and physical properties, BFRs 
have become a ubiquitous group of environmental contaminants. Several detailed 
studies have shown that BFRs are found as contaminants in all environment media 
(indoor and outdoor) and concentrations of some of BFRs in both environment and 
humans are rapidly rising (Alaee and Wenning, 2002).  
 
Models have shown that a large part of the BFRs released to the environment will end 
up in soil or sediment (Palm et al. 2002; Gouin and Harner, 2003). Furthermore, 
PBDEs persist in most environmental compartments such as soil, air, sea sediment 
and some of the PBDEs were also found to bio-magnify in the food chain (de Wit, 
2002). However, some of BFRs, such as the PBBs were removed from the market 
after a contamination incident in Michigan 1974, when PBBs was accidentally mixed 
into animal feed. The exposed animals showed symptoms such as a reduction in feed 
consumption, abnormal growth, lameness and deaths (WHO, 1994). 
 
Previous study have been shown that PBDEs levels in soil analyzed from a city centre 
can be as much as 50 times higher than those found in soil from rural sites (Harrad 
and Hunter, 2006). Furthermore, this study also showed that the outdoor air levels of 
PBDEs were found to be about 8 times higher in the city compared to rural 
environments (i.e. 23.3 and 2.8 pg/m
3
, respectively), and alarmingly air samples 
collected near HBCD-processing plants were excessively high at roughly 28500 
ng/m
3
 (National Chemicals Inspectorate (KEMI), 2005).  
 
Several BFR are bio-accumulating in both animals and humans (Damerud, 2003). In 
fact some of the PBDEs congeners (BDE209) have been found in human tissues and 
fluids, including blood, breast milk, and adipose tissue at high concentrations i.e. 
160ng/g serum lipid weight (lw) (equivalent to 0.3 µM) (Sjodin et al., 2004). Several 
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Swedish studies showed that the monitored blood levels of some PBDEs congeners 
were significantly higher in electronic recycling workers and computer technicians 
compared to those than in control group of workers (Sjodin et al., 1999; Jakobsson 
et al., 2002). Another recent study investigated the blood levels of PBDEs in workers 
from Chinese electronics dismantling plant, which showed that some individuals had 
highest ever recorded levels BDE-209 in their blood samples of 3400ng/g serum lw 
(Qiu et al., 2007). In one study, TBBPA was found in 80 % of the serum samples 
from computer technicians, at levels ranging up to 3.4 pmol/g lw (Jakobsson et al., 
2002) and in appreciably higher levels in workers continually exposed to high levels 
of this chemical, in electronics dismantling facilities (Tomsen et al., 2001). In 
humans, the major intake of HBCD is from food, indoor air and dust (Remberger et 
al., 2004). The concentrations of HBCD were measured in a variety of samples (air, 
animals, and human). Furthermore, high concentrations of up to 19200 ng/g lw were 
found in birds of prey (equivalent to 12µM) and more than 9600 ng/g Iw in marine 
mammals (equivalent to 6µM) while lower concentrations of 20 ng/g lw (equivalent 
to 30nM) were reported in a limited human study (Covaci et al., 2006).  
 
 
1.9.6- Toxicity of BFRs 
 
In recent years, BFRs have been of considerable concern regarding their potential 
toxicity to humans (Sjodin et al., 2003). Based on toxicity information from in-vitro 
and rodent studies, there are differences among the BFR groups, Some BFRs are 
capable of accumulating and levels of these chemicals have increased over time in 
some populations. For example, the PBDE congeners like PentaBDE may cause 
biochemical and toxicological effects such as altered growth, morphology and cardiac 
and neural functions in experimental animals (Lema et al., 2007). Furthermore, 
environmentally relevant concentrations of TBBPA in rodents reduced their 
reproductive success (Kuiper et al., 2007). However, several studies on animals and 
in cells using a variety of BFRs has shown them to have multiple disruptive effects on 
many physiological processes, such as neurological function and neuro development, 
endocrine function and immune function. Behavioural studies have demonstrated 
adverse neurodevelopmental effects on learning and memory after BFRs exposure, 
using some of the PBDEs congeners (Reistad et al., 2002; Wiegand et al., 2001; 
Alm et al. 2006). Furthermore, Viberg et al. (2006) demonstrated that exposure of rat 
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neonates to higher brominated PBDEs, such as the PBDE-203 and PBDE-206, 
showed that they can cause developmental neurotoxic effects, manifested as defective 
spontaneous behavior, reduced or lack of habituation, and impaired learning and 
memory functions. Theses neurobehavioral effects were not only observed upon 
exposure of these chemicals in neonates, but rather exposure to low dose of these 
PBDEs in pregnant rats caused similar effects in their offspring (Kuriyama et al., 
2005). In-vitro studies suggest that a variety of other BFRs such as TBBPA and 
HBCD affect rat brain synaptosomes which influence memory and learning 
mechanisms in brain by inhibiting their ability to take up neurotransmitters like 
dopamine, and GABA (Mariussen et al., 2002; Reistad et al., 2002; Fonnum et al., 
1995). Excess glutamate in the synaptic cleft leads to increases in the neuron of 
excitotoxicity (Fonnum, 1998). Further, BFRs have been shown to affect cholinergic 
(Vilberg et al., 2003) and catecholaminergeric systems within the developing brain 
(Alm et al., 2006). 
 
 
1.9.7- Effects BFRs on endocrine function 
 
An endocrine disrupter has been defined as an exogenous agent which interferes with 
the synthesis, secretion, transport, binding, action, or elimination of natural hormones 
in the body which are responsible for the maintenance of homeostasis, reproduction, 
development or behaviour (Kavlock et al., 1996). The extensive description includes 
all substances that can affect endocrine function via interference with hormone 
pathways (i.e. estrogen, androgen, or thyroid hormone). There are also several studies 
that have shown that BFRs have the potential to cause endocrine disruption 
(Darnerud, 2008; Legler, 2008). A variety of BFRs at low concentrations have been 
shown to cause endocrine disruption by acting as agonists or antagonists of steroid 
hormones such as estrogen (Meerts et al., 2001), androgens (Larsson et al., 2006) 
and also thyroid hormones (Kitamura et al., 2002). 
 
1.9.7.1- Thyroid signalling  
 
Several rodent studies have shown that exposure to BFRs such as PBDEs, (like some 
other organohalogenated compounds) leads to reduction of serum total and free forms 
of 3,3‟,5-tetraiodo-L thyronine (T3) and 3,3‟,5,5‟-tetraiodo-L thyronine (T4) levels 
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(Fowles et al., 1994; Zhou et al., 2001, 2002; Hallgren et al., 2001; Hallgren and 
Darnerud, 2002). The mechanism of action of interference of organohalogens with 
the thyroid hormone (TH) system may include three different mechanisms: (1) thyroid 
gland function and regulation; (2) TH metabolism; and (3) TH plasma transport 
(Brouwer et al., 1998). Some PBDEs congeners appear to interfere with the TH 
signalling at several levels by increasing the catabolism of T4 and T3 through 
induction of hepatic UDP-glucuronosyl transferases (UDPGT), thus lowering the 
circulating amounts of the hormones in the blood (Zhou et al., 2001, 2002; 
Birnbaum and Staskal, 2004), and their hydroxylated metabolites can compete with 
T4 for binding to the plasma transport protein transthyretin (TTR) (Meerts et al., 
2000). Further, hydroxylated PBDEs (BDE 47, BDE 99 and BDE100) have a high 
affinity for thyroid receptors (Marsh et al., 1998). Low micromolar concentration of 
TBBPA has also been shown to inhibit thyroid hormone sulfation (Schuur et al., 
1998).  
 
1.97.2- Steroid signalling 
 
Endocrine disruption happens also, when steroid synthesis, metabolism or function 
are unregulated. One of the major pathways involved in steroid metabolism is that of 
steroid sulfonation. Furthermore, Estrogen sulfates are pharmacologically inactive and 
are the main form of the steroids in plasma; free estrogens are then released at the 
target tissues by the action of cell-surface sulfatases. Formation of estrogen sulfates is 
carried out by sulfotransferase enzymes (SULT isoforms) which are cytosolic and use 
3′-phosphoadenosine-5′-phosphosulfate (PAPS) as a co-factor in transferring a 
sulfonate group. The majority of endocrine disruptor research has focused on 
interference of compounds with the sex hormone homeostasis, resulting in effects on 
sexual differentiation and reproduction. FRs have also been described as endocrine 
disrupters (Fonnum et al., 2006). Studies on the estrogenic effects of BFRs in-vivo 
are limited. In-vitro estrogenic activity of TBBPA has revealed no estrogenic effects 
in embryo development (Berg et al., 2001). Furthermore, TBBPA was unable to alter 
circulating testosterone levels, testis weight and sexual behavior (Halldin et al., 2001; 
2005). However, other studies have been shown that TBBPA can inhibit estrogen 
sulfotransferase in-vitro (Kester et al., 2002; Hamers et al., 2006) and enhanced 
proliferation in an estrogen-dependent cell line (Kitamura et al., 2002). TBBPA is 
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also able to detrimentally affect testicular Sertoli cell function (this cell is involved in 
sperm development and dictates the number and quality of mature sperm) (Ogunbayo 
et al., 2008). Additional in-vitro studies indicated that several PBDEs congeners 
(BDE-71 BDE-47, BDE-99, BDE-100, and BDE-154) inhibited binding of the 
synthetic androgen (R1881) to cytosolic androgen receptor (AR) from the rat ventral 
prostate (Stoker et al., 2005). Also, DE-71 has anti- androgenic activity causing a 
delay of puberty in male rats by inhibition of androgens binding to the AR (Stoker et 
al., 2005), but the significance of these observations for exposure in vivo is not 
known. 
 
1.9.7.3- Liver function (Hepatotoxicity) 
 
Liver cytochrome P450 (CYP) plays a vital role in the oxidation of xenobiotics, 
including drugs and environmental pollutants, and therefore represents a primary 
focus of toxicological and drug metabolism research (Anzenbacher and 
Anzenbacherova, 2001). Numerous in-vitro studies have shown that exposure of 
rodents and various cells lines to PBDE congeners induced both phase I and phase II 
detoxification enzymes in the liver by the increased activity of liver microsomal 
ethoxyresorufin-O-diethylase (EROD) after exposure (von Meyerinck et al., 1990; 
Hanberg et al., 1991). EROD activity, a catalytic function of the CYP1A 
(microsomal oxygenase subfamily), is a popular biomarker for exposure to 
xenobiotics (Zhou et al., 2002). 
 
Hepatotoxicity of other BFRs such as TBBPA can inhibit hepatic enzymes such as 
CYP2C9 alanine aminotransferase (ALT), L-γ-glutamyl-transferase (γ-GT), 
glutathione (GSH) and malondialdehyde (MDA) by destabilizing membrane 
mitochondria (Boecker et al., 2001; Szymanska et al., 2000). 
 
1.9.7.4- Immune function 
 
Many animal studies on the immune system have showed that exposure to some of the 
PBDEs congener‟s leads to decrease in the weight and size of the lymph glands, 
number of neutrophils, lymphocytes and certain subsets of T-cells (Martin et al., 
2007). Also, observed is a reduction in circulating both IgG and IgM and an increase 
in some interleukins (Thuvander and Darnerud, 1999; Martin et al., 2007). In-
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vitro immunotoxicology study has shown that exposure to low concentrations of 
TBBPA has immunotoxic potency in cell culture by its ability to specifically inhibit 
the expression of CD25 (Pullen et al., 2003), which is required for the proliferation of 
activated T cells. Similar studies have also showed that the TBBPA and some of the 
PBDEs congeners (DE-71) can activate neutrophils leading to an activation of the 
NADPH oxidase primarily by an extracellular signal regulated kinase (ERK) 
pathway. This was followed by increase in intracellular and extracellular ROS 
formation. TBBPA also induced activation of mitogen-activated protein (MAP) 
kinases followed by a stimulation of immune functions in mussel hemocytes (Reistad 
et al., 2005). Furthermore, in a preliminary study in Dr Michelangeli's lab has shown 
that TBBPA can induce degranulation of mast cells and release inflammatory factors 
(personal communication).  
 
1.9.8- The cytotoxicity mechanisms of BFRs 
 
Numerous in-vitro cellular studies using either primary cells or cell lines from 
different tissues organs has shown that most BFRs are toxic, and cause cell death at 
low concentrations. The toxic mechanism of BFRs, which causes cell death, is still 
not clear. Therefore, the mechanism of cytotoxicity for BFRs has been the subject of 
extensive study. Several studies with BFRs suggest that calcium unregulation is a 
possible mechanism of toxicity. Furthermore, in an in-vitro study on cultured cells 
have demonstrated that TBBPA and HBCD cause cell death by mitochondrial-
regulated events involving cellular stress by either inducing the generation of ROS 
and abnormal increases in cytosolic Ca
2+
 concentration level which then induces 
mitochondrial Ca
2+ 
overload and activation the PTP (Ogunbayo et al., 2008; Zhang 
et al., 2008). Other BFRs either appear to cause cell death by non-typical apoptotic 
pathways which do not involved mitochondrial processes (Reistad et al., 2005). 
Furthermore, some BFRs have been reported to cause cell death by a DNA 
fragmentation process, similar to apoptosis, yet this process is caspase-independent in 
some cell types and caspases-dependent in others (Reistad et al., 2005, 2007; 
Ogunbayo et al., 2008). Such results may indicate the involvement of the apoptosis-
inducing factor (AIF) which can trigger apoptosis without the initial involvement of 
caspases (Lorenzo and Susin, 2007). All these observations suggest that different 
routes of BFR-induced cell death are activated, dependent upon the species of BFR 
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used and the cell type studied. Additional studies by others have also shown that some 
of the PBDEs congeners can cause translocation of protein kinase C (PKC) to the 
plasma membrane. As there appears to be a correlation between the extent of PKC 
translocation and the degree PBDE congeners accumulation within the cells, this is 
being considered as a potential indicator or "biomarker" for the assessment toxic 
levels of exposure (Reistad et al., 2005). Similar effects were observed for mussel 
hemocytes exposed to TBBPA with a rapid increase in phosphorylation of the 
mitogen activated protein kinase (MAPK) family member, c-JNK, and PKC followed 
by a delayed increase in phosphorylated ERK2 (Canesi et al., 2005). 
 
Dr Michelangeli's group is the first to suggest a specific molecular target for BFR 
interactions inside the cell. Recent work by this group has shown that TBBPA, which 
causes abnormal elevation of intracellular Ca
2+
 levels within cells, causes its effects 
by directly binding to and inhibiting intracellular Ca
2+
 pumps (SERCA Ca
2+
- ATPase) 
in sub-micro molar range and activating RyR, type Ca
2+
 channels (Ogunbayo et al., 
2008). This effect is not through indirect effects caused by oxidative damage of these 
proteins by ROS as was previously consideration (Reistad et al., 2007). From 
enzymological, spectroscopic and modeling studies have also identified the potential 
binding site (s) for TBBPA on the Ca
2+
 pumping ATPase (Ogunbayo and 
Michelangeli, 2007).  
 
 
1.9.9- Metabolism and pharmacokinetics of BFRs 
 
BFR metabolism is an important factor in determining the bioaccumulation as well as 
the fate, pharmacokinetics (toxicokinetics), and potential toxicity of BFRs in exposed 
organisms. Bioaccumulation is the net uptake and retention of a compound in living 
tissue from all routes of exposure (van den Berg et al., 1998) resulting in higher 
concentration within the organism compared with ambient concentration. Living 
organisms can be exposed to contaminants by water, air, food, and soil and 
contaminants can occur through the respiratory system, the skin, and the digestive 
system. This bioaccumulation process can lead to exposure of organisms to high 
concentrations of potentially toxic compounds. Although xenobiotic metabolism is the 
set of metabolic pathways that modify the chemical structure of xenobiotics, they are 
- 63 - 
 
compounds foreign to an organism's normal biochemistry, such as drugs and poisons. 
These pathways are a form of biotransformation present in all major groups of 
organisms, mainly in the liver, kidney, lung, intestine and placenta. These reactions 
often act to detoxify poisonous compounds; however, in some cases, the intermediates 
in xenobiotic metabolism can themselves be the cause of toxic effects. 
 
Xenobiotic metabolism is divided into two phases. In phase I reactions (oxidation, 
reduction and hydrolysis), enzymes such as cytochrome P450 oxidases introduce 
reactive or polar groups into xenobiotics. These modified compounds are then 
conjugated to polar compounds in phase II reactions. These reactions are catalyzed by 
transferase enzymes such as glutathione S-transferases. Finally, the conjugated 
xenobiotics may be further modified and excreted.  
 
Studies on the metabolism of a variety of BFRs have shown it to be susceptible to 
several metabolic processes including oxidative debromination, reductive 
debromination, oxidative CYP enzyme-mediated biotransformation, and/or phase II 
conjugation (glucuronidation and sulphation). Moreover, BFRs exposure can affect in 
the induction of phase I CYP monooxygenase enzymes and phase II conjugation 
enzymes (glucuronosyltransferases, sulfotransferases, and glutathione-S-transferases) 
(Nelson et al., 1996; Lewis et al., 1998). For instance, the most common inducers of 
CYP1A are planar aromatics like polynuclear aromatic hydrocarbons (PAHs) and 
coplanar polychlorinated biphenyls (PCBs), although CYP2B and CYP3A are 
induced by globular molecules such as ortho-chlorine substituted (PCBs). Phase I 
hydroxylated metabolites (OH–PCBs) are subsequently metabolized via phase II 
conjugation, although competition with protective mechanisms such as protein 
binding may result in tissue retention. Reductive and oxidative dehalogenations are 
also both prospective enzyme-mediated processes that can lead to dehalogenated 
metabolites. 
 
Metabolism studies on PBDE in rats have shown that both debromination and CYP 
enzyme-mediated OH-metabolite formations are the main biotransformation pathways 
(Hakk and Letcher, 2003). The distribution of some of PBDE congeners (BDE-47, 
BDE-85 and BDE-99) have also been studied in animals. The animals were subjected 
to whole-body autoradiography using 
14
C-labelled BDE-47, BDE-85 and BDE-99 
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(Klasson-Wehler et al., 1996; Orn and Klasson-Wehler, 1998; Hakk et al., 2002; 
Darnerud and Risberg, 2006). Labelled BDE-85 and -99 were also used in 
quantitative studies on milk transfer and tissue concentrations during the neonatal 
period (14 days post partum), (Darnerud and Risberg, 2006). High radioactivity 
concentrations results show that PBDE congeners (BDE-47) were effectively 
absorbed in the fat deposits and other organs (i.e. liver, adrenal and ovary, lung and 
brain). At longer post-injection time, the concentration in most tissues was 
considerably lower, and radioactivity was mainly found in fat deposits and the liver. 
The data indicate that no considerable difference in distribution between the three 
studied PBDE congeners was observed. Following maternal exposure, the foetal 
uptake was limited. Alternatively, during lactation a considerable fraction of the dose 
(about 20% of the studied BDEs) given to the dam was transferred to the offspring 
(Darnerud and Risberg, 2006). Furthermore, uptake, distribution, metabolism and 
excretion of PBDEs congeners (BDE-47) have been studied in animals (rats and mice) 
dosed orally with 
14
C-labelled BDE-47 (Klasson-Wehler et al., 1996; Orn 1997; 
Orn and Klasson-Wehler, 1998), results showed, 14% from labelled BDE-47 was 
excreted in rats faeces and less than 0.5% in urine while 20% of the same dose was 
excreted in faeces and 33% in urine of mice during 5-days. These studies also showed 
that all tissues analyzed contained labelled BDE-47 and the highest concentrations 
were found in adipose tissue; such as liver, lung, kidney, and brain. These results 
suggest that mice have a limited ability to metabolize BDE-47(Orn and Klasson-
Wehler, 1998).The liver also a contained low concentration of PBDE congener‟s 
hydroxylated metabolites (Orn and Klasson-Wehler, 1998; Darnerud and Risberg, 
2006). 
 
Another study by Meerts et al., (1999) has shown that in exposure of pregnant rats to 
14
C-labelled TBBPA, a major portion of radioactivity was excreted in faeces (79.8%) 
over a period of 13-days. In-vivo studies on TBBPA metabolism have shown that oral 
exposure of
 
both humans and rodents to TBBPA lead to low blood levels
 
of TBBPA 
and its metabolites were excreted in urine due to the high molecular
 
weight of TBBPA 
metabolites (Hakk and Letcher, 2003), while at the high doses used in rats,
 
TBBPA 
or its metabolites were detected in bile, and excreted predominantly in faeces (Hakk 
et al., 2000; Szymanska et al., 2001). In addition, TBBPA metabolites attributed
 
to 
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conjugation reactions of TBBPA with glucuronic acid and with
 
sulfate were also 
observed (Schauer et al., 2006). 
 
Yu and Atallah, (1980) have been shown that HBCD was rapidly absorbed, 
distributed and metabolized in the entire body with highest concentrations found in 
adipose tissue, followed by liver, kidney, lung and gonads when the animal was fed a 
single oral dose of 
14
C-labelled HBCD. Another study found that 72% of fed HBCD 
was eliminated mainly in faeces and 16% by urine within 72h (de Wit, 2002). Four 
metabolites were found but no information on their structures was given. HBCD 
absorption followed a two-compartment open model system, with the central 
compartment consisting of blood, muscle, liver, kidney and other non-adipose tissues, 
and the peripheral compartment consisting of fat tissue. Elimination from fat was 
slower than for the central compartment. Furthermore, another study by Ryuich et al. 
(1983) has shown that when Rats are fed HBCD daily for 5 days no urinary excretion 
of HBCD was detected (de Wit, 2002), and excretion accounted for 29-37% of the 
administered amount. HBCD was found to accumulate mainly in the adipose tissue 
and absorbed from the intestine (de Wit, 2002). 
 
1.10- Environmental plasticisers and related chemicals  
 
Environmental plasticisers (EPs) and related chemicals are global pollutants that are 
found ubiquitously in the environment, and which are used in food and drink 
packaging (e.g., water and infant bottles); the resins are used as lacquers to coat metal 
products such as food cans, bottle tops, and water supply pipes contaminating water, 
air, food and sediments. These pollutants are produced in enormous volumes (hundred 
of thousands of tonnes annually) (Soto et al., 1991; Ben-Jonathan and Steinmetz, 
1998; Balaguer et al., 1999). 
 
Exposure to EPs may be from numerous sources and most probably from mixtures of 
different chemicals. It has been suggested that most EPs have been shown to have 
endocrine disrupting activities (Sumpter et al., 1998; Kirk et al., 2003), and acts as 
„xenoestrogens‟ that have the potential to interfere with hormonal regulations and the 
normal endocrine system and consequently cause health effects in animals and 
humans (Sumpter et al., 1998; Guilette et al., 1999; Skakkebaek et al., 2001; 
Toppari et al., 1996). EDs such as bisphenol-A (BPA) and 4-n-nonylphenol (NP) 
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have oestrogenic effects (Jobling et al., 1995; Routledge and Sumpter, 1997). BPA 
was shown to possess anti-androgenic activities and NP was also found to be a weak 
androgen agonist (Sohoni and Sumpter, 1998). EPs are generally much less potent at 
activating hormone receptors when compared to endogenous hormones. For example, 
NP has much lower affinities for the oestrogen receptors (ERs) compared to 
endogenous hormone 17β-oestradiol (Pillon et al., 2005). Some of these EDs have 
been shown to disrupt development, the immune system, and the neural system in 
animals such as fish, reptiles and possibly humans (Bonefeld-Jorgensen 2004; 
Bonefeld- Jorgensen and Ayotte, 2003; Owens and Koeter, 2003; vom Saal and 
Hughes et al., 2000). Further, in-vitro studies have been shown that BPA and NP can 
hinder male sexual development and sperm production (Han et al., 2004; de Jager et 
al., 1999) and are highly toxic to spermatogenic and other testicular cells at low 
micromolar concentration (Raychoudhury et al., 1999; Hughes et al., 2000).  
 
Most of the EDs are synthetic compounds, some of which were designed to act as 
estrogens (e.g., oral contraceptives), while many were designed for other uses and 
accidentally found to be oestrogenic, because they contaminated in-vitro experiments 
studying natural oestrogens (Krishnan et al., 1993; Soto et al., 1991). Naturally 
occurring xenoestrogens in the environment include phytoestrogens produced by 
plants which have numerous effects, including antioxidative and apoptotic activity, 
inhibitors of kinases, and suggested anticancer actions on prostate and breast 
carcinomas (Basly and Lavier,  2005; Mueller,  2002; Sirtori et al., 2005). 
 
1.10.1- Bisphenol-A (BPA) 
 
BPA (2,2-bis(4-hydroxyphenyl) propane) was first synthesized in 1891. In the 1930's, 
BPA was investigated in the search for synthetic oestrogens. It was discounted as a 
therapeutic agent by the discovery of the much more potent synthetic hormone 
diethylstilbestrol (DES) (Quesada et al., 2002). The structure, metabolism and action 
of BPA are very similar to DES (see fig.1.12). BPA is a white solid, organic 
compound with two phenol functional groups (fig.1.12). Global production of BPA in 
2003 was estimated to be over 2 million metric tonnes (NTP-CERHR, 2008) and is 
used as a monomer in the manufacture of epoxy resins, polyester resins, polysulfone 
resins, polyacrylate resins, polycarbonate plastics, and flame retardants (European-
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Union, 2003; Krishnan et al., 1993). Some polymers used in dental sealants and 
tooth coatings contain BPA (European-Union, 2003). It is also used as an 
antioxidant and polymerization inhibitor in polyvinylchloride (PVC) production (vom 
Saal et al., 1995).  
 
BPA may be present in the environment as a result of direct releases from 
manufacturing or processing facilities via leaching from polycarbonate plastic 
products (Krishnan et al., 1993). Exposure to the general population can occur 
through direct contact with BPA or by exposure to food or drink that has been in 
contact with a material containing BPA (EFSA, 2006). 
 
BPA is one of the most common EDs found ubiquitously in environment. It mimics 
17β-oestradiol by binding ER (α) and ER (β) and can modulate target gene expression 
(Kuiper et al., 1998, Matthews et al., 2001; Singleton et al., 2004), although it's 
oestrogenic activity was about four orders less potent than that of 17β-oestradiol 
(Gaido et al., 1997). Quesada et al., (2002) also showed that low doses of BPA and 
17β-oestradiol activated the transcription factor cAMP-responsive element binding 
protein (CREB) with similar potencies, which can modulate transcription of genes 
containing upstream cAMP/Ca
2+
 response elements. However, industry funded 
studies previously indicated that there were no human health risks from BPA at 
concentration found in the environment. Current risk assessments indicate that BPA is 
not thought to be a carcinogenic risk to humans. On the other hand, most of 
independent studies showed that there were potential human risks associated with 
BPA exposure (vom Saal et al., 1995). BPA is demonstrated to induce male 
reproductive toxicities such as reductions in epididymis weight, seminal vesicle 
weight, sperm motility and cell function in in-vivo models (Takahashi and Oishi, 
2001; Takao et al., 1999). Furthermore, BPA induced cell death in many kinds of 
cells in in-vitro models (Hughes et al., 2000). Results from epidemiological human 
studies have shown a relationship between high urine or blood concentrations of total 
or free BPA and a variety of health disorders including cardiovascular disease and 
diabetes (Melzer et al., 2010). 
 
Environmental exposure to BPA is calculated as less 1µg/kg body weight/day. It was 
suggested that BPA may be metabolized in-vitro to more toxic metabolites (Bonefeld- 
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Jorgensen and Ayotte, 2003). Recent studies, however, propose that it is rapidly 
glucuronidated and excreted, without producing potentially reactive intermediates 
(Haighton et al., 2002). 
 
1.10.2- Alkylphenols 
 
Alkylphenols (APS) are initiating materials for the synthesis of AP ethoxylates 
through the alkylation of phenols ring, which can differ in size, branching, and 
position. The most significant members are ethoxylates of nonylphenol and 
octylphenol (OP). AP ethoxylates are commonly used as non ionic detergents or 
dispersive agents in paper and leather manufacturing, emulsifiers for pesticide 
formulations and as auxiliary agents for drilling and flotation. The number of 
ethoxylate units can be more than 100. AP ethoxylates are produced in huge 
quantities; the annual worldwide usage is estimated to be approximately 600,000 tons 
(Groshart et al., 2001). There is data indicating that both the position and branching 
of the alky group can influence endocrine disrupting effects of APs (Routledge and 
Sumpter, 1997). There may be significant consequences of human exposure to APs, 
as these compounds are known to be persistent and bio-accumulate and be 
biomagnified through the food chain (Guenther et al., 2002). 
 
NP is a common name for several isomeric substances of the general chemical 
formula C6H4 (OH)C9H19, consists mainly of a phenol which is substituted in para-
position with side chains of different degrees of branching. Moreover, 4-n-
nonylphenol (NP) in which the n-name side chain is attached to the carbon directly 
opposite the hydroxyl group (OH), is the most common member of NP (NRC, 1982) 
(fig. 1.13). They bio-accumulate within man, with levels in the µM concentration 
range reported in human tissues (Michelangeli et al., 2008) and have oestrogenic 
effects in-vitro and in-vivo (Harris et al., 1997). Kuiper et al., (1998) showed that 
NP completes with 17β-oestradiol to bind to ER (α) and ER (β). Effects were 
observed with low concentration (0.1-1µM), although binding affinities to the ERs 
were much lower than those observed for 17β-oestradiol. NP is ubiquitous in food and 
data collected indicated that amounts in food varied between 0.1 and 19.4µg/kg, 
regardless of the fat content of the food (Guenther et al., 2002). Recent studies have 
found levels of nonylphenol in samples of human milk to be as high as 56 ng/ml 
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(equivalent to 0.26 µM) (Ademollo et al., 2008) and, as high as 268 ng/g (equivalent 
to 1.2 µM) in some human blood plasma samples (Chen et al., 2008). More recently 
however, other potential routes for endocrine disruption have been shown, which 
includes NP binding to ARs (where the IC50 value for androgen receptor binding was 
about 20µM for nonylphenol) (Xu et al., 2005); cytochrome P450 expression (where 
effects were seen in the low µM concentration range) (Hasselberg et al., 2004); 
aromatase activity (where the IC50 for nonylphenol was approximately 300µM) 
(Benachour et al., 2007), sulfotransferase activity (where amylphenol was effective 
at less from 1µM) (Harris et al., 2000) and sulphate supply enzymes (where the 
effects for nonylphenol were also seen in the sub-µM concentration range) (Turan et 
al., 2005). 
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Figure 1.12: chemical structures of DES and BPA. 
 
 
 
 
 
 
 
 
Figure 1.13: chemical structure of 4-n-nonylphenol. 
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1.11- Aims of this study:- 
 
 
In order to understand the mechanism or mechanisms by which a number of 
environmentally prevalent brominated flame retardants (BFRs) and alkylphenols (AP) 
cause toxicity within neuronal cells (in-vitro) the following objectives will be 
addressed:- 
 
1- To identify the types of BFRs and AP which cause neurotoxicity within SH-SY5Y 
human neuroblastoma cells (as model of brain cells) and to determine which are most 
toxic.  
 
2- To what extent do commonly utilized BFRs and AP have the ability to dys-regulate 
Ca
2+
 signalling within SH-SY5Y cells by causing excessive changes in intracellular 
[Ca
2+
] levels and to investigate if these abnormal changes in Ca
2+
 involve modulation 
of intracellular Ca
2+
 transport proteins. 
 
3- To determine the mechanism by which BFRs and AP cause abnormal changes in 
intracellular Ca
2+
 levels leading cell death. Focus on the potential neurodegenerative 
effects of some commonly used BFRs and AP by investigating their effects on 
SHSY5Y human neuronal cells to elucidate the mechanisms of cell death, by 
monitoring there effects on caspases, mitochondria, cytochrome c release, ROS 
production and also their ability to secrete -amyloid peptide, indicative of the 
potential to induce AD. 
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CHAPTER 2 
 
 
 
 
Materials and Methods 
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2.1-Materials  
 
2.1.1-Cell culture 
 
All cell culture work was done using aseptic conditions and techniques. A Calls II 
Holten LaminAir Biological Safety Cabinet was used and all consumables and regents 
were purchased as sterile or were autoclaved prior to use. Ethanol, 70 % (v/v) was 
used to clean the cabinet and devices before and after use. Cells were cultured at 37°C 
and 5% carbon dioxide (CO2) humidified sterile incubator. 
 
2.1.1.1- Cell line investigated 
 
The human neuroblastoma SH-SY5Y cell line is similar to common nerve cells in 
terms of shape, physiological and biochemical function. SH-SY5Y cells are therefore 
commonly used as a cellular model to investigating a number of neurological 
pathologies (Gilany et al., 2008; Schaeffer et al., 2008). The SH-SY5Y cells are a 
thrice-cloned sub-line of SK-N-SH. Cells have dopamine-beta-hydroxylase activity 
and can convert glutamate to the neurotransmitter GABA. It is recommended not to 
use cells after passage 20 due to loss of neuronal characteristics (ECACC). The SH-
SY5Y and COS-7 cells were retrieved from the liquid nitrogen store of Dr. Frank 
Michelangeli, University of Birmingham, UK. 
 
2.1.1.2- Tissues 
 
Rabbit muscle was obtained from New Zealand white rabbits. Each rabbit was killed a 
by lethal dose of the anaesthetic, sodium phenobarbitone. Porcine cerebellar 
microsomes were obtained from a local abattoir and returned to the laboratory on dry 
ice. All tissues were frozen in liquid nitrogen and stored at -80 °C. 
 
2.1.2- Chemicals 
 
Nine different commercial available of BFRs were purchased from different sources; 
tetrabromobisphenol-A (TBBPA) (purity 100%) (CAS No. 79-94-7) was purchased 
from Acrôs Organics, dibromobiphenyl 98%, tetrabromohydroquinone 100%, 
hexabromocyclododecane (HBCD) 100%, decabromodiphenyl ether (DBPE) 100%, 
Tetrabromobisphenol A diallyl ether  99%, and tribromophenol  99% were purchased 
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from Sigma-Aldrich (UK), whereas, two commercial mixtures of polybrominated 
diphenyl ethers: pentabromodiphenyl ether (TBDE-71X) and octabromodiphenyl 
ether (TBDE-79) were purchased from Wellington Laboratories Inc, and 4-n-
nonylphenol which were bought from Lancaster Synthesis Ltd and bisphenol-A 
(BPA) from Sigma-Aldrich (UK) 
 
The caspases substrates: where specific peptides attached to 7-amino-4-
methylcoumarin (AMC), caspase-3 fluorogenic substrate; Ac-DEVD-AMC, caspase-8 
fluorogenic substrate; (Ac-IETD-AMC), and caspase-9 fluorogenic substrate; (Ac-
LEHD-AMC) were purchased from Alexis Biochemicals (UK). Caspase-8 Inhibitor (Z-
IETD-FMK) and caspase-9 Inhibitor (Z-LEHD-FMK) were purchased from Merck 
Chemicals Ltd (UK). 
 
MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide thiazole 
blue), 2‟,7‟-dichlorofluorescein diacetate (DCFH-DA), Rhodamine123 (Rh 123), 
Fluo-3, A23187 and fluorecein 5'-isothiocyanate (FITC) were purchased from Sigma-
Aldrich (UK). [γ-32P] ATP was purchased from Amersham Life Science Ltd. (Little 
Chalfont, Bucks, UK). Metafectene
TM
 transfection reagent was purchases from 
Biontex Laboratories, GmbH. 
 
Dulbecco‟s Modified Eagle‟s medium (DMEM) were purchased from Lonza (UK). 
Phosphocreatine and creatine kinase were obtained from Boehringer Mannheim 
(Diagnostic and Biochemicals) Ltd. (Lewes Sussex, UK).  
 
All other chemicals were of analytical grade and were obtained from either Bio-Rad 
Laboratories Ltd, (Hemel Hempstead, UK), Sigma-Aldrich Co. Ltd or BDH 
Laboratory Supplies (Poole, Dorset, UK).  
 
2.1.3- Reagent preparation 
 
All BFRs congeners that were dissolved in dimethylsulfoxide (DMSO, Sigma), which 
was no more than 2.0% (v/v) of the assay volume.  
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2.2- Methods 
 
2.2.1- Culture medium and sub-culture routine  
 
Human neuronal SH-SY5Y cells were grown in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 2 mM L-glutamine, 1% penicillin (20 units/ml), 
streptomycin (20 mg/ml), containing 10% (v/v) heat-inactivated foetal bovine serum 
(FBS), and 1% (v/v) non essential amino acids. SH-SY5Y cells were routinely sub-
cultured by splitting sub-confluent cultures (70-90%) at a rate of 1:3 to 1:10 (seeding 
at density of 10
3
- 10
5
 cells/cm
2
). 
 
2.2.2- Storing Cells in liquid nitrogen   
 
Stock aliquots of cells were frozen and stored under gaseous phase of liquid nitrogen 
at -80 °C. The aliquots contained a cryopreservant (10% v/v DMSO), which 
prevented cellular lysis (from intracellular ice crystals and alterations in osmotic 
balance) during the freezing process. 
 
2.2.3- Preparation of SR Ca
2+
-ATPase (SERCA1)  
 
Sarcoplasmic reticulum (SR) was prepared from rabbit skeletal muscle as described 
by Michelangeli and Munkonge (1991) and typically had a purity of approximately 
80% of SERCA Ca
2+
-ATPase. Briefly, Minced rabbit muscle (around 300 g) was 
added to 300 ml of ice cold homogenization buffer (300 mM sucrose, 20 mM L-
histidine, 1mM dithiothreitol (DTT), 5 µM phenylmethylsulponyl flouride (PMSF), 
pH 8.0) and homogenized in dual speed waring blender for about 1 min. The 
homogenized muscle was centrifuged for 20 min at 10000g. The supernatant was 
filtered through 2 layers of muslin and kept on ice. The pellet was re-homogenized 
and centrifuged as before, in further 300 ml of homogenization buffer. The resultant 
supernatant was filtered as previously done and then combined with the previous 
supernatant. The pooled supernatant was centrifuged at 30,000g for 90 min and the 
resultant pellet resuspended in 100 ml of cold buffer containing 300 mM sucrose, 10 
mM L-histidine, 600 mM KCl, 1mM DTT, 5 µM PMSF, pH 8.0. The homogenate 
was then left on ice for 30 min to allow actin and myosin precipitation, before further 
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centrifugation for 20 min at 5,000g. The supernatant was carefully removed and 
centrifuged at 30,000g for 120 min. The pellet (SR) was resuspended in 
approximately 10 ml of buffer (250 mM sucrose, 1000 mM KCl, 50 mM K2HPO4, pH 
8.0) and dialyzed overnight in 1000 ml of the same buffer. It was then aliquoted into 
50µl fractions, snap-frozen in liquid N2 and then stored at -80 °C. 
 
2.2.4- Preparation of microsomal membranes 
 
This method was described previously by Michelangeli et al., (1991). Microsomal 
membranes were prepared from either SH-SY5Y cells or whole pig brain 
(cerebellum). SH-SY5Y cells (1x10
6 
cells/cm
2
) which were harvested by 
centrifugation at 1,000g for 10 min 4°C and washed with PBS, while pig brain was 
minced. Both were homogenized using a Teflon Potter-Elvejem homogenizer in 10 
vol. of buffer containing 300 mM sucrose and 5 mM Hepes, pH 7.4, in the presence of 
0.1 mM PMSF, 10 µM leupeptin, 10 µM pepstatin A and 50 µM benzamidine, and 
then centrifuged for 10 min at 500g. The pellet was resuspended in 5 vol. of the same 
buffer re-homogenized and centrifuged as above. The resulting supernatants were 
pooled and centrifuged for 20 min at 10,000g. The supernatant from this stage was 
centrifuged for 1 h at 100,000g and the resulting pellet (microsomal membrane) was 
resuspended in approximately 2 ml of the buffer, divided into 50-100 µl fractions, 
snap-frozen in liquid nitrogen and stored at -80 °C until use. 
 
2.2.5- Determination of protein concentration 
 
Protein estimations of the microsomal extracts were carried out using the Bio-Rad 
protein assay regent, following the manufacturer's instructions and using bovine 
serum albumin (BSA) as the standard. Protein estimations were measured by 
determining the absorbance at 590nm. Measurements were carried out in a 
spectrophotometer, (Amersham Pharmacia Biotech Ultraspec 1000 UV/Vis). 
 
2.2.6- Cell viability assay 
 
Cells were seeded in 24-well cell plates (4x10
4
 cells/well) and allowed to cell grow at 
37 °C until 80-90% confluence was reached. Pre-treatment with compound was 
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undertaken in the culture medium with DMEM (high glucose/without phenol or FBS). 
Stock solutions of compounds were prepared by dissolving in DMSO less than 2%. 
The cells were exposed to varying concentrations of compounds for 22-24h; cell 
viability was determined by MTT assay, using thiazolyl blue tetrazolium bromide 
(MTT reagent). Viable cells form an intracellular formazan product when incubated 
with MTT reagent for 2-3h, this product is solubilised with 1ml acidic isopropanol 
and then quantified spectroscopically by measuring the difference in absorbance (Δ A 
=A570- A650) and compared to cells not exposed to compounds (but in DMSO alone up 
to 2%). 
 
2.2.7- Caspase activity 
 
Caspase-3, -8, and -9 activities in lysates were assayed using synthetic fluorogenic 
substrates (Ac-DEVD-AMC; substrate for caspase-3, Ac-IETD-AMC; substrate for 
caspase-8 and granzyme B, Ac-LEHD-AMC; substrate for caspase-9). SH-SY5Y 
cells (5x10
5
 cells/35 mm dish) were incubated in the presence of varying 
concentration of compound for 12h and then lysed in 500 µl of lysis buffer (10 mM 
Tris-HCl, pH 7.5, 130 mM NaCl, 1% Triton
®
-X- 100, 10 mM Na4P2O7.10H2O, and 
10 mM Na2HPO4) on ice. After the addition of 1ml of protease buffer (20 mM 
HEPES, 10% glycerol and 2mM DTT) 20µM fluorogenic substrate (final 
concentration), was added to 100 µl protein of the cell lysates and the mixture was 
incubated for 1 h at 37 °C. The fluorescence (release of AMC) in the whole reaction 
mixture was measured with a spectrofluorimeter with an excitation wavelength of 380 
nm and an emission wavelength of 460 nm. Fluorescence was converted to nmoles of 
AMC released, using the standard curve employing 7-amino-4- methylcoumarin. 
 
 
2.2.8- Cytochrome c release assay 
 
Detection of cytochrome c in mitochondrial and cytosolic protein extracts, using 
Immunoblotting. SH-SY5Y cells (5 x 10
5
 cells/35 mm dish) were incubated in the 
presence of compound in DMEM culture medium for 12 h. The cells were suspended 
in lysis buffer (20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 
mM EGTA, 1 mM DTT, and 1 mM PMSF), and disrupted using a Dounce 
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homogenizer. The cells lysates were centrifuged at 10,000g for 10min and the 
supernatants were further centrifuged at 100,000g for 30min. Both proteins in the 
final supernatant (cytosolic fraction) and the first centrifuged pellet (mitochondrial 
fraction) were separated by 15% SDS-PAGE, followed by electroblotting onto a 
nitrocellulose membrane (Protran Nitrocellulose, Whatman GmbH, Germany). 
Nonspecific binding sites were blocked by treatment with PBS containing 5% 
skimmed milk for 1 h. After a wash with PBS containing 0.1% Tween 20 (T-PBS), 
the membrane was incubated with primary antibody „goat IgG‟ (cytochrome c (C-20), 
Santa Cruz Biotechnology, INC) at a dilution of 1:500 for 1 h. After washing, the 
membrane was then incubated with anti-goat IgG peroxidase (whole molecule) 
(1:3000) (Sigma, UK) in T-PBS for 1 h at room temperature. After further washing 
with T-PBS, the enhanced chemiluminescence assay was preformed, and the positive 
bands were detected with the chemiluminescent HRP substrate (Millipore 
Corporation, UK). Protein bands were visualized
 
and analysed using a Fluor-S 
Multimager (Bio-Rad) and Quantity One 4.1.1 software.  
 
2.2.9-Preparation of coverslips 
 
Acid-etched sterile glass coverslips were placed into petri dish and coated with sterile 
2% porcine skin gelatin (prepared in deionised water).  
 
2.2.10- Measurement of mitochondrial membrane potential  
 
Mitochondrial membrane potential (MMP) in SH-SY5Y cells were monitored using 
the fluorescent dye Rhodamine123 (Rh123) as described in (Hong and Liu, 2004). 
Depolarization of MMP results in the loss of Rh123 from the mitochondria and a 
decrease in intracellular fluorescence (Satoh et al., 1997). SH-SY5Y cells were plated 
on coverslips which were pre-coated with 2% gelatine; and incubated in the dark in 
Hanks Balanced Salt Solution (HBSS) (2 ml) containing 10 µM Rh123 (dissolved in 
ethanol) for 15 min at 37°C. Cells were washed twice with pre-warmed HBSS and 
exposed to varying concentrations of compounds and then analyzed by fluorescence 
microscopy, with the microscope fitted with a FITC filter cube. Up to 10 min video 
recordings were then made to observe the decrease in fluorescence with time upon 
exposure to the compounds. 
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2.2.11- Detection of reactive oxygen species 
 
Reactive oxygen species (ROS) formation was measured by using the fluorescent 
probe 2‟,7‟-dichlorofluorescein diacetate (DCFH-DA). DCFH-DA is de-esterified by 
cells to 2',7'-dichlorodihydrofluorescein (DCFH2), and then DCFH2 is oxidized by 
ROS to form fluorescent 2',7'-dichlorofluorescein (DCF), as previously described 
(Fotakis et al., 2005). Briefly, SH-SY5Y cells were cultured in 12-well plates, before 
exposure to compounds for 22-24 h, and then the cells were washed with PBS and 
then loaded with 40 µM DCFH-DA in hanks buffer (1 ml) (DCFH-DA was dissolved 
in DMSO 1%), at 37 °C  with 5% CO2 and constant humidity for 30 min. At the end 
of the incubation, the cells were washed with PBS. Then, 1000 µl NaOH (1 M) was 
added to extract the fluorescent product from the cells. These extract were transferred 
to cuvette and the fluorescent intensity was measured with a Perkin Elmer LS-50B 
spectrofluorimeter with an excitation wavelength of 485 nm and an emission 
wavelength range of 530 nm. ROS formation was expressed as the amount of DCF 
formed using a DCF standard curve (10-100 µM). 
 
2.2.12- Fluorescence measurement of changes in intracellular [Ca
2+
] 
 
SH-SY5Y cells on the coverslips were allowed to grow to 40-50% confluence (2x10
5 
cells/35 mm dish). The coverslips were incubated in sodium hydrogen carbonate-
supplemented HBSS (pH 7.2), which contained 0.08 µM sulfinpyrazone, 1% bovine 
serum albumin, 0.025% pluronic acid and typically 10 µM Fluo-3-acetoxymethyl 
ester (Fluo-3 AM) for 50 min. This dye solution was then removed, replaced with 
fresh HBSS containing 0.08 µM sulfinpyrazone, and incubated for an additional 
20 min. Both incubations were done with the coverslip kept in the dark (to minimise 
photo-bleaching) and at 35 °C (to keep cells viable and minimise dye leakage). Fluo-3 
AM was dissolved in DMSO and cells were not exposed to more than 1% DMSO 
during the dye-loading process.  
 
Each coverslip was then moved into a 35 mm plastic petri dish (Falcon) containing 
fresh HBSS (2 ml final volume), placed onto a heated microscope stage maintained at 
35 °C and observed with a Nikon TS100F microscope in epi-fluorescence mode. The 
microscope was fitted with an FITC filter cube so that Fluo-3 fluorescence could be 
- 80 - 
 
monitored. Recordings of the cells, viewed at about 200x magnification, were taken 
using an Astrovid StellaCam-EX3 connected to a Hauppauge USB TV live video 
capture device for viewing on a PC. Win TV (Hauppauge; version 1.4) was used to 
record fluorescence videos of the cells at a frame rate of either 1frame/5s or 
1frame/1s. Recordings were initiated about 50s before the compounds were added, 
which allowed the initial un-stimulated fluorescence intensity (Fo) to be determined. 
The compounds were dissolved in DMSO (some compounds such as HBCD need 
presence of 2-hydroxypropyl-β-cyclodextrin (450mg/ml) to improve the aqueous 
solubility) and cells were exposed to  1% DMSO (such as  30 µl in 3 ml of buffer) 
in experiments (this maximum concentration had no effect on the Fluo-3 fluorescence 
intensity of cells when added alone). Each series of images were analysed using 
Image J software (version 1.32j; National Institutes of Health USA). For each 
recording, the analysis involved the measurement of the mean intensity /cell area for a 
number of cells. After corrections for background fluorescence and photo-bleaching 
were made, these values were then converted into ratios of fluorescence intensities 
with respect to unstimulated fluorescence intensity (such as F/Fo) for each cell. These 
experiments were replicated at least three times.  
 
2.2.13- Transfection 
 
2.2.13.1- Making Luria-Bertani (LB) - Agar Plates 
 
LB- Agar (1.2 % agar in LB media autoclaved) was heated in a microwave in a 80 ml 
bottle (for 1 minute on full power), followed by 5 minutes on medium power. The 
LB- Agar was allowed to cool on bench until warm enough to hold. Next, 1µl of 
0.1g/ml Ampicillin for every 1ml of LB- Agar (e.g. 80µl of Ampicillin for 80ml of 
LB- Agar) was added and mixed gently to avoid bubbles in the LB- Agar). This was 
then poured into 10cm diameter petri dishes (80ml of LB- Agar should give 3 plates).  
 
2.2.13.2- Plasmid preparation and transformation of DH5α cells 
 
The expression vector pcDNA3.1 (+) (Invitrogen) containing an EGFP-tagged (at the 
C-terminal) of the SERCA1 sequence was constructed and provided by J.M. East 
(University of Southampton, UK) as described in (Newton et al., 2003). Competent 
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DH5α cells were heat shocked to take up the plasmid DNA and transfered into LB-
agar plates. Plates were incubated for 24h to allow colony growth. Selected colonies 
were transfered to LB liquid broth and an overnight culture was performed. 
 
Plasmid DNA was then isolated from three overnight cultures, using PureLink™ 
HiPure Plasmid Filter Maxiprep Kits purchased from Sigma, (following the 
manufacturer's instructions). 
 
2.2.13.3- Restriction digest and gel electrophoresis of maxiprep 
 
A restriction digest enzyme such as NdeI was performed to ensure the maxiprep 
consists of only plasmids containing the SERCA1 gene. NdeI cuts at only one 
restriction site, which is not within any multiple cloning sites of pcDNA3.1 (+) or 
SERCA1 gene sequence. This allows the insertion of almost any specific fragment of 
DNA into plasmid vectors, which can be efficiently "cloned" by insertion into 
replicating bacterial cells. After restriction digest, DNA can then be analysed using 
0.8 % agarose gel electrophoresis for 30 min at 80 volt then the gel was stained with 
Invitrogen SybrSafe DNA gel dye and visualized under UV light as shown in chapter 
5 figure 5.2.1.1 
 
2.2.13.4- Estimating plasmid DNA quality 
 
The DNA concentration was estimated by measuring its absorbance at 260 nm (A260). 
The DNA solution was diluted in 1in 10 mM Tris-HCl, pH 7.5 in a spectrophotometer 
where an absorbance of 1 (1 cm path length) is equivalent to 50 µg DNA / ml. The 
concentration of DNA was calculated using the formula in equation.1 (Eq.1):  
 
 
 
The plasmid DNA was relatively pure with an estimated concentration of 0.91µg/ml. 
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2.2.13.5- Transfection of SH-SY5Y cells 
 
The SH-SY5Y cells were grown in 24-well tissue culture plates (4x10
4 
cells/well) in 
1ml of in Dulbecco‟s Modified Eagle‟s Medium (DMEM), supplemented with 10% 
fetal bovine serum (FBS) and 1% penicillin/ streptomycin, at 37°C under a 5% CO2 
atmosphere. The optimum transfection condition ratio of (1:8) was used the SERCA1 
plasmid DNA: Metafectene
TM
 (Biontex). To over-express SERCA1, the SERCA1-
EGFP pcDNA3.1 (+) plasmid was added to SH-SY5Y cells, according to the 
manufacturer‟s instructions. Briefly, when the cells reached 40-50% confluence they 
were washed once with PBS. The solutions of plasmid and metafectene transfection 
reagents were mixed with media (without FBS or antibiotics) and added to the cells 
and incubated for a period of 24 h. After that, the metafectene was discarded and fresh 
culture media, supplemented with FBS and antibiotics were added to the cells. 
Metafectene alone was used as a positive control for transfection, added in DMEM 
without phenol red, serum and antibiotics, following manufacturer procedures. 
Transfection required 48 h to complete. 
 
2.2.13.6- MTT cell viability assay: after transfection  
 
Fluorescent microscope images were taken 48 h after transfection to observe the 
proportion or efficiency of cells transfected with SERCA1-EGFP. In order to assess 
whether the transfected SH-SY5Y cells provided protection against compound-
induced cell death, MTT cells viability assay were also carried out after transfection. 
The cells were exposed with the compounds for 22 h. MTT assays were then 
conducted using the same method as described previously and percentage cell 
viability was determined. 
 
2.2.14- Flow cytometry 
  
The cells were transfected and incubated at 37°C for 48 h before analysis for green 
fluorescent protein (GFP) expression. Cells were exposed to compound for 22-24h 
then washed with PBS and incubated with 0.05% trypsin-EDTA (Invitrogen, USA) 
until cells detached from the surface. After incubation, complete medium was added 
to inhibit trypsin, followed by centrifugation and washing with PBS. They were then 
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replenished with PBS containing 2% serum and 3µM of PI (Propidium iodide, 
Invitrogen, USA). Transfection efficiency was assessed by Flouresence-activated cell 
sorting analysis (FACS) analysis with the aid of a FACScalibur (BD Biosciences, 
CA), which used the 488 nm line of an argon laser to excite both PI and GFP. After 
cell observation with fluorescent microscopy, cell samples were transferred to FACS 
tubes and directly analyzed without any additional treatment. Data was then analyzed 
with Flowjo software (Treestar; USA), using appropriate controls and gates. Dead 
cells (PI positive) and cell debris were excluded from the calculation of the 
percentage of cells expressing GFP. 
 
2.2.15- Ca
2+
- ATPase activities 
 
2.2.15.1- Measurement of SR Ca
2+
-ATPase activity employing the coupled 
enzyme assay 
 
The effects of compounds on SERCA activity in rabbit skeletal muscle SR were 
investigated at pH 7.2 and 25°C, using a coupled enzyme assay as previously 
described by Michelangeli and Munkonge (1991). Typically, 10 µg/ml of SR Ca
2+
-
ATPase protein was added to a buffer containing 40 mM HEPES/KOH (pH 7.2), 
1mM EGTA, 5 mM MgSO4, 2mM ATP, 0.42 mM phosphoenolpyruvate, 0.15 mM 
NADH, 8.0 units pyruvate kinase, and 20 units lactate dehydrogenase. SR Ca
2+
-
ATPase was incubated for 10 min at 25°C in 2.5 ml of assay buffer. ATPase activity 
was initiated by the addition of 90 µl of 25 mM CaCl2, to give a free Ca
2+
 
concentration of 6.5 µM (pCa 5.2). SR Ca
2+
-ATPase activities were also investigated 
as a function of [Ca
2+
], [ATP] and [Mg
2+
] at pH 7.2, employing the coupled enzyme 
assay. In all experiments where the Ca
2+
 was varied, free Ca
2+ 
concentrations were 
calculated by using the binding parameters as in Gould et al., (1987).  
 
The Ca
2+
-ATPase activity was measured by monitoring the consequent oxidation of 
NADH to NAD
+
, using an Amersham Pharmacia Biotech Ultrapspec 1000 UV/Vis 
spectrophotometer to monitor the change in absorbance at 340 nm. ATPase activity is 
expressed as international I.U/mg of protein employing the following (Eq.2): 
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The SR Ca
2+
- ATPase activity data measured as a function of free [Ca
2+
] gave a 
typical bell-shape profile. This profile was fitted using Eq.3: 
 
 
 
Where Ks is the stimulatory constant and Ki is the inhibitory constant. 
 
While the activity data as a function of [ATP] was fitted into Eq.4: 
 
 
 
 
Where Vmax (cat) and Km (cat) are the enzymatic parameters for the catalytic ATP 
site and Vmax (reg) and Km (reg) are the enzymatic parameters for the regulatory 
ATP site as previously described in (Coll and Murphy, 1991). 
 
The Ca
2+
-ATPase activity data was also measured as a function of [Mg
2+
] was fitted 
to a simple enzyme inhibition equation; Eq.5: 
 
 
 
 
2.2.15.2-Determination of Ca
2+
-ATPase activity in microsomal extracts 
employing the phosphate liberation assay 
 
The Ca
2+
-dependent ATPase activity of pig brain and SH-SY5Y microsomal 
membranes was performed using the phosphate liberation assay as described by 
Longland et al., (1998) with minor modifications as described in Wootton and 
Michelangeli (2006). Briefly, microsomal extracts (5 µg) were re-suspended in 200 
µl of buffer containing 45 mM HEPES/KOH (pH 7.0), 6 mM MgCl2, 2 mM NaN3, 
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250 mM sucrose, 12.5 µg/ml A23187 ionophore, and EGTA with CaCl2 added to give 
a free [Ca
2+
] of 1µM. Assays were pre-incubated at 37 °C for 10 minutes prior to 
addition of ATP (final concentration 6 mM) to initiate activity. The reaction was 
stopped by addition of 50µl 6.5% (w/v) trichloroacetic acid (TCA) after 30 min. The 
samples were put on ice for 10 min before centrifugation for 10 min at 14,000g. The 
supernatant (100 µl) was added to 150 µl buffer containing (11.25% (v/v) acetic acid, 
0.25% (w/v) copper sulphate, and 0.2 M sodium acetate pH 4.0). Ammonium 
molybdate (25 µl of 5% (w/v)) was then added, followed by the addition on 25µl of 
ELAN solution (2% (w/v) p-methyl-aminophenol sulphate and 5% (w/v) sodium 
sulphate). The samples were mixed and the blue colouration was allowed to develop 
for 10 min prior to measuring the absorption at 870 nm using a Dynatech Laboratories 
ELISA plate reader. The amount of Pi liberated due to Ca
2+
 independent ATP 
breakdown could then be calculated and subtracted from the amount liberated in the 
presence of 1µM free [Ca
2+
], to give the Ca
2+ 
-dependent ATPase activity. 
 
2.2.16- ATP-dependent Ca
2+
 uptake and release  
 
ATP-dependent Ca
2+
 uptake from SH-SY5Y microsomal membrane and release from 
SR were by monitoring changes in fluorescence of the Ca
2+
 indicator dye Fluo-3 (free 
acid) as described by Michelangeli (1991). Briefly, microsomal membranes (100-
300µg) were added to a stirred cuvette containing 2 ml of 40 mM Tris/phosphate, 
100 mM KCl (pH 7.2) in the presence of 1.25 µM Fluo-3 (free acid), 10 µg/ml 
creatine kinase, and 10 mM phospho-creatine. Range of concentration of compounds 
was then added prior to Ca
2+
 accumulation. Ca
2+
 uptake within the membranes was 
then initiated by the addition of 1.5 mM Mg-ATP. Total Ca
2+
 accumulation was 
measured by the addition of the calcium ionophore A23187 (12.5μg/ml). The initial 
rate of Ca
2+
 uptake was calculated by measuring the [Ca
2+
] change during the first two 
min. Fluorescence changes were measured in a Perkin Elmer LS-50B 
spectrofluorimeter, using excitation and emission wavelengths of 506 nm and 526 nm, 
respectively. Ca
2+
 concentrations were determined using the following Eq.6 
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where Kd is the dissociation constant for Ca
2+
 binding to Fluo-3 (900 nM at 37 °C, pH 
7.2, in 100 mM KCl), F is the fluorescence intensity of the sample, and Fmin and Fmax 
are the fluorescence intensities in the presence of 0.25 M EGTA and 1 M CaCl2, 
respectively (Mezna and Michelangeli, 1996). Percentage Ca2+ released (%) was 
determined comparing the amount of Ca
2+
 released by the compounds with that 
observed with the addition 12.5μg/ml A23187 (Ca2+ ionophore). 
 
2.2.17- Phosphorylation studies 
 
Phosphorylation of SERCA by [γ -32P] ATP was carried out at 25 °C as described in 
(Michelangeli et al., 1990; Longland et al., 1999; Bilmen et al., 2002; Ogunbayo 
and Michelangeli, 2007). The SERCA was diluted to 0.1 mg/ml in 40 mM 
Hepes/Tris (pH 7.2) containing 100 mM KCl, 5 mM MgSO4, 1 mM CaCl2, BSA 
(final conc. 1 mg/ml) and 12.5μg/ml A23187 in a total volume of 1 ml of ATP stock 
(0.5 mM) with specific radioactivities of 10 Ci/ mol was made in the above buffer to 
cover the range between 0 and 20 µM. The reaction was initiated by the addition of [γ 
-
32
P] ATP and stopped by the addition of 250μl ice-cold 40% (w/v) TCA after 15s. 
The samples were placed on ice for 30 min. SR Ca
2+
-ATPase was separated from the 
solution by filtration through Whatman GF/C filters. The filters were washed with 30 
ml of 12.5 % (w/v) TCA containing 0.2 M H3PO4 and left to dry. The filters were 
placed in scintillant and counted. 
 
 
2.2.18- Effects of HBCD on FITC-labelled Ca
2+
-ATPase 
 
 
SR Ca
2+
-ATPase was labelled with fluorescein 5'-isothiocyanate (FITC), according to 
the method described by Michelangeli et al. (1990), to monitor the E2  E1 
transition. The Ca
2+
-ATPase (1.1mg/ml) was added in equal volume to the starting 
buffer (1 mM KCl 250 mM sucrose and 50 mM potassium phosphate pH 8.0). FITC 
in dimethylformamide was then added at a molar ratio of FITC/ATPase, (0.5: 1 molar 
ratio). The reaction was incubated for 1h at 25 °C and stopped by the addition of 
250µl of stopping buffer (0.2 M sucrose, 50 mM Tris/HCl pH 7.0), which was left to 
incubate for 30 min at 30 °C prior to being placed on ice until required. Fluorescence 
measurements of FITC-ATPase were made in a buffer containing 50 mM Tris, 50 
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mM maleate, 5 mM MgSO4 and 100 mM KCl at pH 6.0. Fluorescence was measured 
in a PerkinElmer LS50B fluorescence spectrophotometer at 25 °C (excitation 495 nm, 
emission 525 nm). Ca
2+
 (400 µM) was then added to induce changes in fluorescence 
intensity. 
 
 
2.2.19- The effects of different types of BFRs and APs on Amyloid 
Precursor Protein (APP) processing in SH-SY5Y cells 
 
2.2.19.1- Measurements of Beta-Amyloid (Aβ) peptide level by ELISA 
 
Aβ 1-42 level was determined by using the BetaMark x-42 ELISA kit (Covance). In 
brief, SH-SY5Y cells (seeded at 4x10
4 
cells/100 mm petri dish) were incubated in the 
presence of different concentrations of compounds for up to 12h. After the desired 
incubation times, cell culture supernatants were removed and centrifuged to 
precipitate any cellular debris. Proteinaceous material was precipitated with 10% 
TCA for 15 min at 4°C followed by centrifugation at 21,000g. The resultant pellets 
were resuspended in a buffer containing 150 mM Tris- HCl buffer (pH 7.5) containing 
150 mM NaCl, 1% Nonidet P-40, 0.1% sodium dodecyl sulfate (SDS), 2 mM EDTA, 
in presence of protease inhibitors (10µM leupeptin) for 24 h at 4 °C and protein 
concentrations determined with the protein assay of Bradford. Samples were diluted 
to 1mg/ml with working incubation buffer according to the manufacturer‟s 
instructions. Antigen is coated on the surface of a microtiter plate as capture antibody. 
A second antibody conjugate serves as the detection 1-42 Aβ antibody in the assay. 
The antibodies and the respective amyloid-peptide form antibody-amyloid-antibody 
(sandwich) complexes. Peroxidase enzyme catalyzes the conversion of a substrate 
(Chromogen) into a coloured product, which subsequently is measured by photometry 
and correlates directly to the 1-42 Aβ concentration present in the sample. Measured 
values are quantified in correlation to a synthetic peptide standard. The assay is run on 
standard plate reader and all Aβ-ELISAs were performed in triplicate. The standard 
curve was constructed by plotting the mean value of each duplicate absorbance of Aβ 
x-42 standard peptide and then this was used to determine the concentration of Aβ x-
42 of unknown samples. 
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2.2.19.2- Immunoblotting of APP fragments 
  
Cellular proteins from cultured SH-SY5Y cells (growing in 4x10
4 
cells/100 mm petri 
dish) were extracted after expose to different of compounds of 12 h by lysis buffer 
containing 150 mM Tris-HCl, 150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, and 2 
mM EDTA, pH 7.5, in the presence protease inhibitors; 1 mM PMSF and 10 µg/ml 
leupeptin). Lysates were completed by sonication and protein levels determined. 
Samples were separated by SDS-PAGE on an 8% polyacrylamide Tris/glycine gels 
and transferred to a nitrocellulose membrane (Hybond ECL, Amersham Pharmacia 
Biotech Inc., USA). Non-specific binding sites will block by treatment with PBS 
containing 10% skimmed milk for 1 hr, and then washed with PBS containing 0.1% 
Tween 20 (T-PBS). The membrane was incubated with a 1:100 dilution of the β-
Amyloid antibody (20.1): sc-53822, Santa Cruz Biotechnology, Inc). After 1 h 
incubation at room temperature the membrane was washed and incubated with a 
second antibody (1:2000) alkaline phosphates conjugated anti-mouse IgG for an 
additional hour, washed again and finally the blot developed by incubated for 5-10 
with the BCIP/NBT ((5-bromo-4-chloro-3-indolyl phosphate/ nitro blue tetrazolume): 
Sigma, UK) and the APP positive bands were recorded on Kodak digital science 
camera (DC120). 
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CHAPTER 3 
 
 
Cell Toxicity Mechanism 
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3.1- Introduction 
 
Brominated flame retardants (BFRs) are incorporated into a wide range of consumer 
products that have been the ability of potentially being a fire hazard. These include 
every day items such as TV-sets, household appliances, computers, and textiles and 
their addition is used as an essential safety feature of modern design and production 
(Karter, 2008). BFRs are a diverse group of chemicals, which are used to slow down 
or inhibit the development of fires but are also a group of global environmental 
contaminants (de Boer et al, 1998). Recently, concern for this emerging class of 
chemicals has a risen because of the occurrence of several classes of BFRs in the 
environment and in human and animal biota. The widespread production and use of 
BFRs, the increasing contamination of the environment, wildlife, and people and the 
limited knowledge of their potential adverse health effects, increases the importance 
of identifying emerging issues associated with the use of BFRs (Birnbaum and 
Staskal, 2004). Commonly occuring BFRs include tetrabromobisphenol-A (TBBPA), 
hexabromocyclododecane (HBCD), polybrominated diphenyl ethers (PBDEs) such as 
Deca-, Pent- and Octa-bromodiphenyl ethers, tribromophenol, dibromobiphenyl, 
tetrabromohydroquinone, and tetrabromobisphenol-A diallyl ether, which are all 
examined in this study. Cell viability, caspase activation, cytochrome c release, 
measurement of mitochondrial membrane depolarisation, detection of reactive oxygen 
species and intracellular [Ca
2+
] levels measurement assays were used to elucidate the 
mechanism of cytotoxicity of these chemicals in the SH-SY5Y human neuronal cells 
line. Additionally, this study also examined environmental plasticisers and related 
chemicals of which some are known to be endocrine disruptors (EDs), such as 
bisphenol-A (BPA) and 4-n-nonylphenol (NP) (Jobling et al., 1995, Routledge and 
Sumpter, 1997). EDs may have impacts at much lower levels than those of traditional 
concern to toxicologists (Geck et al., 2000). BPA induces cell death in many kinds of 
cells in in-vitro models (Hughes et al., 2000). Recently alkylphenols have also been 
shown to affect Ca
2+
 signalling pathways (Michelangeli et al., 2008).  
 
This study focuses on two alkylphenol EDs, these being NP and BPA and investigates 
their ability to modulate neuronal SH-SY5Y cell viability, mitochondrial 
depolarisation and Ca
2+
 homeostasis. 
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3.2- Results 
 
3.2.1- The effects of various BFRs, BPA, and NP on the viability of 
SH-SY5Y cells as monitored using the MTT assay  
 
Initially a series of neuronal cell viability assays were performed with a range of 
concentration of BFRs and APs to determine their potential for neurotoxicity. 
 
Figure 3.2.1A-K; shows the dose-dependent affects of different types and 
concentrations of BFRs and APs on SH-SY5Y cell viability. The cells were incubated 
for about 22-24h of exposure at 37 °C in CO2 incubator and cell viability was 
measured using the MTT based assay and compared to cells not exposed to these 
compounds but to DMSO (2%) alone. All data represent the mean ± the SD of 
between 3-4 determinations. Figure 3.2.1A insert shows cell viability was measured 
by flow cytometry. SH-SYSY cells treated with 2% DMSO (control) and 3µM HBCD 
for 22h. 3μM HBCD also caused about 50% cell death as determined by propidium 
iodide stained cells and FACS analysis (fig.3.2.1A insert). Table 3.2.1; lists the lethal 
concentration 50 (LC50) for cell viability of these compounds. It can be seen that 
HBCD is the most potent inhibitor (the LC50 was 2.7 ± 0.7µM) compared to other 
compounds. In contrast, TBBPA-diallyl ether and BPA were weakly toxic (with LC50 
of > 300 µM and 243 ± 38 µM, respectively). All other compounds tested had LC50 
values of between 12-150µM. 
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Figure 3.2.1 
 
 (A) 
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Figure 3.2.1A-K; shows the cytotoxic effects of different concentrations of BFRs, NP 
and BPA on the viability of SH-SY5Y cells. The cells were treated with different 
[compound] for ~ 22 h prior to measurement, using the MTT assay. Figure 3.2.1 (A) 
insert shows cell viability measured by FACS analysis, (histograms of both control 
cells treated with 2% DMSO and cells treated with 3µM HBCD for 22h). The data 
shows that viable cells were 72% (in control) compared to 40% of viable cells when 
exposed with 3µM HBCD. All data represent the mean ± the SD of between 3-4 
determinations.  
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Table 3.2.1 comparison of lethal concentration 50 (LC50) values of different 
compounds. All data represent the mean ± the SD of between 3-4 determinations. 
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3.2.2- Caspases activation induced by TBBPA, HBCD, DBPE, NP 
and BPA using a fluorogenic substrate (Ac-DEVD-AMC (casp-3), 
Ac-IETD-AMC (casp-8), and Ac-LEHD-AMC (casp-9))  
 
In order to determine whether cell death by these compounds was, at least in part by 
apoptosis, caspase activities were measured. 
 
As shown in figure 3.2.2.1; caspases-3, -8 and -9 activities were determined in SH-
SY5Y cells where they were incubated in the presence of three different 
concentrations of HBCD, TBBPA, NP, DBPE and BPA for 12h. In figure 3.2.2.1A; 
all compounds tested showed activation of the executioner caspase (caspase-3) at all 
of the concentrations tested. TBBPA, HBCD and NP were particularly potent at 
increasing caspase-3 activity as they showed statistically significant levels of activity, 
above those of control, at 1µM. However, DBPE and BPA were least effective only 
showing significant activity above control at 10 µM and 50 µM, respectively.  
 
In order to determine whether caspase activation was by intrinsic (via caspase-9) or 
the extrinsic (via caspase-8) apoptotic pathways, the activities of these caspases were 
also measured (figure 3.2.2.1B&C). The results showed that most compounds tested 
were equally effective at increasing the activities of both caspase-8 and -9. However, 
a notable exception was NP which appeared to preferentially activate caspase-9 
compared to -8, highlighting that it activated a specific apoptotic pathway.     
 
In order to understand whether BFRs caused activation of the two caspases pathways 
independently or concertedly, a time course of caspase-8 and caspase-9 activation was 
undertaken with HBCD (5µM). Figure 3.2.2.2A shows that the time course for the 
induction of caspase-8 and -9 activities were similar. 
 
In order to assess whether there was sequential activation of either pathways by 
HBCD, experiments with caspase-8 and -9 inhibitors were undertaken. Figure 
3.2.2.2B shows that cells pretreated with either caspase-8 or -9 inhibitors partially 
protected the cells from cell death. It should be noted, however, that the addition of 
either caspase inhibitors did not fully protect against 2µM HBCD-induced cell death.  
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Figure 3.2.2.1 
 
(A) 
 
  
 (B) 
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(C) 
 
 
 
 
Figure 3.2.2.1; activation of caspases by HBCD, TBBPA, NP, DBPE and BPA using 
caspase-specific fluorogenic substrates. (A) Shows the effects of different 
concentration of HBCD, TBBPA, NP, DBPE and BPA on DEVD-ase activity 
(indicative of caspase-3 cleavage activity), (B) IETD-ase activity (indicative of 
caspase-8 cleavage activity) and (C) LEHD-ase activity (indicative of caspase-9 
cleavage activity), after 12 h of exposure in SH-SY5Y cells. Values are presented as 
means ± SD of 3-4 determinations (* value points were significant different from the 
controls (P  0.05, ** P   0.001), using t-test. 
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Figure 3.2.2.2 
 
 (A) 
 
 
 
 (B) 
 
 
 
Figure 3.2.2.2 (A) Time course of the effects of 5µM HBCD on caspases-3, -8 and -9 
activities in SH-SY5Y cells. (B) Showed that inhibition of either caspase-8 (CI-8) or 
caspase-9 (CI-9) enhanced the viability of cells after the SH-SY5Y cells were treated 
with 2µM HBCD. The data was analysed using the t-test (* indicates significant 
difference from the control (P  0.05, ** P   0.001).  
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3.2.3- Detection of cytochrome c in mitochondrial and cytosolic 
extracts from SH-SY5Y cells by using immunoblotting with a 
cytochrome c antibody 
 
As the caspase-9 pathway was activated, which involves the mitochondria releasing 
pro-apoptotic factors such as cytochrome c, experiments were undertaken to assess 
whether some of the BFRs and APs caused cytochrome c to be released from the 
mitochondria in to the cytoplasm.  
 
Figure 3.2.3 shows cytochrome c was detected by immunoblotting analysis of the 
mitochondrial and cytosolic fractions which were obtained from SH-SY5Y cells 
treated with HBCD, TBBPA, NP and DBPE for 12h. Cytochrome c appeared in 
cytosolic fraction of SH-SY5Y cells after treatment with HBCD, TBBPA, NP and 
DBPE. However, in control cells no cytochrome c in the cytoplasm was detected.    
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Figure 3.2.3 
 
 
 
 
 
 
 
Figure 3.2.3; shows cytochrome c was detected by immunoblotting analysis. SH-
SY5Y cells (5 × 10
5
 cells/35 mm dish) were incubated in the presence of HBCD (5-10 
µM), 5µM TBBPA, 10µM NP and 20µM DBPE for 12 h. Samples form the 
mitochondrial fraction (Mit.) and cytosolic fraction (Cyto.) were extracted from SH-
SY5Y cells by homogenization and centrifugation at 100,000g and were subjected to 
15% SDS-PAGE followed by western blotting with anti-cytochrome c IgG. The blots 
were representative of two repeats. 
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3.2.4- The effects of HBCD, TBBPA, DBPE, NP and BPA on the 
intracellular concentration ([Ca
2+
]i) levels within SH-SY5Y cells 
loaded with Fluo-3 AM 
 
As cell-death can be induced by prolonged elevation of [Ca
2+
]i levels, since previous 
studies have shown that related compounds can cause similar effects (Ogunbayo et 
al., 2008; Michelangeli et al., 2008), experiments were undertaken to investigate 
whether these compounds also elevated [Ca
2+
]i in SH-SY5Y cells. 
  
The figure 3.2.4.1A; shows traces of the relative fluorescence change averaged for 8 
individual cells viewed, using the fluorescence microscope, the profiles of which were 
typical of the majority of cells observed. The arrow indicates the addition of HBCD 
after around 60s from the start of the recording. Under these experimental conditions, 
more than 70% of all cells viewed showed changes in their [Ca
2+
]i levels upon 
exposure. The rise in [Ca
2+
]i measured as an increase in relative fluorescence levels 
attained maximal levels within about 1-2 min of the addition of HBCD. The 
elevations in [Ca
2+
]i levels were transient in nature and returned back towards un-
stimulated levels after about a 5 min period. Figure 3.2.4.1B shows the dose-
dependent effects of increasing [HBCD] on [Ca
2+
]i levels within SH-SY5Y cells. (The 
EC50 was calculated to be 7 ± 0.6 µM). Figure 4.2.4.1C; shows fluorescence 
micrograph images of a number SH-SY5Y cells rendered in greyscale (i.e. black is 
low [Ca
2+
], white is higher [Ca
2+
]), before 20 µM HBCD addition (60s), at a time 
point where the maximal increase [Ca
2+
]i is occurring (240s) and towards the end of 
the experiment (500s). The magnification was equivalent to 500x. Figure 3.2.3.2 
shows that TBBPA, NP, DBPE and BPA also all increase [Ca
2+
]i levels of Fluo-3 AM 
loaded SH-SY5Y cells.  
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Figure 4.2.4.1  
 
(A) 
 
 
(B) 
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(C) 
 
 
 
 
 
Figure 3.2.4.1; the dose-dependent effects of [HBCD] on changes of intracellular 
[Ca
2+
] levels of SH-SY5Y cells. (A) Shows the changes in relative fluorescence 
intensity (F/Fo) versus time of 8 averaged SH-SY5Y cells loaded with Fluo-3, at pH 
7.2, 37 °C, when treaded with 3.3, 10, 20 and 30 µM HBCD (at the point marked with 
the arrow). These traces were typical of those observed in three replicate experiments. 
(B) (■) Shows the summary of effects of increasing [HBCD] on intracellular [Ca
2+
] 
levels within single SH-SY5Y cells. The results represent the mean ± SD of 3 
determinations. (C) Shows fluorescence micrograph images of Fluo-3 AM loaded SH-
SY5Y cells, just prior to exposure (at 60s from start of recording) and after exposure 
to 30 µM HBCD (i.e. at 240s and 500s from the start of recording). The fluorescence 
micrographs are presented in greyscale (where black indicates the lowest level of 
[Ca
2+
] and white the highest). 
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Figure 3.2.4.2 
 
 
 
 
 
 
 
Figure 3.2.4.2; the effects of TBBPA, NP and DBPE on [Ca
2+
]i levels within single 
SH-SY5Y cells. This figure shows the effect of TBBPA, NP and DBPE on the 
increase in [Ca
2+
]i levels within single SH-SY5Y cells loaded with Fluo-3, at pH 7.2, 
37 °C, when treaded with TBBPA, NP and DBPE, 15 µM, 10 µM and 20 µM 
respectively (at the point marked with the arrow). Each trace corresponds to the mean 
of 8 cells averaged together and all traces were typical of those observed in three 
replicate experiments.  
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3.2.5- Mitochondria membrane depolarization of SH-SY5Y cells after 
exposure to HBCD, TBBPA, NP, DBPE and BPA 
 
In order to further explore the relationship between elevation of [Ca
2+
]i and cell death, 
it is known that changes in intracellular Ca
2+
 levels cause Ca
2+
-dependent 
depolarization of the mitochondria membrane (Gunter et al., 2004; Michelangeli et 
al., 2005; Hom et al., 2007). Rhodamine123 (Rh123) is fluorescent dye which 
preferentially goes into mitochondria. When the mitochondria depolarise the dye 
leaks out and decreases its fluorescence. 
      
Figure 3.2.5.1A; shows how the fluorescence intensity of the Rh123-loaded SH-
SY5Y cells decreases after exposure to HBCD. Each trace corresponds to the average 
fluorescence change of 8 cells combined together and the traces show that the 
decrease in fluorescence occurred at all concentrations of HBCD tested. The HBCD 
was added to the cells about 60s after the start of the recordings. When no HBCD was 
added a small decrease in fluorescence was observed probably due to some photo-
bleaching. However, the rate of fluorescence decrease was significantly enhanced 
upon exposure to HBCD, suggesting rapid mitochondrial depolarisation within a few 
seconds of exposure. Figure 3.2.5.1B; shows the fluorescence images of Rh123-SH-
SY5Y cells, prior to 10 µM HBCD exposure (50s) and at the around end of the 
experiment (320s).  
 
Figure 3.2.5.2; also shows similar effects of TBBPA, NP, DBPE and BPA on the 
mitochondria membrane depolarisation. The compounds were added to SH-SY5Y 
cells about 50s after start of the recordings under fluorescence microscopy. The traces 
(each trace contains an average of 8 individual cells) show that the decrease in 
fluorescence occurred for all compounds. 
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Figure 3.2.5.1 
 
 
 (A) 
 
 
 
 
(B) 
 
 
Figure 3.2.5.1 (A); shows the effects of different of [HBCD] on the mitochondrial 
membrane depolarisation. This was monitored in Rh-123-loaded SH-SY5Y cells. 
Traces are the combined average of 8 individual cells recorded from within the field 
of view from the fluorescence microscope. The arrow indicates the time point where 
the HBCD was added. (B); shows the fluorescence images of SH-SY5Y, prior to 
10µM HBCD exposure (50s) and at the around end of the experiment (350s). 
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Figure 3.2.5.2 
    
 
 
 
 
Figure 3.2.5.2 shows the effects of TBBPA, NP, DBPE and BPA on the 
mitochondrial membrane depolarisation of SH-SY5Y cells loaded with Rh123. Upon 
exposure to 10µM of TBBPA, NP, DBPE and 100µM BPA. The traces are the 
combined average of 8 individual cells, within the field of view, and are typical of 3 
replicate experiments.   
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3.2.6- The induction of ROS by HBCD, NP, TBBPA, DBPE and BPA 
 
As mitochondrial disfunction can lead to oxygen free radicals production and 
ultimately to cellular damage, the ability of compounds to cause oxidative stress in 
SH-SY5Y cells was determined by measuring reactive oxygen species formation via 
monitoring 2',7'-dichlorofluorescein (DCF) fluorescence. 
 
Figure 3.2.6.1A shows the production of ROS in SH-SY5Y cells after exposure to 
different concentrations of HBCD for 22-24 hr. Fluorescence of DCF relative to 
control was measured after 30 min treatment with 2‟,7‟-dichlorofluorescein diacetate 
(DCFH2-DA). Of the other compounds tested (i.e. TBBPA, DBPE, NP and BPA), all 
except DBPE and BPA, showed some formation of ROS compared to control. Data 
are presented as means ± SD. (* indicates significant difference from the control (P 
 0.05, ** P   0.001). 
 
Figure 3.2.6.1B ROS formation was also shown to be concentration dependent with 
HBCD having an EC50 of 6 ± 0.4 µM.  
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Figure 3.2.6.1 
 
(A) 
 
 (B) 
 
 
Figure 3.2.6.1 (A); shows the effects of HBCD, TBBPA, NP, DBPE and BPA on 
ROS production as measured by increase in DCF fluorescence. SH-SY5Y cells were 
exposed to the compounds for 24 h. The fluorescence intensity was monitored after 
the reaction mixture was incubated for 30 min (37°C). Data represents the mean ± S.D 
of 3-4 determinations. (*) and (**) indicates statistically significant difference from 
control (2% DMSO), (p < 0.05) and (p < 0.001) respectively. (B) the dose-dependent 
increase of DCF fluorescence intensity in SH-SY5Y cells after exposure to different 
concentrations of HBCD (EC50 value was 6 ± 0.4 µM).  
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3.3- Discussion 
 
Brominated flame retardants (BFRs) and alkylphenols (APs) are chemicals pollutants 
commonly found within the environment and have human health concerns due to their 
endocrine disrupting and cytotoxic effects. BFRs are used to reduce the flammability 
of a variety of consumer products such as foam furnishings, whereas APs are found in 
plastic products used by the food industry. In-vitro studies have shown that a variety 
of the BFRs pollutants are neurotoxic and can affect a range neurological cell 
functions, such as cell signalling processes, neurotransmission and cell death 
(Barclay et al., 2005; Dingemans et al., 2008). Little is, however, known as to the 
molecular mechanisms of action of these BFRs and also whether APs pollutants also 
act on neurons in a similar fashion. The human neuroblastoma SH-SY5Y cell line is 
similar to common nerve cells in terms of shape, physiological and biochemical 
function and is commonly used as model for neurons. 
 
In this chapter, the cell viability, caspases activation, cytochrome c release, 
mitochondria membrane depolarisation, ROS formation and elevation of [Ca
2+
]i levels 
assays were used to assess the mechanism of cytotoxicity of some commonly utilized 
of BFR and APs in SH-SY5Y human neuronal cells.  
 
The data in fig.3.2.4.1A and fig.3.2.4.2, show that HBCD, TBBPA, DBPE and NP 
induce a transient elevation in [Ca
2+
]i within SH-SY5Y cells, these Ca
2+
 transients 
were comparable similar to those observed when these cells were treated with the 
potent Ca
2+
 pump inhibitor, thapsigargin, which is also used to induce cell death by 
Ca
2+
-dependent mechanism (Hughes et al., 2000; Laskay et al., 2005; Hom et al., 
2007). It is well known that mitochondria are important cellular organelles regulating 
metabolism and
 
cell death pathways (Acton et al., 2004). The MTT cell viability 
assay is an indicator of mitochondrial activity and specificity of mitochondrial 
dehydrogenase activity (Fotakis and Timbrell, 2006). It can be deduced that of the 
11 chemicals tested (over a 22 h exposure), the data present here shows that HBCD 
was the most potent at inducing cell death in the SH-SY5Y neuroblastoma cells (see 
table 3.2.1). The LC50 for HBCD and NP calculated to be 2.7 ± 0.7μM and 6 
± 1.8µM, respectively. This range of HBCD potency on inducing cell death is similar 
- 112 - 
 
that observed by Reistad et al., (2006) (the LC50 value was estimated to 3μM in 
cerebellar granule cells) and may indicate that a range of neuronal cell types are 
similarly affected by this chemical, while for NP the LC50 values were similar to that 
found in TM4 Sertoli cells (i.e. LC50 = 10 µM) (Michelangeli et al., 2008). 
 
Furthermore, these results show that HBCD, TBBPA, NP can depolarize 
mitochondria in these neuronal cells at low micromolar concentration (fig.3.2.5.1A 
and fig.3.2.5.2), with the degree and rate of depolarization also being dependent upon 
the concentration of HBCD (fig.3.2.5.1A). Specific toxic stress events can cause Ca
2+
 
overload in the mitochondrial matrix which can trigger mitochondrial membrane 
depolarization, this then causes release of pro-apoptotic factors, by activating the PTP 
and loss of mitochondrial membrane integrity (Michelangeli et al., 2005; Hajnoczky 
et al., 2006; Hom et al., 2007). However, oxidative stress also triggers apoptosis that 
is associated with decreased levels of MMP, increased generation of intracellular ROS 
and accumulation of intracellular Ca
2+
 level (Satoh et al., 1997; Hoyt et al., 1997). 
Although it is established that mitochondrial respiration is an important source of 
ROS production, excessive ROS generated within the mitochondria can also cause 
damage to cellular components (Koizumi et al., 1996) such as proteins, membranes 
and DNA. The fact that micromolar concentrations of HBCD, TBBPA and NP are 
able to generate measurable levels of ROS in SH-SYSY cells, (an observation also 
seen that BFRs cause increased ROS formation in SH-SY5Y cells (He et al., 2008) 
and in Hep G2 cells (Zhang et al., 2008)). This would indicate that further 
experiments investigating the effects of these compounds on DNA damage should be 
undertaken.  
 
There are two major pathways of caspase activation during apoptosis. The first of 
these is the intrinsic (mitochondrial) pathway and the second extrinsic (death 
receptor) pathway. The mitochondrial pathway releases cytochrome c into the cytosol, 
which binds and activates of apoptotic protease activating factor-1 (Apaf-1), 
promoting the activation of caspase-9, which then results in activation of caspase- 3 
(Riedl and Salvesen, 2007). Alternatively, Death receptors are activated by ligand 
binding to the extracellular domain of the receptor causing activation of caspase-8 by 
forming the death-inducing signalling complex (DISC) (Thorburn, 2004). However, 
a recent study has shown that some BFRs cause an increase in [Ca
2+
]i which induced 
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apoptosis in human neuronal SH-SY5Y cells by activation of two caspases pathways 
(He et al., 2009). HBCD, TBBPA and DBPE are shown to induce the activation of 
both caspase-8 and -9, resulting in the activation of caspase-3 (see fig.3.2.2A, B& C), 
while NP appeared to specifically activate caspase-9. The apoptotic pathway through 
mitochondria was further confirmed by cytochrome c release (see fig.3.2.3.4).  
 
Some BFRs have been shown to disrupt Ca
2+
 homeostasis by increasing [Ca
2+
]i in 
SHSY5Y cells which can then activage the death receptor which induces caspase-8. 
This results in activation of the pro-apoptotic Bid which enters the mitochondria and 
blocks the functioning of Bcl-2 resulting in the release of cytochrome c. This 
stimulates caspase-9 which the actives caspase-3 and leads to cell death (He et al., 
2009). These results, at least for HBCD, indicate it unlikely that caspase-9 is activated 
via caspase-8 as shown in studies (Sprick and Walczak, 2004; He et al., 2009), as 
the resuts with caspase inhibitors and the time-course of induction of caspase -8 and -
9 activities, would likely preclude this. 
 
In summary, this study has shown that these pollutants are neurotoxic at low 
concentrations. Some compounds such as HBCD, TBBPA, DBPE and NP induce cell 
death (apoptosis) by caspases activation (Caspse-8, -9 and -3) and cytochrome c 
release at low micromolar concentration. These compounds also cause mitochondria 
membrane depolarisation and increase in intracellular Ca
2+
 levels and some also cause 
ROS formation supporting the possible mechanisms as described in see fig.3.3 
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Figure 3.3 
 
 
 
 
Figure 3.3: schematic representations of the effects of these compounds on apoptosis 
SH-SY5Y cells. 
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CHAPTER 4 
 
 
Molecular Toxicity on 
Ca
2+
 Transporters 
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4.1- Introduction 
 
 
Ca
2+
 is a commonly employed signal within cells that regulates many different 
cellular processes such as contraction, secretion, fertilisation and proliferation by 
increasing in [Ca
2+
]i levels (Khan et al., 2003; David et al., 2000), inadequate or 
prolonged elevation of [Ca
2+
]i may be lead to deleterious effects (Berridge et al., 
1998) and to avoid these effects, [Ca
2+
]i levels must be strictly controlled by SERCA 
Ca
2+
 pumps (Khan et al., 2003; David et al., 2000), which help to maintain low 
cytosolic [Ca
2+
] levels in resting cells (Khan et al., 2003; Ogunbayo et al., 2007).  
 
SERCA Ca
2+
 pumps belong to the P-type ion transporters (Toyoshima and Inesi, 
2004) that exist in three isoforms and exhibit a tissue-specific distribution (Khan et 
al., 2003; Ogunbayo et al., 2007). SERCA1 is expressed exclusively in skeletal 
muscle (MacLennan et al., 1985), SERCA2a isoform is expressed predominantly in 
cardiac tissues and SERCA2b is dominating isoform found in neuronal tissues 
including SH-SY5Y cells (Baba-Aissa et al., 1998, Mbaya et al., 2010). SERCA3 is 
expressed in non- muscle tissues (Wu et al., 1995).  
 
A number of brominated flame retardants (BFRs) have recently been recognized as 
widespread environmental contaminants (Reistad et al., 2006). It is clear that some of 
BFRs are non-isoform specific inhibitors of the SERCA Ca
2+
 pumps at low 
micromolar (µM) concentrations within cells (Ogunbayo and Michelangeli, 2007). 
Mobilisation of intracellular Ca
2+
 stores by inhibiting SERCA activity is one of the 
mechanisms by which BFRs and APs interfere with the Ca
2+
 signalling pathway 
(Hughes et al ., 2000; Ogunbayo and Michelangeli, 2007; Ogunbayo et al., 2008). 
 
It is now evident that a number of BFRs and APs are cytotoxic at low µM 
concentrations within cultured cells (Ogunbayo et al., 2007; Michelangeli et al., 
2008). This has led to investigation the effects of nine BFRs and two APs on SERCA 
Ca
2+
 pumps in skeletal muscle vesicles (SERCA1a), SH-SY5Y microsomal and 
cerebellar microsomes (both SERCA2b) (Plessers et al., 1991; Mbaya et al., 2010). 
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4.2- Results 
 
4.2.1- The effect of BFRs, Thapsigargin (Tg), NP and BPA on skeletal 
muscle (SR) Ca
2+
-ATPase activity   
 
Initially a number of BFRs and APs were tested on the SR Ca
2+
-ATPase using the 
coupled enzyme method, which contains the SERCA 1a isoform. 
  
Figure 4.2.1.1 (A-I) shows effect of nine different types of BFRs on the skeletal 
muscle SERCA 1A isoform of Ca
2+
 -ATPase activity, measured at pH 7.2 at 25°C. Of 
the BFRs tested HBCD was the most potent inhibitors of the SERCA 1a Ca
2+
-
ATPase, with IC50 values calculated to be 1.2 ± 0.4 µM, then TBBPA and apart from 
DBPE (IC50, 1.8 ± 0.6 µM and 36 ± 4.4µM, respectively), the other BFR's tested 
proved to be weak inhibitors of SERCA 1a Ca
2+
-ATPase, since the IC50 were 
calculated to be around 100-300µM (see table 4.2.1). 
 
Figure 4.2.1.2 (A-C) shows the effect of different concentrations of Tg, NP and BPA 
on skeletal muscle SERCA 1A isoform of Ca
2+
-ATPase activity, measured at pH 7.2 
at 25°C. Tg has been shown to be a specific inhibitor of all SERCA isoforms (Lytton 
et al., 1991; Wootton and Michelangeli, 2006). In this study, the IC50 for Tg, the 
most potent SERCA1A inhibitor, was 100 ± 5.6 nM, while that for NP was 9 ± 1.3µM 
and for BPA, 180 ± 27µM.   
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Figure 4.2.1.1 
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Figure 4.2.1.1 (A-I); shows the inhibition of nine BFRs on the skeletal muscle the 
Ca
2+
-ATPase (SERCA1a) activity measured in rabbit skeletal muscle SR membranes 
at 25 °C in buffer at pH 7.2. The data points represent the mean ± SD of between 3-4 
determinations.  
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Figure 4.2.1.2 
 
 
 
 
 
 
 
Figure 4.2.1.2; the effect of Tg (A), NP (B) and BPA (C) on the skeletal muscle SR of 
Ca
2+
-ATPase (SERCA1a) activity, measured at pH 7.2 and at 25°C. The data points 
represent the mean ± SD of between 3-4 determinations  
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4.2.2- The dose-dependent effects of BFRs on the SH-SY5Y 
microsomal membranes and cerebellar microsomes measured by the 
phosphate liberation assay  
 
Microsomal extracts from brain and cells are a good source of Ca
2+ 
stores which 
contain Ca
2+ 
pumps, and Ca
2+ 
release channels such as IP3 receptor and RyR 
(Berridge et al., 2000). Cerebellum is known to express mostly SERCA2b (Plessers 
et al., 1991; Baba-Aissa et al., 1998) and SH-SY5Y cells also contains mainly 
SERCA2b (Cecchi et al., 2000; Mbaya et al., 2010). 
 
Figure 4.2.2 (A-J) shows the effects of a number of BFRs on Ca
2+
- ATPase activity in 
SH-SY5Y microsomal membranes (▼) and cerebellar microsomal (■), using the 
phosphate liberation method. Again for the BFRs, HBCD and TBBPA proved to be 
the most potent at inhibiting the SERCA2b Ca
2+
 pumps of cerebellar microsomal and 
SH-SY5Y microsomal, membranes, with IC50 values for the inhibitors in 4.3-13µM 
concentration range. In general the IC50 values determined for pig cerebellar 
microsomes and SH-SY5Y membranes were comparable. (see table 4.2.1). Of the 
other BFR's tested it was clear that the polybrominated diphenyl ethers were 
reasonably effective inhibitors of SERCA2b, since DBPE, OBPE and PBPE had IC50 
values of between 38 to 93µM. All other Brominated compounds tested were poor 
inhibitors and had IC50 values which ranged from approximately 200-300µM. NP was 
also determined to be an effective inhibitor (IC50 = 13-21 µM).  
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Figure 4.2.2 
 
 
 
 
 
 
 
- 124 - 
 
 
 
 
 
 
 
 
 
 
- 125 - 
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Figure 4.2.1(A-J); shows the inhibition of SH-SY5Y membranes and cerebellar 
microsomal the Ca
2+
-ATPase activity by nine types of BFRs and NP. The effects of 
nine types of BFR and NP on Ca
2+
-ATPase (SERCA2b) activity in SH-SY5Y 
microsomal membranes (▼) and cerebellar microsomal (■) measured at pH 7.2, 37 °C 
by phosphate liberation method The data points represent the mean ± SD of 3-5 
determinations. 
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Table 4.2.1: comparison of IC50 values of the effects of different compounds on Ca
2+
- 
dependent ATPase activity from various tissues. All experiments were performed in 
the presence of ATP 6mM and 1µM free [Ca
2+
], at pH 7.2, 37 °C. Results are the 
mean ± SD of 3-5 determinations. 
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4.2.3- Effects of HBCD, TBBPA, DBPE and NP on intracellular Ca
2+
 
transport proteins 
 
As these compounds increased intracellular [Ca
2+
] levels within cells other types of 
Ca
2+
 transporters could be involved. Therefore, the different compounds were tested 
on SH-SY5Y microsomes and SR vesicles to assess whether they affected both pumps 
and channels. Figures 4.2.3.1A shows the effects of varying concentrations of HBCD 
on the initial rate of ATP-dependent Ca
2+ 
uptake in SH-SY5Y microsomal 
membranes. Ca
2+
 uptake rate in SH-SY5Y microsome is clearly inhibited by HBCD 
at low concentrations. An IC50 value for Ca
2+
 uptake rates was 1.9 ± 0.61 µM, similar 
to that seen in Ca
2+
-ATPase
 
pump inhibition. Figure 4.2.3.1B shows that HBCD is 
also able to induce substantial Ca
2+
 release by itself when skeletal muscle SR vesicles 
are first preloaded with Ca
2+
. When SR is treated with HBCD in presence of 1mM 
tetracaine (a blocker of the release RyR Ca
2+
 release channel) (Tovey et al., 1998), 
the extent of Ca
2+ 
release is considerably reduced compared to the absence of 
tetracaine. Also if the SR was also pre-treated with 20 mM caffeine (a known as RyR 
channel activator (Tovey et al., 1998) which depletes the RyR containing Ca
2+
 stores 
of Ca
2+
), again HBCD, under these condition released little Ca
2+
. These results 
suggest that HBCD may also activate RyR Ca
2+
 channel. 
 
Figure 4.2.3.2 B-C shows effects of TBBPA, DBPE and NP on intracellular Ca
2+
 
transport proteins. Ca2+ uptake from SH-SY5Y microsomal membrane (■) and release 
from SR vesicles (▼). Also Ca
2+
 uptake rate in SH-SY5Y microsome is inhibited by 
TBBPA and NP at low concentrations, the IC50 values determined for TBBPA was 7.2 
± 0.52 µM, and for NP, 9.6 ± 1.3µM. Again, the Ca
2+
 uptake results and Ca
2+
-ATPase 
activity are also similar. All other compounds tested also released Ca
2+
 from SR 
vesicles preloaded with [Ca
2+
], suggesting that they might also activate the RyR is a 
similar fashion to HBCD, but this requires further investigation.   
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Figure 4.2.3.1 
 
 
 
 
 
Figure 4.2.3.1; effects of HBCD on intracellular Ca
2+
 transport proteins. (A) shows 
the effects of HBCD on SH-SY5Y microsomal membranes Ca
2+ 
uptake. SH-SY5Y 
membranes were suspended in 2 ml of 40 mM Tris/phosphate buffer, 100 mM KCl, 
pH 7.2 at 37 °C in the presence of 10 mM phospho-creatine, 10mg/ml of creatine 
kinase, and 1.25 mM Fluo-3. After pre-incubation with HBCD, Ca
2+
 uptake was 
initiated by the addition of 1.5 mM Mg-ATP. The data points represent the mean ± 
SD of 3-4 determinations. (B) Shows the effect of HBCD at inducing on Ca
2+
 release 
from Skeletal muscle SR in the absence (■) or presence (▼) of the RyR inhibitor 
tetracaine (1mM). Pre-treatment with 20mM caffeine followed by the addition of 
3µM HBCD is shown by (●). The extent of release is expressed as percentage of that 
released by 12.5µg/ml A23187.  
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Figure 4.2.3.2 
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Figure 4.2.3.2; shows effects of TBBPA, DBPE and NP on intracellular Ca
2+
 
transport proteins. Ca2+ uptake from SH-SY5Y microsomal membrane (■) and 
release from SR (▼) were monitoring change in fluorescence of the Ca
2+
 indicator dye 
Fluo-3. SH-SY5Y membrane was suspended in 2 ml of 40 mM Tris/phosphate buffer, 
100 mM KCl, pH 7.2 at 37°C in the presence of 10 mM phospho-creatine, 10 mg/ml 
of creatine kinase, and 1.25 mM Fluo-3. Ca
2+
 uptake was initiated by the addition of 
1.5 mM Mg-ATP. The data points represent the mean ± SD of 3-4 determinations. 
Ca
2+
 release from skeletal muscle SR by the addition of 2µM of TBBPA, and 5µM for 
both DBPE and NP, is shown by (▼). The extent of release is expressed as percentage 
of that released by 12.5µg/ml A23187.  
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4.2.4- The effects of HBCD on SR Ca
2+
-ATPase (SERCA1a) activity 
as a function of [Mg
2+
], [Ca
2+
] and [ATP] 
 
4.2.4.1-The effects of HBCD on ATPase activity as a function of [Mg
2+
] 
HBCD at concentrations, which caused approximately 50% inhibition, were pre-
incubated for 10 min with SR (~ 37.5µg) in assay buffer pH 7.2 at 25°C. Ca
2+
-
ATPase activity was then measured in the presence 10µg/ml A23187 as a function of 
Mg
2+
, in the absence (■) and presence ( ) of 3µM HBCD. As shown in figure 4.2.4.1, 
ATPase activity decreases with increasing concentrations of Mg
2+
 both in the absence 
and presence of HBCD. Mg
2+
 inhibits the luminal dissociation of Ca
2+
 from the 
phosphorylated Ca
2+
-ATPase (Duggleby et al., 1999). The IC50 of Ca
2+
-ATPase 
activity in the absence and presence of HBCD is 1.63 ± 0.08 mM and 4.30 ± 0.82 
mM, respectively, whereas the Vmax is decreased from 9.5 ± 0.3 IU/mg to 3.46 ± 0.36 
IU/mg (goodness-of-fit: chi
2
 was 0.99). The data is fitted into Eq.5 (found in chapter-
2). 
 
This suggests that HBCD decreases the apparent affinity for Mg
2+
 binding to the 
vacated Ca
2+
 binding sites of the E2 state. This could be due to the sites not being 
vacated by Ca
2+
 in this state, especially if trapped in an E2 state.  
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Figure 4.2.4.1 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.4.1 shows the effect of HBCD on ATPase activity as function of 
[Mg
2+
]. The effects of varying [Mg
2+
] on Ca
2+
-ATPase activity measured at pH 7.2 
and at 25°C, in the absence of HBCD (■) and presence ( ) of 3µM HBCD both 
occurred Ca
2+
-ATPase activity at 2.5mM Mg
2+
SO4. The data points represent the 
mean ± SD of between 3-5determinations. 
 
 
 
 
 
 
 
 
 
 
- 135 - 
 
4.2.4.2- The effects of HBCD on ATPase activity as a function of free [Ca
2+
]  
 
 
Figure 4.2.4.2 shows the effects of Ca
2+ 
on ATPase activity at pH 7.2 and 25°C, in the 
absence and presence of 3µM HBCD as a function of free Ca
2+
 concentrations. The 
Effects of [Ca
2+
] on Ca
2+
 ATPase activity shows a typical bell-shaped profile. The 
stimulatory phase of the curve, at low Ca
2+
 concentrations reflects Ca
2+
 binding to the 
E1 form (denoted by Ks), while the inhibition part at higher Ca
2+
 concentrations 
reflects, in part, Ca
2+
 binding to the E2 conformation (denoted by Ki). In the absence 
of HBCD the ATPase had a Vmax of 5.26 ± 0.41 IU/mg, with the Ks for the stimulatory 
phase of 6.1x10
-7
 ± 1.3 x10
-7
 M, and a Ki value of 1.2x10
-4
 ± 3x10
-5
 M for the 
inhibitory phase. While, in the present of HBCD (3µM), the data is fitted into Eq.3 
(found in chapter-2) and showed that Vmax was 2.79 ± 0.26 IU/mg, and stimulatory Ks 
and inhibitory Ki values 5.5x10
-7
 ± 1.5 x10
-7
 M and 1.8 x10
-4
 ± 6x10
-5
 M, respectively 
(goodness-of-fit: chi
2
 was 0.97).  
 
These results suggest that HBCD is likely to have little effect on the affinity for Ca
2+
 
binding to the E1 form and E2 form of the Ca
2+
-ATPase. Only the Vmax is affected. 
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Figure 4.2.4.2 
 
 
 
 
 
 
 
 
Figure 4.2.4.2 the effects of HBCD on SERCA activity as function of [Ca
2+
] using 
the coupled enzyme assay, at pH 7.2 and 25°C in the absence (■) or presence ( ) of 
3µM HBCD. The data points represent the mean ± SD of between 3-5 determinations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 137 - 
 
4.2.4.3- The effects of HBCD on ATPase activity as a function of [ATP] 
 
 
Figure 4.2.4.3 shows the activity of ATPase activity at varying concentrations in the 
absences and presence of 3µM HBCD. The data for the SR Ca
2+
-ATPase activity in 
the presence and absence of HBCD shows a biphasic profile and was fitted using a bi-
Michaelis-Menton Equation (Dupont et al., 1985; Coll and Murphy, 1991), 
assuming two independent ATP binding sites designated the high affinity catalytic 
site and the lower affinity regulatory site. The data was fitted to Eq.4 (found in 
chapter-2) 
 
The kinetic parameters for best fit; in the absence of HBCD was for the catalytic Km = 
6.5x10
-7
 ± 2.5x10
-7
M with a Vmax 1.42 ± 0.13 of IU/mg and a regulatory Km and Vmax 
of 0.00162 ± 0.009M and 4.52 ± 1.34 IU/mg, respectively. In presence of 3µM 
HBCD, the data could be fitted assuming, the Km for both catalytic and regulatory 
sites were 1.50x10
-6
 ± 6x10
-7
 M and 7.62 x10
-4
 ± 3.6 x10
-4
 M, respectively. The Vmax 
values, however, were 2.11 ± 0.31 IU/mg for the regulatory and catalytic Vmax value 
were 1.03 ± 0.13 IU/mg IU/mg, respectively (goodness of fit for the data; Chi
2
 was 
0.98). These results suggested that HBCD has a small decrease on affinity for ATP 
binding (i.e., increasing the catalytic Km, but decreasing regulatory Km). However, the 
main affects are the decreases in Vmax for both catalytic site and regulatory site. 
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Figure 4.2.4.3 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.4.3 the effects of HBCD on ATPase activity as a function of [ATP] using 
the coupled enzyme assay, at pH 7.2 and 25°C in the absence (■) or presence ( ) of 
3µM HBCD. The data points represent the mean ± SD of between 3-5 determinations. 
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4.2.5- The effects of HBCD and DBPE on the phosphorylation of 
ATPase by [γ -32P]-ATP 
 
In order to assess the possible effect of HBCD and DBPE on the phosphorylation step 
of Ca
2+
-ATPase by ATP, 
32
P-ATP phosphorylation experiments were performed with 
range ATP concentrations (0, 1.3, 5, 10 and 20µM) in the absence ( ) and presence of 
10 µM HBCD (▼) and 30 µM DBPE ( ), measured at pH 7.2 and 25 °C. As shown in 
figure 4.2.5, the data fitted a single-site binding curve, which gave an E-Pmax and Kd 
for the control data of 6.26 ± 1.7 nmol/mg and 0.143 ± 0.13 µM, respectively, 
whereas in the presence 10 µM HBCD, the data gave an E-Pmax and Kd values of 6.53 
± 1.4 nmol/mg and 3.19 ± 0.78 µM, respectively. For 30 µM DBPE, the data gave an 
E-Pmax and Kd values of 6.68 ± 1.21 nmol/mg and 5.19 ± 1.08 µM, respectively. 
These results suggest that both HBCD and DBPE cause a decrease in the ATP binding 
affinity to the Ca
2+
-ATPase.  
 
 
 
 
 
 
 
 
 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 140 - 
 
Figure 4.2.5 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.5; shows the ATP-dependent phosphorylation of Ca2+-ATPase over a range 
of [γ -32P]-ATP concentration (0-20 µM) in the absence ( ) and presence of 10 µM 
HBCD (▼) and 30 µM DBPE ( ). The data represent the mean ± SD of 3 
determinations. 
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4.2.6-The measurement of E2-E1 conformational change using FITC-
labelled Ca
2+
-ATPase 
 
To determine whether HBCD affects the E2E1 transition of the ATPase, the 
conformational changes of the E2E1 was determined by monitoring the Ca2+-
induced changes in fluorescence of Ca
2+
-ATPase labelled with FITC (Michelangeli et 
al., 1990). This was measured upon the addition of 100µM Ca
2+
 at pH 6, 25 °C where 
the enzyme is predominately in the E2 form (Bilmen et al., 2002). The figure 4.2.6B-
C shows the effects of HBCD on FITC-labelled Ca
2+
-ATPase when Ca
2+ 
added. The 
addition Ca
2+
 leads to decrease in fluorescence of 7% in the absence of HBCD, 
whereas in presences of 2 and 10µM HBCD, the fluorescence change was reduced to 
4.6% and 0.8%, respectively. Also the rate of change in the presence 2µM HBCD was 
considerably reduced compared to control. Theses results indicate that HBCD binds to 
Ca
2+
-ATPase and stabilizes it in the E2 state. 
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Figure 4.2.6 
 
 
(A) 
 
 
 (B) 
 
 
(C) 
 
 
 
Figure 4.2.6; shows the effects of HBCD on the fluorescence intensity of FITC-
labelled Ca
2+
-ATPase upon the addition of Ca2+ in the absence (A), or presences of 
2µM HBCD (B), or 10µM HBCD (C). Measurements were made in buffer containing 
2.3 ml of 50mM Tris, 50mM maleate, 5mM MgSO4, 100mM KCl, at pH 6 and 25 °C. 
These traces are representative of duplicate experiments.    
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4.3- Discussion 
 
Toxicological studies have shown a number of BFRs and APs are toxic at low 
micromolar concentrations for a range of cell types (Reistad et al., 2007; 2005; 
Ogunbayo et al., 2008; Hughes et al., 2000; Michelangeli et al., 2008). 
  
Based on the Ca
2+
-ATPase activity data from this study, HBCD, TBBPA and NP 
proved to be the most potent inhibitors of both SERCA1a (which is found in fast-
twitch skeletal muscle) and SERCA2b (found in both cerebellular microsomes and 
SH-SY5Y cells). This is consistent with the previously reported effect of TBBPA on 
Ca
2+
 pump activity in both skeletal muscle SR membranes and cerebellular 
microsomes (Ogunbayo et al., 2008) and that reported for NP (Michelangeli et al., 
2008). Moreover, it appears that HBCD, TBBPA and NP inhibit SERCA1a better 
than SERCA2b. For the polybrominated diphenyl ethers (DBPE, PBPE, and OBPE), 
they were reasonably effective inhibitors of SERCA Ca
2+
 pumps (IC50; between 30 to 
110 µM), but there appeared to be little correlation between number of bromines and 
potency. All the other BFR's tested were poor SERCA inhibitors. 
 
SERCA are involved in Ca
2+ 
uptake into organelles that also contain RyR Ca
2+
 
channels (Michelangeli et al., 2005). SH-SY5Y neuronal cells contain two types of 
intracellular Ca
2+ 
channels associated with SERCA Ca
2+
 pumps; IP3-sensitive Ca
2+ 
channels (IP3R, type I) (Wojcikiewicz, 1998, Mackrill et al., 1997) and Ryanodine 
receptor Ca
2+
 channels (RyR, type 2) (Mackrill et al., 1997). In this study an 
investigation to assess whether BFR's (HBCD, TBBPA & DBPE) and APs (NP) 
affected both Ca
2+ 
pumps and channels was undertaken. Data presented here show 
that HBCD, TBBPA, and NP are able to inhibit Ca
2+ 
uptake rate in SH-SY5Y 
microsomal membranes and also possibly activate the RyR in SR vesicles (which 
contains a RyR1, Treves et al., 2005) at low concentrations. The effects of TBBPA 
and NP were comparable to that which has been found for both TBBPA (Ogunbayo 
et al., 2007; 2008) and NP (Michelangeli et al., 2008). However, further studies are 
required to fully confirm that these BFRs and NP are able to activate the RyR. 
 
The catalysis and transport mechanism of SERCA involves alternation between two 
major conformational states, known as E1(which is a high affinity Ca
2+
 binding state) 
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and E2 (which is a low affinity Ca
2+
 binding state) (de Meis and Vianna, 1979; 
Danko et al., 2004). The transition between the two states (E1 and E2) is dependent 
on a number of factors, including the presence of Ca
2+
 and Mg
2+
, in addition to pH 
and temperature. 
 
From the activity versus [ATP] (data in fig. 4.2.4.3) it shows that HBCD has a small 
effect on affinity for ATP. This is further supported in fig. 4.2.5 by 
32
P-ATP 
phosphorylation studies. Additionally, HBCD is likely to have little effect on the 
affinity for Ca
2+
 binding to the E1 form and E2 form of the Ca
2+
-ATPase (fig. 
4.2.4.2). However, HBCD decreases the apparent affinity for Mg
2+
 binding and this 
could be due to the sites not being vacated by Ca
2+
 in this state, especially if trapped 
in an E2 state. 
 
The E2-E1 equilibrium was therefore studied by monitoring Ca
2+
-induced changes in 
the fluorescence intensity of FITC-labeled ATPase to assess whether HBCD affects 
the E2E1 transition of the ATPase. In fig.4.2.6 A, B&C  the data shows that the 
addition Ca
2+
 to FITC-labeled ATPase at pH 6, 25 °C, leads to decrease in 
fluorescence at 7%, whereas in presence of 2 and 10µM HBCD, the fluorescence 
change was reduced to 4.6% and 0.8%, respectively. Observations have been reported 
previously which indicate that addition of Ca
2+
 to
 
FITC-labeled ATPase at pH 6 
caused the enzyme to undergo a transition from an E2 state to an E1 state (Bilmen et 
al., 2002). These observations can be explained by the model, displayed in scheme1. 
These results suggest that HBCD binds to Ca
2+
-ATPase and stabilizes it in the E2 
form. This observation has also been reported for Bisphenol, NP and Tg in previous 
studies (Brown et al., 1994; Michelangeli, et al., 1990; Toyoshima and Nomura, 
2002). 
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Scheme 1 
 
 
 
 
 
Scheme1: proposed model of inhibition by HBCD on Ca
2+
-ATPase activity. E, Ca
2+
-
ATPase (enzyme). HBCD binds to Ca
2+
-ATPase and stabilizes it in the E2 state and 
also causes some inhibition by changing the ATP binding affinity to the Ca
2+
-ATPase. 
(steps are marked by X). 
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CHAPTER 5 
 
 
 
 
SERCA over-expression in 
SH-SY5Y cells protects 
against HBCD-induced 
cytotoxicity 
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5.1- Introduction 
 
 
Ca
2+
 is an essential signaling ion involved in range of cellular responses, prolonged or 
exaggerated elevation of intracellular [Ca
2+
] levels may lead to a number of unwanted 
effects such as inappropriate activation of cell signaling pathways or even apoptosis. 
Ca
2+
 homeostasis is, however, vital to cell viability and function (Ogunbayo and 
Michelangeli, 2007; David et al., 2000). To avoid such harmful effects, intracellular 
[Ca
2+
] levels must be stringently controlled by Ca
2+
-ATPases to maintain low 
cytosolic [Ca
2+
] levels in cells, when they are at rest.   
 
The fact that BFRs such as HBCD have been shown to induce cell death by increasing 
intracellular [Ca
2+
] levels and inhibiting Ca
2+
-ATPases, has led to an investigation of  
whether over-expressing SERCA within cultured SH-SY5Y cells provides protection 
against HBCD-induced cell death. Over-expressing SERCA would allow cells to 
overcome the cytotoxic effects of HBCD-induced by elevation of intracellular [Ca
2+
] 
levels, thereby preventing cell death by reducing exaggerated increases in cytosolic 
[Ca
2+
].  
 
In this study, HBCD was tested in SH-SY5Y cells over-expressing SERCA1-EGFP to 
determine whether cytotoxic protection of these cells can be observed. At the time of 
this study SERCA1-EGFP was used, as it was the only SERCA isoform tagged with 
fluorescent GFP protein plasmid available. SERCA1-EGFP was used in order to help 
determine its expression levels with transfected cells.  
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5.2- Results 
 
5.2.1- Over-expression of SERCA  
 
Previous data suggest that the mechanism by which these compounds and related 
chemicals cause cell death is via inhibition of Ca
2+ 
pumps (Ogunbayo et al., 2007; 
Michelangeli et al., 2008). In the experiments described in this results chapter, an 
investigation was undertaken to over-express SERCA1-EGFP in order to see whether 
this could afford some degree of protection against treatment with HBCD. HBCD was 
used since it was shown to be the most potent BFR, at both killing SH-SY5Y cells 
and inhibiting SERCA Ca
2+
- ATPase activity in these cells.   
 
5.2.1.1- Restriction digest and gel electrophoresis of maxiprep 
Figure 5.2.1.1 shows that the restriction digest of the plasmid (SERCA1-EGFP in 
pcDNA3.1 +) and confirmed that it was correct (lanes 3&4), DNA sequencing of this 
plasmid by Dr. Michelangeli's group also confirmed that it contained the SERCA1-
EGFP gene. 
 
5.2.1.2- Optimization of the transfection efficiency in cells SH-SY5Y  
 
To determine optimal conditions for transfection of SH-SY5Y cells with the 
SERCA1-EGFP plasmid, the cells were grown in a 6-well tissue culture plates (until 
40-50% confluent). Four concentrations of metafectene (transfection reagent) and 
DNA (SERCA1-EGFP plasmid were tested as shown in tables 5.2.1.1. Metafectene 
and plasmid DNA for each condition were mixed and incubated at 25 °C for 20 min 
to allow the formation of the DNA-metafectene complex. Media from the wells was 
replaced with DMEM without FBS and antibiotics and the metafectene-DNA mixture 
was added to the medium. Cells were incubated for 24h at 37 °C and 5% CO2. The 
medium was then exchanged with DMEM full media with FBS and antibiotics and 
cells were grown for an additional 24h; transfection was complete after 48 h. Finally, 
the expression of SERCA1-EGFP within the cells was analyzed with a Nikon TS100F 
microscope in epi-fluorescence mode by counting the number of fluorescent cells 
from an average of the two repeats for each transfection condition, and this was used 
to calculate percentage of transfection efficiency (% of SH-SY5Y cells transfected 
with plasmid DNA). The pictures of optimal conditions for transfection is shown in 
figure 5.2.1.2 
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Figure 5.2.1.1 
 
 
 
 
 
Figure 5.2.1.1; restriction digest and gel electrophoresis of plasmid containing the 
SERCA1-EGFP gene. A restriction digest of the plasmid DNA obtained from plasmid 
maxiprep Kit (Sigma). Three repeats were carried out corresponding to three 
overnight cultures. Samples cut with NdeI were loaded into lanes 3 (diluent 1:5) and 4 
(diluent 1:10), while, uncut plasmid DNA samples (not cut with NdeI) were loaded 
into lanes 2 (diluent 1:5), 5 (diluent 1:10), and 6 undiluent). Uncut samples produced 
two bands as expected. Since NdeI only cuts once, electrophoresis of the cut plasmid 
DNA produced one band at ~ 9 Kb, corresponding to the fact that pcDNA3.1 (+) 
containing an EGFP-tagged SERCA1 sequence is approximately 9.428 bp. This 
suggests that the plasmid DNA obtained is the correct plasmid containing SERCA1-
EGFP gene. A 10 Kb DNA marker was loaded into lane 1. This plasmid was also 
confirmed by DNA sequencing (undertaken by the Dr. Michelangeli's group). 
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Figure 5.2.1.2 
 
 
 
 
Figure 5.2.1.2; optimal conditions for transfection in SH-SY5Y human neuroblastoma 
cells. The optimum transfection condition (1:8) (0.25 µg Plasmid DNA: 2 µl 
metafectene). SH-SY5Y cells were grown in a 6-well plate until ~ 40-50 % confluent. 
Cells were visualized under visible and fluorescent light and EGFP-fluorescent cells 
were used to calculate % transfection efficiency (% of SH-SY5Y cells transfected 
with plasmid DNA) from an average of two repeats. Fluorescent microscope pictures 
were taken 48 h after transfection. Cells were viewed photographed at about 200× 
magnification, using an Astrovid StellaCam-EX camera connected to a Hauppauge 
USB TV live video capture device for viewing on a PC. 
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Table 5.2.1.1 
 
Table: 5.2.1.1 transfection-efficiency of SH-SY5Y cells using different amounts of 
metafectence and plasmid DNA 
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5.2.1.3- Western blotting of SERCA1-EGFP in SH-SY5Y cells with anti-SERCA 
antibody (Y/1F4)  
 
Figure 5.2.1.3; shows a Western blot of whole SH-SY5Y cells transfected SERCA1–
EGFP. This blot confirms the presence of SERCA1-EGFP as it gaves a band of the 
correct size 142kDa using anti-SERCA antibody (Y/1F4). It also shows that the 
antibody can detect the endogenously present SERCA2b (97kDa) also present within 
these cells. The intensity of the SERCA1-ECFP band compared to the endogenous 
bands suggests that transfected cells are expressing about 35% more SERCA Ca
2+
 
pumps than non-transfected SH-SY5Y cells. 
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Figure 5.2.1.3 
 
 
 
 
 
 
 
 
 
Figure 5.2.1.3; Western blotting of SERCA in SH-SY5Y cells (30 µg) was resolved 
on a 7.5% SDS-PAGE gel before being transferred onto nitrocellulose. The 
nitrocellulose was incubated with anti-SERCA (Y/1F4) antibody diluted at 1 in 500 
for 1.5 h at room temperature and then with a secondary anti-mouse IgG conjugated 
to alkaline phosphates, for 1 h at room temperature, according to the supplier‟s 
instructions. The blot was incubated for 5-10 min with the BCIP/NBT ((5-bromo-4-
chloro-3-indolyl phosphate/ nitro blue tetrazolume): Sigma, UK) and two positive 
bands were detected within transfected cells, compared to one band in cells not 
transfected. Blots were photographed on a Kodak digital science camera (DC120).  
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5.2.2- Measurement of cell viability of HBCD-treated cells in 
SERCA1-EGFP expressing cells   
 
Since HBCD is able to induce cell death by causing a rise in [Ca
2+
]i levels, partly by 
inhibition of SERCA activity, the over-expression of SERCA Ca
2+ 
-ATPase was 
undertaken using SERCA1-EGFP to see if this protected against cell death via Ca
2+
-
dependent cytotoxicity. After 48 h from start of transfection, the cells were treated 
with HBCD for about 22-24 h. Cell viability was then determined by MTT assays and 
flow cytometry analysis.  
 
 
5.2.2.1- MTT cell viability assays in non- transfected and transfected EGFP-
tagged SERCA1 in SH-SY5Y cells 
 
To observe whether over-expression of SERCA in cultured SH-SY5Y cells provided 
protection against HBCD-induced cell death, a MTT cell viability assay was carried 
out on the cells after transfection. Once the transfection was completed, the cells were 
treated with HBCD for 22-24 h over the same concentrations undertaken previously 
(see chapter 3). MTT assays were undertaken using the same method as before and % 
cell viability was calculated for each HBCD concentration used.  
 
Figure 5.2.2.1 shows the dose-dependent affects of HBCD on SH-SY5Y cell viability 
which were ether non transfected ( ) or transfected ( ) with EGFP-tagged SERCA1. 
Exposure to 1µM HBCD for 22-24h caused more than 25% cell death in non-
transfected compared to only 12% cell death after transfection. At 30 µM HBCD 
again there were non viable cells compared to control cells. The calculated LC50 in 
untransfected cells for HBCD was 5 ± 0.8µM, while in transfected cells more HBCD 
was required to cause 50% cell death (i.e. LC50 = 15 ± 1.4 µM).  
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Figure 5.2.2.1 
 
 
 
 
 
 
Figure 5.2.2.1; effects of HBCD on SH-SY5Y cells viability in the absence or 
presence of SERCA1-EGFP. SH-SY5Y cells were grown in 24-well tissue culture 
plates in 1ml of fresh complete medium and incubated at 37 °C in a CO2 incubator 
until they were at a confluence of 40-50%. The optimum transfection condition (1:8) 
(0.25 µg plasmid DNA: 2 µl metafectene) was used to over-express SERCA1-EGFP 
in these SH-SY5Y cells. They were mixed and incubated at room temperature for 20 
min. After 48 h for transfection to take place the cells were treated with HBCD for 
22-24 h. Cell viability was determined by MTT assay, non-transfected cells (■) and 
transfected cells (▲). The data points represent the mean ± SD of 3-5 determinations. 
(* p  0.05, ** p < 0.01, compared to their corresponding values in non-transfected 
cells).  
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5.2.2.2- Flow cytometry analysis 
 
Figure 5.2.2.2A shows that cells that have been not transfected or treated with HBCD 
are mainly viable (92%) when assessed with propidium iodide (PI) staining and flow 
cytometry analysis. In figure 5.2.2.2B, the SH-SY5Y cells have been transfected with 
SERCA1-EGFP and treated with 3µM HBCD. The flow cytometry analysis shows 4-
subpopulations of cells which is consistent with 2-subpopulations of cells which are 
not transfected and therefore show low levels of GFP fluorescence. One of these 
populations has low levels of PI fluorescence and therefore contains viable cells, 
while the other has higher levels of PI fluorescence, which indicate they are non-
viable. The percentages of cells within these 2-subpopulations were similar at 17% 
and 14%, respectively. This would indicate that in cells which were not transfected, 
3µM HBCD was causing approximately half the numbers of cells to die and 
consistent with previous findings. Of the 2-subpopulations which showed high levels 
of GFP fluorescence, about 63% of the cells were viable (i.e. low levels of PI) and 
only 6% of the cells were non-viable. This result would indicate that in SH-SY5Y 
cells over-expressing SERCA1-EGFP only about 10% of the cells are non-viable in 
the presence of 3µM HBCD. 
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Figure 5.2.2.2 
 
 (A) 
 
 
 
(B) 
 
 
 
Figure 5.2.2.2 (A-B); flow cytometry measurement of cell viability in SH-SY5Y cells 
treated with HBCD. (A) dot plot of SH-SY5Y cells (control) treated with 2% DMSO, 
while (B) the cells were treated with 3 µM HBCD for 22-24h. Cells over-expressing 
SERCA1-EGFP, from FACS analysis indicates a significant transfection rate of 66% 
for the SH-SY5Y cell populations. Values represent the mean ± the SD of between 4 
determinations. The quadrants were placed to distinguish the 4- subpopulations of 
cells i.e. untransfected (viable and non viable) and transfected (viable and non viable). 
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5.2.3- Measurements of Ca
2+
-ATPase activity in SH-SY5Y cells either transfected 
or non-transfected with SERCA1–EGFP 
 
In order to assess whether over-expressing SERCA1-EGFP actually produces 
functional SERCA protein, Ca
2+
-ATPase activity were undertaken in SERCA1-EGFP 
in transfected SH-SY5Y cell microsomes and compared to SH-SY5Y cell microsomes 
that were not transfected. In SH-SY5Y transfected cells membranes it can clearly be 
seen that the Ca
2+
-ATPase activity is substantially increased (by 32%) (fig. 5.2.3).  
 
Figure 5.2.3; also shows the effects different concentration HBCD on untransfected 
and transfected SH-SY5Y microsomal Ca
2+
-dependent ATPase activity. As can be 
seen the SERCA activity in the SERCA1-EGFP transfected cell membranes is 
consistently higher than control cell membranes upon 3µM HBCD concentrations. 
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Figure 5.2.3 
 
 
 
 
Figure 5.2.3; the effects different [HBCD] on untransfected or transfected SERCA1-
EGFP SH-SY5Y microsomal Ca
2+
-dependent ATPase activity. SH-SY5Y cell 
membranes microsomal were isolated from both SERCA1–EGFP transfected and non 
transfected cells. The Ca
2+
-dependent ATPase activities were measured using 
phosphate liberation assay at pH 7.0, 37 °C. The values represent the mean ± SD of 
between 3 or 4 determinations. (*) indicates values that are statically significant (p  
0.05) compared to non-transfected cell membranes. 
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5.3- Discussion  
 
The data presented in this study demonstrate that the commonly used BFRs, HBCD is 
able to induce death of cultured SH-SY5Y cells by presumably elevating [Ca
2+
] levels 
and especially by inhibiting SERCA Ca
2+
-ATPase activity. Over-expression of 
SERCA Ca
2+
-ATPase activity in SH-SY5Y cells provides protection to some degree 
against HBCD-induced cell death, further supporting the fact that some BFRs induce 
cell death by a Ca
2+
-dependent mechanism (Ogunbayo et al., 2008) and Ca
2+
 dys-
regulation is involved in the cytotoxicity of these compounds (Reistad et al., 2007). 
 
SERCA Ca
2+
-ATPase in SH-SY5Y cells would allow excess Ca
2+
 from the cytosol to 
move back in to the ER, thereby preventing HBCD-induced cell death by maintaining 
low cytosolic [Ca
2+
]
 
levels. This study has shown that cell death was reduced after 
SERCA transfection, when cells were exposed to low µM concentration of HBCD in 
comparison to non-transfection cells. Cell death was further reduced by 44% when 
cells were exposed to 3µM HBCD (fig.5.2.2.2B). Also the data in figure 5.2.2.1; 
demonstrates that if SH-SY5Y cells over-express SERCA, the LC50 for HBCD 
cytotoxicity dramatically changes from 5 ± 0.8µM in normal cells to 15 ± 1.4µM in 
cells over-expressing SERCA1-EGFP. Therefore over-expressing SERCA1-EGFP in 
SH-SY5Y cells does provide protection to some extent against HBCD-induced cell 
death. However, it is important to state that this protection was only apparent when 
cells were exposed to low µM concentrations of HBCD. Once a higher concentration 
of HBCD was reached, over-expressing SERCA1-EGFP in SH-SY5Y cells could no 
longer provide protection against HBCD-induced cell death, as indicated by the fact 
that little improvement in % cell viability could be seen after transfection at 10µM 
HBCD. 
 
Previous studies showed that SERCA over-expression has a different effect on 
cultured cardiac cell (Wu et al., 2004). This study suggested that over-expression of 
SERCA in neonatal cardiomyocytes induces cell death (O'Donnell et al., 2001; Wu 
et al., 2004), while SERCA over-expression in adult cardiomyocytes does not. In 
contrast, these data clearly suggest that over-expressing SERCA1 improved cell 
viability especially in cells exposed to certain cytotoxic chemicals such as HBCD. 
This study is the first experiment of this type to be performed. 
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Additional experiments are therefore required to investigate whether SERCA can also 
give protection against other BFRs and APs. In addition, other experiments should be 
undertaken to assess whether other types of Ca
2+
 pumps (i.e. different SERCA 
isoforms, PMCA or SPCA) can also give some protection against their cytotoxic 
pollutants.  
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CHAPTER 6 
  
 
 
 
 
 
 
 
 
 
 
Amyloidogenic effects of 
brominated flame 
retardants and alkylphenols 
in SH-SY5Y cells 
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6.1- Introduction 
 
There have been a number of studies to suggest that some persistent organic 
pollutants (POPS) such as brominated flame retardants (BFRs) and polychlorinated 
biphenyls (PCBs) are neurotoxic in nature. Animal studies have shown that exposure 
to environmental relevant concentrations of some of these pollutants can lead to 
impaired neurological function. Several rodent studies have shown that exposure to 
environmentally relevant concentrations of BFRs caused profound neurological 
disturbances in spontaneous behaviour and disrupted habituation in the adult animal 
(Birnbaum and Staskal, 2004). Some as yet identified pollutants are also believed to 
be a risk factor in Alzheimer disease (AD) (Dosunmu et al., 2007; Santibanez et al., 
2007). Furthermore, AD causes progressive destruction of neurons within the brain 
leading to a loss of cognitive function and dementia. The most commonly observed 
histological biomarkers of AD, used to confirm diagnosis, are the presence of -
amyloid plaques (A) and or neurofibrillary tangles (NFT) within the brain (Shankar 
et al., 2008; Jack et al., 2010). The accumulation A is the main cause of neuronal 
death (Lesne et al., 2006; Shankar et al., 2008). A peptides are produced from the 
cleavage of amyloid precursor protein (APP) by - and -secretases (Selkoe et al., 
1996). -Secretase inhibitors are currently being extensively studied as a compound to 
treat AD by reducing A peptide levels in the brain (Jack et al., 2010; Wu and 
Zhang, 2009; Panza et al., 2010) 
 
Of the BFRs studied, most attention has been placed on their effects upon 
neurological and behavioural development and little attention has been paid to the 
effects that these pollutants might cause to neurodegenerative diseases by causing 
neuronal cell death. In fact there is a correlation between the increased incidence of 
AD and industrialisation, where people are more likely to be exposed to higher levels 
of these pollutants. In this study focused on the potential neurodegenerative effects of 
some commonly used BFRs and APs by investigating their effects on APP cleavage 
and their ability to secrete -amyloid peptide from SH-SY5Y human neuronal cells.  
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6.2- Results 
 
6.2.1- Effects of BFRs and APs on the cleavage of Amyloid Precursor 
Protein (APP) and the secretion of eta-amyloid peptide (Aβ) from 
human neuronal SH-SY5Y cells 
 
There appears to substantial evidence to indicate a link between disruption of Ca
2+
 
homeostasis within neuronal cells and the initiation of AD (Kato-Negishi, 
Kawahara, 2008; Celsi et al., 2009). One of the key molecular factors in AD is the 
formation of A plaques which are neurotoxic. A plaques are formed from the 
aggregation of soluble A peptides which have been cleaved from the plasma 
membrane bound APP by the action of a number a secretase enzymes. 
 
6.2.1.1- Immunoblotting of APP fragments 
 
Initial studies were to investigate the potency of BFRs and APs to cause APP 
cleavage in neuronal SH-SY5Y cells. Figure 6.2.1.1 A-B; shows a number of Western 
blots of whole SH-SY5Y cells that had been pretreated with a number of BFRs and 
nonylphenol for 12 h. The blots were probed with an anti-APP antibody and in control 
cells the antibody cross reacted with proteins that were around 110kDa and 160kDa in 
size, which corresponded to intact APP (Dovey et al., 2001; Shipley et al., 2005). 
Figure 6.2.1.1 A-B; also shows that upon treatment with HBCD, TBBPA, DBPE and 
NP, additional smaller protein bands were labelled by the antibody at molecular 
weights between about 12 to 24kDa. These bands probably correspond to partially 
cleaved APP and were not detected in control cell extracts. In figure 6.2.1.1B it can be 
seen that if the cells are co-treated with DAPT (30μM), which is a -secretase 
inhibitor, in addition to 3μM HBCD the 12-20kDa and the 24kDa bands becomes 
more intense. This would suggest a build up of the partially processed APP protein 
prior to the formation of soluble -amyloid peptide by the action of -secretase 
inhibitor. This observation has also been shown in previous studies (Dovey et al., 
2001).  
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Figure 6.2.1.1 
 
 (A) 
 
 
 
 
 (B)  
 
 
 
Figure 6.2.1.1; the effects of different types of BFRs and NP on APP processing in 
SH-SY5Y cells. (A) SH-SY5Y cells were either untreated (control), a also treated 
with 2% DMSO, or cells treated 10µM of HBCD, TBBPA, NP and DBPE dissolved 
in DMSO, then incubated for 12 h. Cell lysates were separated by SDS-PAGE on 8% 
polyacrylamide Tris/glycine gel, transferred into nitrocellulose membranes and 
immunostained using a β-Amyloid antibody (20.1: sc-53822, Santa Cruz). (B) shows 
the effects of 3µM HBCD in presence or absence of 30µM DAPT (γ-secretase 
inhibitor) on APP cleavage in SH-SY5Y cells. Blots are representative of 3 replicates. 
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6.2.1.2- Measurements of Aβ peptide level by ELISA assay 
 
In order to confirm that APP was cleaved to the A peptide and transported out of the 
cell, the extracellular fluid was analysed and quantified by sandwich ELISA using a 
-amyloid-42 antibody (as of the several A peptides that are known to be formed, 
A-42 is believed to be the most fibrillogenic and is thus more closely associated with 
AD). 
 
Figure 6.2.1.2 A; shows the calibration curve with Aβ x-42 standard peptide which 
was used to determine the concentration of Aβ x-42 of unknown samples. Figure 
6.2.1.2B; shows that HBCD causes an increase in the extracellular presence of A-42 
in both a time dependent and dose-dependent fashion. Significant levels of A-42 
peptide were detected, compared to control, in cells exposed for 12h with 3μM HBCD 
and also increased in a time-dependent fashion. Figure 6.2.1.2C; shows the effects of 
TBBPA, NP and DBPE on secreted Aβ 1-42 levels from SH-SY5Y cells for 12 h. 
Secreted A-42 levels from SH-SY5Y cells increased above those of control with 3 
and 10μM of TBBPA and NP, while only 10μM of DBPE and BPA increased the A-
42 levels of above those of control (fig. 6.2.1.2C). 
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Figure 6.2.1.2 
 
 
(A) 
 
 
 
 
 
(B) 
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 (C) 
 
 
 
 
Figure 6.2.1.2; measurements of Aβ peptide level by ELISA. (A) the calibration curve 
with Aβ x-42 standard. (B) shows the effects of different HBCD concentration on 
secreted Aβ 1-42 levels from SH-SY5Y cells and also its time-dependent effects. (C) 
shows the effects of different concentrations of NP, TBBPA, PBPE and BPA on the 
secreted Aβ 1-42 levels from SH-SY5Y cells, when exposed for 12h. (* data points 
where the value were statistically significant from control; (a value * P  0.05, ** P 
  0.001)). Each bar represents the mean ± SD of 3 experiments. 
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6.3- Discussion 
 
Over recent years much focus has been given to the potentially neurotoxic effects of 
BFRs with particular attention being paid to impaired neurological function. Several 
rodent studies have shown that gestational or neonatal expose to environmental 
relevant concentrations of BFRs caused effects on spontaneous behaviour and 
disrupted habituation in the adult animal and also had profound effects on learning 
and memory. Interestingly, memory loss and diminished learning skills were also 
reported in humans that had been occupationally exposed to high levels of dioxins 
(which are chemically related to PBDEs). AD is a neurological disorder characterized 
by an accumulation of Aβ1-42 plaques in the brain (Glenner and Wong, 1984; 
Roher et al., 1993; Iwatsubo et al., 1994; Jin et al., 2004). Aβ is a protein fragment 
snipped via the amyloidogenic processing pathway by the β-secretase which generates 
a soluble N-terminal fragment (β-APPs), and a ~12 kDa C-terminal fragment of APP 
(CTF or C99). This remaining C99 fragment is then further cleaved to release the free 
40 to 42 amino acid Aβ peptide by -secretase (Citron et al., 1996).  
 
The data in fig 6.2.1.1A; shows that levels of full length APP decline in human 
neuronal SH-SY5Y cells after treated with HBCD, TBBPA and NP. The amount of a 
C-terminal 12-24 kDa APP fragment which contains the Aβ sequence appears to 
increase in treated cells. This suggests that these compounds induced cleavage of APP 
and might lead to increased generation of Aβ. The data presented here shows that 
release Aβ 1-42 into culture medium was increased by exposure of SH-SY5Y cells to 
HBCD, TBBPA, NP, DBPE and BPA (see fig. 6.2.1.2A&B). 
 
The process of directly reducing Aβ production is by the inhibition of the specific 
secretases. DAPT (-secretase inhibitor) was used to reduce Aβ levels in vivo and is 
being used as a potential treatment for AD (Micchelli et al., 2003). Furthermore, our 
data also shows that SH-SY5Y cells exposed to 3µM HBCD in the presence of DAPT 
(30 µM) leads to increased levels of 12 to 24 kDa bands (Aβ is cleaved from ~12 kDa 
C-terminal fragment of APP), therefore reducing its ability to form Aβ 1-24 
(fig.6.2.1.1B). These results suggest that all compounds tested at low concentrations 
are amyloidgenic and could be implicated in the development of AD. 
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There is substantial evidence to indicate that molecular lesions associated with AD are 
caused by disruption of Ca
2+
 signalling and mitochondrial function (Ferreiro et al., 
2008). Some of this evidence has been generated using cells expressing presenilins 
(which have been shown to be mutated in certain forms of genetically induced 
familial forms of AD). Presenilins (PSs) form part of the -secreatase complex. 
Mutant presenillins have been shown to affect store-operated Ca
2+
 entry into cells, 
increase the activity and or expression of intracellular Ca
2+
 channels such as the 
Ryanodine receptor (RyR) and Inositol 1,4,5-trisphosphate receptor (IP3 R) (Chan et 
al., 2000; Landman et al., 2006), and modulate the function of SERCA Ca
2+
 pumps 
(Green et al., 2000; Small et al., 2010). Furthermore, it is believed that A peptides 
form oligiomers within the plasma membrane of neurons and this then causes 
excessive Ca
2+
 influx into the cells. In fact one popular current idea in regards to 
neuronal cell death in AD is that of the „ER Ca2+ overload hypothesis‟, whereby ER 
and possibly other Ca
2+
 stores become overfilled with Ca
2+
 leading to exaggerated 
increases in cytosolic [Ca
2+
] levels. Although the effects of excess cytosolic Ca
2+
 can 
initially be subtle and have negligible pathological effects, with increasing age (or 
indeed toxicological assault), the Ca
2+
 homeostatic machinery it is known to become 
less effective in combating such changes leading to Ca
2+
- and mitochondrial- induced 
neuronal cell death (Hensley et al., 1994; Celsi et al., 2009). Moreover, Aβ has 
previously been shown to induce cytochrome c release from mitochondria and the 
formation of ROS (Lee et al., 2005) and also shown to activate of caspase-3 (Kim et 
al., 2002). However, there is an urgent need to determine the extent to which common 
environmental pollutants are a risk factor for the development of AD and to 
characterise their mechanism of action.  
 
A further study could assess whether cells expressing mutant PS, are more susceptible 
to cellular stress / cell death. The ratio of A1-42/ A1-40 production could be 
measured, which may prove to be a more informative indicator of the potency of these 
pollutants to cause neuronal cells to initiate A plaque formation. It could also be 
determined whether these pollutants also affect Tau hyper-phosphorylation, as Tau 
proteins also play a central role in the pathogenesis of various neurodegenerative 
tauopathies, including AD. 
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7.1- Overall Discussion 
  
 
Some persistent organic pollutants (POPS) such as brominated flame retardants 
(BFRs) and alkylphenols (APs) are chemicals commonly found within the 
environment and have human health concerns. In-vitro studies have shown that a 
variety of the BFRs and APs are toxic at low micromolar concentrations for a range of 
cell types (Reistad et al., 2007; 2005; Ogunbayo et al., 2008; Hughes et al., 2000; 
Michelangeli et al., 2008). 
 
The data in this study show that HBCD was the most potent at inducing cell death in 
the SH-SY5Y human neuronal cells (see table 3.2.1 in chapter-3). The LC50 for 
HBCD were determined to be 2.7 ± 0.7μM, and was similar in potency to that 
observed by Reistad et al., (2006) (the LC50 value was estimated 3μM in cerebellar 
granule cells).  
 
Furthermore, these results show that HBCD, TBBPA, NP can depolarize 
mitochondria (see fig.3.2.5.1A and fig.3.2.5.2 in chapter-3) and are able to generate 
measurable levels of ROS in SH-SYSY cells at low micromolar concentration, (an 
observation also seen in another study in these neuronal cells (He et al., 2008) and in 
Hep G2 cells (Zhang et al., 2008)). This would indicate that further experiments 
investigating the effects of these compounds on DNA damage should be undertaken. 
 
HBCD, TBBPA and DBPE are shown to induce the activation of both caspase-8 and  
-9, resulting in the activation of caspase-3 (see fig.3.2.2A, B&C); while NP appeared 
to specifically activate caspase-9. The apoptotic pathway through mitochondria was 
further confirmed by cytochrome c release (see fig.3.2.3.4).  
 
Some BFRs have been shown to disrupt Ca
2+
 homeostasis by increasing [Ca
2+
]i in SH-
SY5Y cells which can the then activate the death receptor which induces caspase-8. 
This results in activation of the pro-apoptotic Bid which enters the mitochondria and 
blocks the functioning of Bcl-2 resulting in the release of cytochrome c. This 
stimulates caspase-9 which then activates caspase-3 and leads to cell death (He et al., 
2009). These results, at least for HBCD, indicate it unlikely that caspase -9 is 
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activated via caspase-8 as shown in studies (Sprick and Walczak, 2004; He et al., 
2009), as the results with caspase inhibitors and the time-course of induction of 
caspase -8 and -9 activities, would likely preclude this. The most likely mechanism is 
that BFRs activate both intrinsic and extrinsic pathways of apoptosis independently. 
 
Based on the Ca
2+
-ATPase activity data from this study, HBCD, TBBPA and NP 
proved to be the most potent inhibitors of both SERCA1a (which is found in fast-
twitch skeletal muscle) and SERCA2b (found in both cerebellular microsomes and 
SH-SY5Y cells). This is consistent with the previously reported effect of TBBPA on 
Ca
2+
 pump activity in both skeletal muscle SR membranes and cerebellular 
microsomes (Ogunbayo et al., 2008) and that reported for NP (Michelangeli et al., 
2008). Moreover, it appears that HBCD, TBBPA and NP inhibit SERCA1a better 
than SERCA2b. For the polybrominated diphenyl ethers (DBPE, PBPE, and OBPE), 
they were reasonably effective inhibitors of SERCA Ca
2+
 pumps (IC50; between 30 to 
110 µM), but there appeared to be little correlation between number of bromines and 
potency. All the other BFR's tested were poor SERCA inhibitors. 
 
SERCA are involved in Ca
2+ 
uptake into organelles that also contain RyR Ca
2+
 
channels (Michelangeli et al., 2005). SH-SY5Y neuronal cells contain two types of 
intracellular Ca
2+ 
channels associated with SERCA Ca
2+
 pumps; IP3-sensitive Ca
2+ 
channels (IP3R, type I) (Wojcikiewicz, 1995, Mackrill et al., 1997) and Ryanodine 
receptor Ca
2+
 channels (RyR, type 2) (Mackrill et al., 1997). Data presented here 
shows that HBCD is able to inhibit Ca
2+ 
uptake rate in SH-SY5Y microsomal 
membranes and also possibly activate the RyR in SR vesicles (which contains a 
RyR1, Treves et al., 2005) at low concentrations. The effects of TBBPA and NP were 
comparable to that which has been found for both TBBPA (Ogunbayo et al., 2007; 
2008) and NP (Michelangeli et al., 2008). However, further studies are required to 
fully confirm that these BFRs and NP are able to activate the RyR. 
 
The catalysis and transport mechanism of SERCA involves alternation between two 
major conformational states, known as E1(which is a high affinity Ca
2+
 binding state) 
and E2 (which is a low affinity Ca
2+
 binding state) (de Meis and Vianna, 1979; 
Danko et al., 2004). The transition between the two states (E1 and E2) is dependent 
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on a number of factors, including the presence of Ca
2+
 and Mg
2+
, in addition to pH 
and temperature. 
 
From the activity versus [ATP] (data in fig. 4.2.4.3); it shows that HBCD has a small 
effect on affinity for ATP. This is further supported in fig. 4.2.5 by 
32
P-ATP 
phosphorylation studies. Additionally, HBCD is likely to have little effect on the 
affinity for Ca
2+
 binding to the E1 form and E2 form of the Ca
2+
-ATPase (fig. 
4.2.4.2). However, HBCD decreases the apparent affinity for Mg
2+
 binding and this 
could be due to the sites not being vacated by Ca
2+
 in this state, especially if trapped 
in an E2 state. The E2-E1 equilibrium was therefore studied by monitoring Ca
2+
-
induced changes in the fluorescence intensity of FITC-labelled ATPase to assess 
whether HBCD affects the E2E1 transition of the ATPase. In fig.4.2.6 A, B&C the 
results suggest that HBCD binds to Ca
2+
-ATPase and stabilizes it in the E2 form (see 
scheme-1 in chapter-4). This observation has also been reported for bisphenol, NP and 
Tg in previous studies (Brown et al., 1994; Michelangeli, et al., 1990; Toyoshima 
and Nomura, 2002). 
 
However, virtual modelling experiments suggest that HBCD can fit into the same 
pocket in the E2 form of SERCA as cyclopiazonic acid (CPA) (Moncoq et al., 2007) 
(see fig. 7.1). This is also suggesting that TBBPA and BHQ could bind to this in the 
SERCA (Ogunbayo et al., 2007). It would be interesting to undertake such as 
modelling experiments with a range of BFRs and APs used in my work to determine 
whether all these molecules bind to the same site on SERCA. 
 
The results of this research show that HBCD is able to induce death of cultured SH-
SY5Y cells by presumably elevating [Ca
2+
] levels and especially by inhibiting 
SERCA Ca
2+
-ATPase activity. The results also shown that over-expression of 
SERCA Ca
2+
-ATPase activity in SH-SY5Y cells provides protection to some degree 
against HBCD-induced cell death, further supporting the fact that some BFRs induce 
cell death by a Ca
2+
-dependent mechanism (Ogunbayo et al., 2008) and that Ca
2+
 
unregulation is involved in the cytotoxicity of this compound (Reistad et al., 2007). 
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Figure 7.1 
 
 
 
 
Figure 7.1: predicted binding sites for HBCD on E2 SERCA. 
The three cytoplasmic domains of SERCA are colour coded accordingly: N (green), P 
(yellow), and A (blue). The SERCA structure was from the program Swiss Pdb-
Viewer 3.7(file 2EAV). HBCD is shown as pink elliptic.  
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The results in this study showed that HBCD-induced cell death was reduced after 
SERCA over-expression, where cell death was reduced by 44% when cells were 
exposed to 3µM HBCD (fig.5.2.2.2B). Previous studies showed that SERCA over-
expression has a different effect on cultured cardiac cell (Wu et al., 2004). This study 
suggested that over-expression of SERCA in neonatal cardiomyocytes induces cell 
death (O'Donnell et al., 2001; Wu et al., 2004). These data clearly suggest that over-
expressing SERCA1 improved cell viability especially in cells exposed to certain 
cytotoxic chemicals such as HBCD. This study is the first experiment of this type to 
be performed. 
 
Additional experiments are therefore required to investigate whether SERCA can also 
give protection against other BFRs and APs. In addition, other experiments should be 
undertaken to assess whether other types of Ca
2+
 pumps (i.e. different SERCA 
isoforms, PMCA or SPCA) can also give some protection against their cytotoxic 
pollutants.  
 
Over recent years much focus has been given to the potentially neurotoxic effects of 
BFRs with particular attention being paid to impaired neurological function. Several 
rodent studies have shown that gestational or neonatal expose to environmental 
relevant concentrations of BFRs caused effects on spontaneous behaviour and 
disrupted habituation in the adult animal and also had profound effects on learning 
and memory. Interestingly, memory loss and diminished learning skills were also 
reported in humans that had been occupationally exposed to high levels of dioxins 
(which are chemically related to PBDEs). AD is a neurological disorder characterized 
by an accumulation of Aβ1-42 plaques in the brain (Glenner and Wong, 1984; 
Roher et al., 1993; Iwatsubo et al., 1994; Jin et al., 2004). Aβ is a protein fragment 
snipped via the amyloidogenic processing pathway by the β-secretase which generates 
a soluble N-terminal fragment (β-APPs), and a ~12 kDa C-terminal fragment of APP 
(CTF or C99). This remaining C99 fragment is then further cleaved to release the free 
40 to 42 amino acid Aβ peptide by -secretase (Citron et al., 1996).  
 
The data in fig 6.2.1.1A; shows that levels of full length APP decline in human 
neuronal SH-SY5Y cells after treated with HBCD, TBBPA and NP. The amount of a 
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C-terminal 12-24 kDa APP fragment which contains the Aβ sequence appears to 
increase in treated cells. This suggests that these compounds induced cleavage of APP 
and might lead to increased generation of Aβ. The data presented here shows that 
release Aβ 1-42 into culture medium was increased by exposure of SH-SY5Y cells to 
HBCD, TBBPA, NP, DBPE and BPA (see fig. 6.2.1.2A&B). 
 
The process of directly reducing Aβ production is by the inhibition of the specific 
secretases. DAPT (-secretase inhibitor) was used to reduce Aβ levels in vivo and is 
being used as a potential treatment for AD (Micchelli et al., 2003). Furthermore, our 
data also shows that SH-SY5Y cells exposed to 3µM HBCD in the presence of DAPT 
(30 µM) leads to increased levels of 12 to 24 kDa bands (Aβ is cleaved from ~12 kDa 
C-terminal fragment of APP), therefore reducing its ability to form Aβ 1-24 
(fig.6.2.1.1B). These results suggest that all compounds tested at low concentrations 
are amyloidgenic and could be implicated in the development of AD. 
 
A further study could assess whether cells expressing mutant PS, are more susceptible 
to cellular stress / cell death. The ratio of A1-42/ A1-40 production could be 
measured, which may prove to be a more informative indicator of the potency of these 
pollutants to cause neuronal cells to initiate A plaque formation. It could also be 
determined whether these pollutants also affect Tau hyper-phosphorylation, as Tau 
proteins also play a central role in the pathogenesis of various neurodegenerative 
tauopathies, including AD. 
 
In summary, this study has been shown these pollutants (BFRs & APs) induce Ca
2+ 
release from ER to by SERCA inhibition and RyR Ca
2+
 channel stimulation. Previous 
study by Dr. Michelangeli‟s group has shown that BFRs (TBBPA) inhibited the 
SERCA pump in addition to activating the RyR (Ogunbayo et al., 2008). Increases in 
intracellular [Ca
2+
] induce cleavage of APP which might the lead to increased 
generation of Aβ by activation of β & γ-secretases. Furthermore, increase intracellular 
[Ca
2+
] cause mitochondrial dysfunction. 
 
Aggregate Aβ outside the cell leads to the formation of amyloid plaques and this 
cause‟s oxidative stress by excessive Ca2+ entry through the plasma membrane which 
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then leads excessive Ca
2+ 
influx in mitochondria. Ca
2+ 
overload in the mitochondrial 
matrix can collapse mitochondrial membrane potential (Δψmit) and increase 
intracellular accumulation of ROS. Loss of Δψmit can also result from the opening of 
the mitochondrial permeability transition pore (PTP), resulting in the release of 
apoptogenic factors, including cytochrome c. Once in the cytosol, cytochrome c binds 
to the apoptosis-inducing factor (AIF) and activates caspase-9, which activates 
caspase-3 and leads to cell death (see fig. 7.2). 
 
In conclusion, I feel that there is sufficient evidence from my research to indicate that 
both BFRs and APs could be potentially neurotoxic to humans and could also be 
implicated in neurodegenerative diseases. More research is, however, clearly required 
to be definitive. 
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Figure 7.2 
 
 
 
 
Figure 7.2: schematic showing summary of the study 
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